CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: chalcones
Accession: CHEBI:23086
browse the term
Definition: A ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
Synonyms: related_synonym: chalconoid; chalconoids
xref: KEGG:C15589
xref_mesh: MESH:D047188
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions increases expression
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased expression of BAX protein] Chalcones analog results in increased expression of BAX mRNA; Chalcones analog results in increased expression of BAX protein
CTD
PMID:30576621 PMID:32856275
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO
Chalcones analog results in decreased expression of BCL2 mRNA; Chalcones analog results in decreased expression of BCL2 protein; Chalcones results in decreased expression of BCL2 protein BCL2 protein inhibits the reaction [Chalcones analog results in decreased expression of BID protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP8 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP9 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP4 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP6 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP7 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of PARP1 protein]; BCL2 protein inhibits the reaction [Chalcones analog results in increased expression of BAX protein]
CTD
PMID:23562496 PMID:30576621 PMID:32856275
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bid
BH3 interacting domain death agonist
multiple interactions decreases expression
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in decreased expression of BID protein]
CTD
PMID:30576621
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
Birc2
baculoviral IAP repeat-containing 2
affects binding
ISO
Chalcones analog binds to BIRC2 protein
CTD
PMID:32856275
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Casp3
caspase 3
multiple interactions increases expression
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP3 protein]; Chalcones analog results in increased cleavage of and results in increased activity of CASP3 protein Chalcones analog results in increased expression of CASP3 mRNA
CTD
PMID:30576621 PMID:32856275
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp4
caspase 4
increases cleavage multiple interactions
ISO
Chalcones analog results in increased cleavage of CASP4 protein BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP4 protein]
CTD
PMID:30576621
NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
G
Casp6
caspase 6
multiple interactions increases cleavage
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP6 protein]
CTD
PMID:30576621
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
increases cleavage multiple interactions
ISO
Chalcones analog results in increased cleavage of CASP7 protein BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP7 protein]
CTD
PMID:30576621
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions increases expression
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP8 protein]; Chalcones analog results in increased cleavage of and results in increased activity of CASP8 protein Chalcones analog results in increased expression of CASP8 mRNA
CTD
PMID:30576621 PMID:32856275
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases expression
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of and results in increased activity of CASP9 protein]; Chalcones analog results in increased cleavage of and results in increased activity of CASP9 protein Chalcones analog results in increased expression of CASP9 mRNA
CTD
PMID:30576621 PMID:32856275
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
increases activity
EXP
Chalcones analog results in increased activity of CAT protein
CTD
PMID:23963778
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Chalcones analog results in decreased expression of CDK4 mRNA
CTD
PMID:32856275
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Gsr
glutathione-disulfide reductase
increases activity
EXP
Chalcones analog results in increased activity of GSR protein
CTD
PMID:23963778
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Il6
interleukin 6
multiple interactions
EXP
Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 mRNA]; Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL6 protein]
CTD
PMID:22410118
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Keap1
Kelch-like ECH-associated protein 1
decreases expression
EXP
Chalcones analog results in decreased expression of KEAP1 protein
CTD
PMID:23963778
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
G
Mmp1
matrix metallopeptidase 1
decreases expression
ISO
Chalcones analog results in decreased expression of MMP1 mRNA
CTD
PMID:32856275
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp9
matrix metallopeptidase 9
decreases expression multiple interactions
ISO
Chalcones results in decreased expression of MMP9 mRNA Chalcones results in decreased expression of and results in decreased activity of MMP9 protein
CTD
PMID:23562496
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpo
myeloperoxidase
multiple interactions
EXP
Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]
CTD
PMID:22410118
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
decreases expression
ISO
Chalcones analog results in decreased expression of COX1 protein
CTD
PMID:32856275
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
EXP
Chalcones analog results in increased expression of NFE2L2 protein
CTD
PMID:23963778
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
Chalcones analog results in increased expression of NQO1 protein
CTD
PMID:23963778
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of PARP1 protein]
CTD
PMID:30576621
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pecam1
platelet and endothelial cell adhesion molecule 1
multiple interactions
EXP
Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PECAM1 protein]
CTD
PMID:22410118
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid affects the localization of RELA protein]
CTD
PMID:22410118
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
Chalcones inhibits the reaction [Lipopolysaccharides results in increased expression of TNF] Chalcones inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein]
CTD
PMID:18720166 PMID:22410118
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression
ISO
Chalcones analog results in increased expression of TP53 mRNA
CTD
PMID:32856275
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
EXP
Chalcones analog results in increased expression of UGT1A1 protein
CTD
PMID:23963778
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
Chalcones analog results in decreased expression of VEGFA protein
CTD
PMID:32856275
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of GCLC mRNA]
CTD
PMID:31029725
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA] 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 mRNA; 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein
CTD
PMID:31029725
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il1b
interleukin 1 beta
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL1B protein]
CTD
PMID:31029725
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions increases expression
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]
CTD
PMID:31029725
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]
CTD
PMID:31029725
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]
CTD
PMID:31029725
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased phosphorylation of MAPK8 protein 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK8 protein]
CTD
PMID:31029725
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of IL6 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone affects the localization of NFE2L2 protein]
CTD
PMID:31029725
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the expression of and affects the stability of NFKBIA protein]
CTD
PMID:31029725
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NOS2 mRNA]
CTD
PMID:31029725
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA Acetylcysteine inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]; SB 203580 inhibits the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of NQO1 mRNA]
CTD
PMID:31029725
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Tnf
tumor necrosis factor
multiple interactions
ISO
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein]; NFE2L2 protein affects the reaction [2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone results in increased expression of TNF mRNA]
CTD
PMID:31029725
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of naringenin chalcone
CTD
PMID:14557274
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of naringenin chalcone
CTD
PMID:14557274
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Abcg2
ATP binding cassette subfamily G member 2
increases response to substance multiple interactions
ISO
ABCG2 protein results in increased susceptibility to 2',5'-dihydroxychalcone 2',5'-dihydroxychalcone promotes the reaction [ABCG2 protein results in increased export of Glutathione]
CTD
PMID:20332504
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of 2',5'-dihydroxychalcone
CTD
PMID:14557274
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of 2',5'-dihydroxychalcone
CTD
PMID:14557274
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity multiple interactions
ISO
2'-hydroxychalcone results in decreased activity of CYP1A1 protein 2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]
CTD
PMID:15596260
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity multiple interactions
ISO
2'-hydroxychalcone results in decreased activity of CYP1B1 protein 2'-hydroxychalcone inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]
CTD
PMID:15596260
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Hmox1
heme oxygenase 1
increases expression
ISO
2'-hydroxychalcone results in increased expression of HMOX1 protein
CTD
PMID:23942037
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
2',4'-dihydroxychalcone results in decreased expression of BIRC5 mRNA
CTD
PMID:20471467
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
increases activity
ISO
2',4'-dihydroxychalcone results in increased activity of CASP3 protein
CTD
PMID:20471467
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of 2',4'-dihydroxychalcone
CTD
PMID:14557274
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of 2',4'-dihydroxychalcone
CTD
PMID:14557274
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Afp
alpha-fetoprotein
affects binding
EXP
4'-hydroxychalcone binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Shbg
sex hormone binding globulin
affects binding
ISO
4'-hydroxychalcone binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions increases expression
ISO
[4'-methoxychalcone analog co-treated with TNF protein] results in increased expression of ADIPOQ mRNA 4'-methoxychalcone analog results in increased expression of ADIPOQ mRNA
CTD
PMID:28528971
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]
CTD
PMID:28528971
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Fabp4
fatty acid binding protein 4
multiple interactions increases expression
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of FABP4 mRNA] 4'-methoxychalcone analog results in increased expression of FABP4 mRNA
CTD
PMID:28528971
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fasn
fatty acid synthase
increases expression multiple interactions
ISO
4'-methoxychalcone analog results in increased expression of FASN mRNA 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of FASN mRNA]
CTD
PMID:28528971
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Il6
interleukin 6
multiple interactions
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]
CTD
PMID:28528971
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases expression
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]; 4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein 4'-methoxychalcone analog results in increased expression of PPARG mRNA
CTD
PMID:28528971
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Serpine1
serpin family E member 1
multiple interactions
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of SERPINE1 mRNA]
CTD
PMID:28528971
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Slc2a4
solute carrier family 2 member 4
increases expression
ISO
4'-methoxychalcone analog results in increased expression of SLC2A4 mRNA
CTD
PMID:28528971
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Tnf
tumor necrosis factor
multiple interactions
ISO
4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of FABP4 mRNA]; 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of FASN mRNA]; 4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]; 4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]; 4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; 4'-methoxychalcone analog inhibits the reaction [TNF protein results in increased expression of SERPINE1 mRNA]; [4'-methoxychalcone analog co-treated with TNF protein] results in increased expression of ADIPOQ mRNA
CTD
PMID:28528971
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Afp
alpha-fetoprotein
affects binding
EXP
4-hydroxychalcone binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ar
androgen receptor
affects binding
EXP
4-hydroxychalcone binds to AR protein
CTD
PMID:14565775
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity affects chemical synthesis
ISO EXP
4-hydroxychalcone results in decreased activity of CYP1A1 protein CYP1A1 protein affects the chemical synthesis of 4-hydroxychalcone
CTD
PMID:15596260 PMID:15863696
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects chemical synthesis
EXP
CYP1A2 protein affects the chemical synthesis of 4-hydroxychalcone
CTD
PMID:15863696
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
4-hydroxychalcone results in decreased activity of CYP1B1 protein
CTD
PMID:15596260
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
affects chemical synthesis
EXP
CYP2C6V1 protein affects the chemical synthesis of 4-hydroxychalcone
CTD
PMID:15863696
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Shbg
sex hormone binding globulin
affects binding
ISO
4-hydroxychalcone binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Sod2
superoxide dismutase 2
increases expression
ISO
bavachalcone results in increased expression of SOD2 mRNA; bavachalcone results in increased expression of SOD2 protein
CTD
PMID:25766656
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
butein results in decreased phosphorylation of AKT1 protein Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of AKT1 protein]
CTD
PMID:20696233 PMID:35130734
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
butein results in increased expression of BAX protein
CTD
PMID:11055382
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
butein results in decreased expression of BCL2 protein
CTD
PMID:11055382
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
butein results in decreased expression of BCL2L1 protein
CTD
PMID:11055382
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Casp3
caspase 3
increases activity multiple interactions
ISO
butein results in increased activity of CASP3 protein Acetylcysteine inhibits the reaction [butein results in increased activity of CASP3 protein]
CTD
PMID:24931875 PMID:35130734
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
butein results in increased activity of CASP8 protein
CTD
PMID:35130734
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity
ISO
butein results in increased activity of CASP9 protein
CTD
PMID:35130734
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cdh1
cadherin 1
multiple interactions
ISO
butein affects the reaction [IL6 protein affects the expression of CDH1 protein]
CTD
PMID:35130734
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Dio2
iodothyronine deiodinase 2
decreases activity
ISO
butein results in decreased activity of DIO2 protein
CTD
PMID:17327447
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Gpx4
glutathione peroxidase 4
decreases expression
ISO
butein results in decreased expression of GPX4 protein
CTD
PMID:35130734
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[butein results in increased expression of HMOX1 protein] inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]; [butein results in increased expression of HMOX1 protein] which results in decreased susceptibility to Hydrogen Peroxide; [tin protoporphyrin IX results in decreased expression of and results in decreased activity of HMOX1 protein] inhibits the reaction [butein inhibits the reaction [Hydrogen Peroxide results in increased abundance of Reactive Oxygen Species]]; butein results in increased expression of and results in increased activity of HMOX1 protein; pyrazolanthrone inhibits the reaction [butein results in increased expression of HMOX1 protein]
CTD
PMID:23318726
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Il6
interleukin 6
multiple interactions
ISO
butein affects the reaction [IL6 protein affects the expression of CDH1 protein]; butein affects the reaction [IL6 protein affects the expression of MMP2 protein]; butein affects the reaction [IL6 protein affects the expression of MMP9 protein]; butein affects the reaction [IL6 protein affects the phosphorylation of STAT3 protein]
CTD
PMID:35130734
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases lipidation
ISO
Acetylcysteine inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein]; MK 2206 promotes the reaction [butein results in increased lipidation of MAP1LC3B protein]; pyrazolanthrone inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein]
CTD
PMID:35130734
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation multiple interactions
ISO
butein results in increased phosphorylation of MAPK8 protein Acetylcysteine inhibits the reaction [butein results in increased phosphorylation of MAPK8 protein]
CTD
PMID:35130734
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mmp2
matrix metallopeptidase 2
multiple interactions
ISO
butein affects the reaction [IL6 protein affects the expression of MMP2 protein]
CTD
PMID:35130734
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [butein results in decreased expression of MMP9 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [butein results in decreased expression of MMP9 protein]; Bortezomib promotes the reaction [butein results in decreased expression of MMP9 protein]; butein affects the reaction [IL6 protein affects the expression of MMP9 protein]; butein inhibits the reaction [TNF protein results in increased expression of MMP9 protein]; prolinedithiocarbamate promotes the reaction [butein results in decreased expression of MMP9 protein] butein results in decreased expression of MMP9 mRNA; butein results in decreased expression of MMP9 protein
CTD
PMID:20696233 PMID:35130734
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mtor
mechanistic target of rapamycin kinase
decreases phosphorylation multiple interactions
ISO
butein results in decreased phosphorylation of MTOR protein Acetylcysteine inhibits the reaction [butein results in decreased phosphorylation of MTOR protein]
CTD
PMID:35130734
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization
ISO
butein affects the localization of NFE2L2 protein
CTD
PMID:23318726
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
affects localization
ISO
butein affects the localization of NFKB1 protein
CTD
PMID:20696233
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
butein results in increased activity of NR1I2 protein
CTD
PMID:29933105
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
butein results in increased cleavage of PARP1 protein
CTD
PMID:24931875
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression decreases response to substance
ISO
butein results in decreased expression of PTTG1 protein PTTG1 protein results in decreased susceptibility to butein
CTD
PMID:24931875
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization
ISO
butein affects the localization of RELA protein
CTD
PMID:20696233
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Sirt1
sirtuin 1
increases activity
ISO
butein results in increased activity of SIRT1 protein
CTD
PMID:17327447
NCBI chr20:25,307,225...25,329,273
Ensembl chr20:25,306,917...25,329,260
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
butein affects the reaction [IL6 protein affects the phosphorylation of STAT3 protein]
CTD
PMID:35130734
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
butein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNF protein]; butein inhibits the reaction [TNF protein results in increased expression of MMP9 protein]
CTD
PMID:20696233
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
butein results in decreased expression of VEGFA mRNA
CTD
PMID:20696233
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Ache
acetylcholinesterase
increases activity
EXP
cardamonin results in increased activity of ACHE protein
CTD
PMID:31034797
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
EXP
cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]
CTD
PMID:28966130
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases cleavage
ISO
cardamonin results in increased cleavage of CASP3 protein
CTD
PMID:37268255
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
EXP
cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased activity of CAT protein]
CTD
PMID:28966130
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Il1b
interleukin 1 beta
multiple interactions
ISO
cardamonin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:22696397
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
cardamonin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:22696397
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mpo
myeloperoxidase
multiple interactions
ISO
cardamonin inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein]
CTD
PMID:22696397
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
EXP
cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NFKB1 protein]
CTD
PMID:28966130
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of NOS2 mRNA]
CTD
PMID:28966130
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nos3
nitric oxide synthase 3
multiple interactions
EXP
cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of NOS3 mRNA]
CTD
PMID:28966130
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
cardamonin results in increased cleavage of PARP1 protein
CTD
PMID:37268255
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
cardamonin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] cardamonin inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of TNF protein]
CTD
PMID:22696397 PMID:28966130
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Afp
alpha-fetoprotein
affects binding
EXP
Chalcone binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ar
androgen receptor
affects binding
EXP
Chalcone binds to AR protein
CTD
PMID:14565775
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Car1
carbonic anhydrase 1
decreases activity
ISO
Chalcone results in decreased activity of CA1 protein
CTD
PMID:30431690
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
decreases activity
ISO
Chalcone results in decreased activity of CA2 protein
CTD
PMID:30431690
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of CASP3 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP3 protein]
CTD
PMID:20620131
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of CASP8 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP8 protein]
CTD
PMID:20620131
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of CASP9 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein]
CTD
PMID:20620131
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases hydroxylation
EXP
CYP1A1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases hydroxylation
EXP
CYP1A2 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases hydroxylation
EXP
CYP2C6V1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases hydroxylation
EXP
CYP3A23-3A1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Chalcone analog results in increased expression of GCLM mRNA; Chalcone analog results in increased expression of GCLM protein
CTD
PMID:31299238
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Hat1
histone acetyltransferase 1
decreases activity
ISO
Chalcone analog results in decreased activity of HAT1 protein
CTD
PMID:22155221
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Il6
interleukin 6
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:22155221
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:22155221
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]
CTD
PMID:22155221
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
CTD
PMID:22155221
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]
CTD
PMID:22155221
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Myc
MYC proto-oncogene, bHLH transcription factor
affects response to substance multiple interactions
ISO
MYC protein affects the susceptibility to Chalcone Chalcone promotes the reaction [MYC protein results in increased abundance of Reactive Oxygen Species]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP3 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP8 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of PARP1 protein]
CTD
PMID:20620131
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
Chalcone analog results in decreased ubiquitination of and results in decreased degradation of and affects the localization of NFE2L2 protein; NFE2L2 promotes the reaction [Chalcone analog results in increased abundance of Glutathione]
CTD
PMID:31299238
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:22155221
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2] which results in increased abundance of Nitric Oxide]; Chalcone analog inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:22155221
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Chalcone analog results in increased expression of NQO1 mRNA; Chalcone analog results in increased expression of NQO1 protein
CTD
PMID:31299238
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of PARP1 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of PARP1 protein]
CTD
PMID:20620131
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
Chalcone analog results in increased expression of PPARG mRNA
CTD
PMID:28528971
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgr1
prostaglandin reductase 1
multiple interactions
EXP
[PTGR1 protein co-treated with NADP] affects the reduction of Chalcone
CTD
PMID:11524419
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased phosphorylation of RELA protein] which results in increased acetylation of RELA protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of RELA mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
CTD
PMID:22155221
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Shbg
sex hormone binding globulin
affects binding
ISO
Chalcone binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:22155221
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides affects the localization of [JUN protein binds to FOS protein]]
CTD
PMID:23727179
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Il1b
interleukin 1 beta
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]
CTD
PMID:23727179
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:23727179
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides affects the localization of [JUN protein binds to FOS protein]]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of JUN protein]
CTD
PMID:23727179
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]
CTD
PMID:23727179
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides promotes the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide]]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:23727179
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides promotes the reaction [PTGS2 protein results in increased chemical synthesis of Dinoprostone]]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:23727179
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]
CTD
PMID:23727179
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO
flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; flavokawain A inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:23727179
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
flavokawain B results in decreased phosphorylation of AKT1 protein TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of AKT1 protein]
CTD
PMID:30025493
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Atf4
activating transcription factor 4
multiple interactions increases expression
ISO
4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of ATF4 protein]; ATF4 protein affects the reaction [flavokawain B results in increased expression of DDIT3 protein]; ATF4 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; ATF4 protein affects the reaction [flavokawain B results in increased expression of TRIB3 protein]
CTD
PMID:30025493
NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446
G
Atg5
autophagy related 5
multiple interactions affects response to substance
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein; [ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of CDKN1A protein; [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of GLB1 protein; [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MAP1LC3B protein modified form; [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MKI67 protein; ATG5 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]
CTD
PMID:30025493
NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209
G
Atg7
autophagy related 7
affects response to substance multiple interactions
ISO
ATG7 protein affects the susceptibility to flavokawain B [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein; [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; ATG7 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]
CTD
PMID:30025493
NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
G
Casp3
caspase 3
multiple interactions
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein; [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein
CTD
PMID:30025493
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of CDKN1A protein; [Chloroquine co-treated with flavokawain B] results in decreased expression of CDKN1A protein
CTD
PMID:30025493
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of DDIT3 protein]; ATF4 protein affects the reaction [flavokawain B results in increased expression of DDIT3 protein]; DDIT3 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]
CTD
PMID:30025493
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases phosphorylation
ISO
flavokawain B results in increased phosphorylation of EIF2AK3 protein
CTD
PMID:30025493
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation
ISO
flavokawain B results in increased phosphorylation of EIF2S1 protein
CTD
PMID:30025493
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Glb1
galactosidase, beta 1
multiple interactions increases expression
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of GLB1 protein; [Chloroquine co-treated with flavokawain B] results in decreased expression of GLB1 protein flavokawain B results in increased expression of GLB1 protein
CTD
PMID:30025493
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
G
H2ax
H2A.X variant histone
increases phosphorylation
ISO
flavokawain B results in increased phosphorylation of H2AX protein
CTD
PMID:30025493
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
flavokawain B results in increased expression of HSPA5 protein
CTD
PMID:30025493
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
multiple interactions increases expression
ISO
3-methyladenine inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; 4-phenylbutyric acid inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MAP1LC3B protein modified form; [Chloroquine co-treated with flavokawain B] results in increased expression of MAP1LC3B protein modified form; ATF4 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; ATG5 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; ATG7 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; Chloroquine promotes the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]; DDIT3 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]
CTD
PMID:30025493
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
G
Mki67
marker of proliferation Ki-67
multiple interactions
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MKI67 protein; [Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein
CTD
PMID:30025493
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions decreases phosphorylation
ISO
TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of MTOR protein]
CTD
PMID:30025493
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
[ATG5 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; [flavokawain B co-treated with 3-methyladenine] results in increased cleavage of PARP1 protein
CTD
PMID:30025493
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases phosphorylation multiple interactions
ISO
flavokawain B results in decreased phosphorylation of RPS6KB1 protein TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:30025493
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Sqstm1
sequestosome 1
increases expression
ISO
flavokawain B results in increased expression of SQSTM1 protein
CTD
PMID:30025493
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Trib3
tribbles pseudokinase 3
multiple interactions increases expression
ISO
ATF4 protein affects the reaction [flavokawain B results in increased expression of TRIB3 protein]; TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of AKT1 protein]; TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of MTOR protein]; TRIB3 protein affects the reaction [flavokawain B results in decreased phosphorylation of RPS6KB1 protein]
CTD
PMID:30025493
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
Enzymes and Coenzymes inhibits the reaction [isobavachalcone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]]; isobavachalcone inhibits the reaction [ABCB11 protein results in increased transport of Taurodeoxycholic Acid]
CTD
PMID:35101544
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Ces1d
carboxylesterase 1D
decreases activity
ISO
isobavachalcone results in decreased activity of CES1 protein
CTD
PMID:26560012
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity multiple interactions
EXP
isobavachalcone results in decreased activity of CYP2E1 protein isobavachalcone inhibits the reaction [[CYP2E1 protein results in increased metabolism of 4-nitrophenol] which results in increased chemical synthesis of 4-nitrocatechol]
CTD
PMID:31870919
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions decreases activity
EXP
isobavachalcone inhibits the reaction [[CYP3A4 protein results in increased metabolism of Testosterone] which results in increased chemical synthesis of 6 beta-hydroxytestosterone] isobavachalcone results in decreased activity of CYP3A4 protein
CTD
PMID:31870919
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
isobavachalcone results in increased cleavage of PARP1 protein
CTD
PMID:30890322
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Afp
alpha-fetoprotein
affects binding
EXP
isoliquiritigenin binds to AFP protein
CTD
PMID:23013281
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene affects the localization of AHR protein]
CTD
PMID:25110319
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
decreases response to substance multiple interactions decreases phosphorylation
ISO
AKT1 protein modified form results in decreased susceptibility to isoliquiritigenin isoliquiritigenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased activity of AKT1 protein]; 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 mRNA]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]; CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased activity of AKT1 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; isoliquiritigenin results in decreased phosphorylation of and results in decreased activity of AKT1 protein; Leukotriene B4 inhibits the reaction [isoliquiritigenin results in decreased activity of AKT1 protein] isoliquiritigenin results in decreased phosphorylation of AKT1 protein
CTD
PMID:23747687 PMID:25094029 PMID:27117918
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Arg1
arginase 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 protein]
CTD
PMID:25026504
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
isoliquiritigenin results in increased expression of BAX mRNA; isoliquiritigenin results in increased expression of BAX protein
CTD
PMID:11055382 PMID:27702603
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases phosphorylation
ISO
isoliquiritigenin results in decreased phosphorylation of BCL2 protein
CTD
PMID:23747687
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression decreases phosphorylation
ISO
isoliquiritigenin results in decreased expression of BCL2L1 protein isoliquiritigenin results in decreased phosphorylation of BCL2L1 protein
CTD
PMID:11055382 PMID:15729620 PMID:23747687
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression
ISO
isoliquiritigenin results in decreased expression of BIRC2 protein
CTD
PMID:15729620
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
isoliquiritigenin results in decreased expression of BIRC3 protein
CTD
PMID:15729620
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Casp3
caspase 3
multiple interactions increases activity increases cleavage
ISO
20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; CAY 10580 inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP3 protein]; isoliquiritigenin results in increased cleavage of and results in increased activity of CASP3 protein isoliquiritigenin results in increased activity of CASP3 protein
CTD
PMID:15729620 PMID:16158945 PMID:23747687 PMID:25094029
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity
ISO
isoliquiritigenin results in increased activity of CASP8 protein
CTD
PMID:16158945
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases activity increases cleavage
ISO
20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]; CAY 10580 inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in increased cleavage of CASP9 protein]; isoliquiritigenin results in increased cleavage of and results in increased activity of CASP9 protein isoliquiritigenin results in increased activity of CASP9 protein
CTD
PMID:16158945 PMID:23747687 PMID:25094029
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
EXP ISO
isoliquiritigenin inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] isoliquiritigenin inhibits the reaction [Paroxetine results in decreased activity of CAT protein]
CTD
PMID:25450236 PMID:36740106
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cckar
cholecystokinin A receptor
multiple interactions increases expression
ISO
fulvestrant inhibits the reaction [isoliquiritigenin results in increased expression of CCKAR mRNA]
CTD
PMID:27702603
NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747
G
Ccnd2
cyclin D2
decreases expression
ISO
isoliquiritigenin results in decreased expression of CCND2 mRNA
CTD
PMID:27702603
NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
G
Ccne2
cyclin E2
decreases expression
ISO
isoliquiritigenin results in decreased expression of CCNE2 mRNA
CTD
PMID:27702603
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
isoliquiritigenin results in increased expression of CDKN1A mRNA; isoliquiritigenin results in increased expression of CDKN1A protein
CTD
PMID:27702603
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
decreases expression
ISO
isoliquiritigenin results in decreased expression of CDKN1B mRNA
CTD
PMID:27702603
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
decreases expression
ISO
isoliquiritigenin results in decreased expression of CDKN1C mRNA
CTD
PMID:27702603
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of CEBPA protein]
CTD
PMID:27117918
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of CHUK protein]
CTD
PMID:18295200
NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065
G
Cxcl10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA]
CTD
PMID:25026504
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
decreases expression
ISO
isoliquiritigenin results in decreased expression of CYP17A1 mRNA
CTD
PMID:27773742
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression
ISO
isoliquiritigenin results in decreased expression of CYP19A1 mRNA
CTD
PMID:27773742
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A1 protein]; isoliquiritigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD
PMID:25110319
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions decreases activity
ISO
isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1A2 mRNA]; isoliquiritigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A2 mRNA] isoliquiritigenin results in decreased activity of CYP1A2 protein
CTD
PMID:25110319 PMID:29753067
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions increases expression
ISO
isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 mRNA]; isoliquiritigenin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CYP1B1 protein]; isoliquiritigenin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; isoliquiritigenin promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA]; isoliquiritigenin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] isoliquiritigenin results in increased expression of CYP1B1 mRNA
CTD
PMID:25110319 PMID:26134484
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases activity
ISO
isoliquiritigenin results in decreased activity of CYP2C9 protein
CTD
PMID:29753067
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
isoliquiritigenin results in decreased activity of CYP2C19 protein
CTD
PMID:29753067
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA]; isoliquiritigenin inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 protein]
CTD
PMID:25450236
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
isoliquiritigenin results in decreased activity of CYP3A4 protein
CTD
PMID:29753067
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of DDIT3 mRNA]
CTD
PMID:37561086
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of ERN1 mRNA]
CTD
PMID:37561086
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]
CTD
PMID:27117918
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Gadd45gip1
GADD45G interacting protein 1
increases expression
ISO
isoliquiritigenin results in increased expression of GADD45GIP1 mRNA
CTD
PMID:27702603
NCBI chr19:23,320,662...23,323,211
Ensembl chr19:23,320,159...23,323,236
G
Gfap
glial fibrillary acidic protein
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of GFAP protein]
CTD
PMID:19834288
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [Paroxetine results in increased activity of GPT protein]
CTD
PMID:36740106
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsr
glutathione-disulfide reductase
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Cisplatin results in decreased activity of GSR protein]
CTD
PMID:37561086
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Havcr1
hepatitis A virus cellular receptor 1
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of HAVCR1 protein]
CTD
PMID:37561086
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Hmox1
heme oxygenase 1
increases expression
ISO
isoliquiritigenin results in increased expression of HMOX1 protein
CTD
PMID:23942037
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
decreases expression
ISO
isoliquiritigenin results in decreased expression of HSD17B1 mRNA
CTD
PMID:27773742
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
G
Hsp90b1
heat shock protein 90 beta family member 1
multiple interactions
EXP
[isoliquiritigenin co-treated with Cisplatin] results in increased expression of HSP90B1 protein
CTD
PMID:37561086
NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression
EXP
[Cisplatin co-treated with isoliquiritigenin] results in increased expression of HSPA5 mRNA isoliquiritigenin results in increased expression of HSPA5 mRNA
CTD
PMID:37561086
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Ifng
interferon gamma
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IFNG protein]; isoliquiritigenin inhibits the reaction [IFNG protein results in increased abundance of Nitrites] isoliquiritigenin promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA]
CTD
PMID:23942037 PMID:25026504 PMID:26134484
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL10 protein]
CTD
PMID:25026504
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il1rn
interleukin 1 receptor antagonist
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL1RN protein]
CTD
PMID:25026504
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6
interleukin 6
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of IL6 protein]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of IL6 protein]
CTD
PMID:18295200 PMID:25026504
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in decreased activity of and results in increased oxidation of PTPN1 protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of CEBPA protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; isoliquiritigenin inhibits the reaction [INS1 protein results in increased phosphorylation of INSR protein]
CTD
PMID:27117918
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Insr
insulin receptor
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in increased phosphorylation of INSR protein]
CTD
PMID:27117918
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
G
Itgam
integrin subunit alpha M
multiple interactions increases expression
ISO
TEMPOL-H inhibits the reaction [isoliquiritigenin results in increased expression of ITGAM protein]
CTD
PMID:24369695
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]
CTD
PMID:18295200
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]
CTD
PMID:18295200
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Melk
maternal embryonic leucine zipper kinase
decreases expression
ISO
isoliquiritigenin results in decreased expression of MELK mRNA; isoliquiritigenin results in decreased expression of MELK protein
CTD
PMID:36893906
NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
G
Mfn2
mitofusin 2
increases expression
EXP
isoliquiritigenin results in increased expression of MFN2 protein
CTD
PMID:37561086
NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
isoliquiritigenin results in decreased expression of MKI67 mRNA; isoliquiritigenin results in decreased expression of MKI67 protein
CTD
PMID:27702603
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp2
matrix metallopeptidase 2
multiple interactions decreases expression
ISO
20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 mRNA]; 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 mRNA]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 protein]; CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 mRNA]; CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 mRNA]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP2 protein] isoliquiritigenin results in decreased expression of MMP2 mRNA; isoliquiritigenin results in decreased expression of MMP2 protein
CTD
PMID:25094029
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]; 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]; AKT1 protein modified form inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]; CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]; CAY 10580 inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 mRNA]; Dinoprostone inhibits the reaction [isoliquiritigenin results in decreased expression of MMP9 protein] isoliquiritigenin results in decreased expression of MMP9 mRNA; isoliquiritigenin results in decreased expression of MMP9 protein
CTD
PMID:25094029
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mrc1
mannose receptor, C type 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MRC1 protein]
CTD
PMID:25026504
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of NFKB1 protein]
CTD
PMID:18295200
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases expression multiple interactions decreases phosphorylation
ISO
isoliquiritigenin results in increased expression of NFKBIA protein isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased degradation of and results in increased phosphorylation of NFKBIA protein] isoliquiritigenin results in decreased phosphorylation of NFKBIA protein
CTD
PMID:15729620 PMID:18295200
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NOS2 protein]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]; isoliquiritigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; isoliquiritigenin inhibits the reaction [Methamphetamine results in increased expression of NOS2 protein]
CTD
PMID:18295200 PMID:19834288 PMID:25026504 PMID:26134484
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
isoliquiritigenin results in increased expression of NQO1 protein
CTD
PMID:26473469
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity increases expression
ISO
isoliquiritigenin results in increased activity of NR1I2 protein isoliquiritigenin results in increased expression of NR1I2 mRNA
CTD
PMID:29933105
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
isoliquiritigenin results in increased cleavage of PARP1 protein benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [isoliquiritigenin results in increased cleavage of PARP1 protein]
CTD
PMID:23747687
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pdk1
pyruvate dehydrogenase kinase 1
decreases phosphorylation
ISO
isoliquiritigenin results in decreased phosphorylation of PDK1 protein
CTD
PMID:25094029
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
G
Pla2g5
phospholipase A2, group V
decreases expression
ISO
isoliquiritigenin results in decreased expression of PLA2G5 mRNA
CTD
PMID:23747687
NCBI chr 5:151,041,339...151,109,433
Ensembl chr 5:151,041,340...151,062,658
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein]
CTD
PMID:27117918
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptger4
prostaglandin E receptor 4
decreases expression
ISO
isoliquiritigenin results in decreased expression of PTGER4 mRNA; isoliquiritigenin results in decreased expression of PTGER4 protein
CTD
PMID:25094029
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptgs1
prostaglandin-endoperoxide synthase 1
decreases expression
ISO
isoliquiritigenin results in decreased expression of PTGS1 mRNA
CTD
PMID:25094029
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression multiple interactions
ISO EXP
isoliquiritigenin results in decreased expression of PTGS2 mRNA isoliquiritigenin inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein] isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PTGS2 protein]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]
CTD
PMID:18295200 PMID:23747687 PMID:25026504 PMID:25450236
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptpn1
protein tyrosine phosphatase, non-receptor type 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in decreased activity of and results in increased oxidation of PTPN1 protein]
CTD
PMID:27117918
NCBI chr 3:156,638,811...156,687,503
Ensembl chr 3:156,638,769...156,687,504
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization multiple interactions decreases activity
ISO
isoliquiritigenin affects the localization of RELA protein isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein] isoliquiritigenin results in decreased activity of RELA protein
CTD
PMID:15729620 PMID:18295200
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Slc2a1
solute carrier family 2 member 1
multiple interactions decreases activity
ISO
isoliquiritigenin inhibits the reaction [SLC2A1 protein affects the transport of Glucose] isoliquiritigenin results in decreased activity of SLC2A1 protein
CTD
PMID:14642735
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc2a4
solute carrier family 2 member 4
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]
CTD
PMID:27117918
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [Methamphetamine results in decreased expression of SLC6A3 protein]
CTD
PMID:19834288
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
multiple interactions decreases activity
EXP
[isoliquiritigenin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [isoliquiritigenin results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Methotrexate
CTD
PMID:32259555
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
G
Sod2
superoxide dismutase 2
affects response to substance
ISO
SOD2 protein affects the susceptibility to isoliquiritigenin
CTD
PMID:23526725
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Star
steroidogenic acute regulatory protein
increases expression
ISO
isoliquiritigenin results in increased expression of STAR mRNA
CTD
PMID:27773742
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of STAT3 protein]
CTD
PMID:25026504
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of TGFB1 protein]
CTD
PMID:25026504
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TNF protein]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; isoliquiritigenin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNF protein] isoliquiritigenin promotes the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA] isoliquiritigenin inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]
CTD
PMID:18295200 PMID:25026504 PMID:25450236 PMID:26134484
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression
ISO
isoliquiritigenin results in increased expression of TRP53 mRNA
CTD
PMID:27702603
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases glucuronidation
ISO
UGT1A1 protein results in increased glucuronidation of isoliquiritigenin
CTD
PMID:14557274
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
increases glucuronidation
ISO
UGT1A9 protein results in increased glucuronidation of isoliquiritigenin
CTD
PMID:14557274
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Xbp1
X-box binding protein 1
multiple interactions
EXP
isoliquiritigenin inhibits the reaction [Cisplatin results in increased expression of XBP1 mRNA]
CTD
PMID:37561086
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
licochalcone A inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein]
CTD
PMID:26134484
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Akt1
AKT serine/threonine kinase 1
decreases expression
ISO
licochalcone A results in decreased expression of AKT1 mRNA
CTD
PMID:30055311
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
licochalcone A results in increased expression of BAD mRNA
CTD
PMID:30055311
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
licochalcone A results in increased expression of BAK1 mRNA
CTD
PMID:30055311
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
licochalcone A results in increased expression of BAX mRNA
CTD
PMID:30055311
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
licochalcone A results in increased expression of BBC3 mRNA
CTD
PMID:30055311
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
increases expression
ISO
licochalcone A results in increased expression of BCL2 mRNA
CTD
PMID:30055311
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
licochalcone A results in decreased expression of BIRC5 mRNA
CTD
PMID:30055311
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Casp3
caspase 3
increases cleavage multiple interactions increases expression
ISO
licochalcone A results in increased cleavage of CASP3 protein SB 203580 inhibits the reaction [licochalcone A results in increased cleavage of CASP3 protein] licochalcone A results in increased expression of CASP3 mRNA
CTD
PMID:30055311 PMID:30983163
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases expression increases cleavage
ISO
SB 203580 inhibits the reaction [licochalcone A results in increased cleavage of CASP8 protein] licochalcone A results in increased expression of CASP8 mRNA
CTD
PMID:30055311 PMID:30983163
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO
licochalcone A results in increased cleavage of CASP9 protein SB 203580 inhibits the reaction [licochalcone A results in increased cleavage of CASP9 protein]
CTD
PMID:30983163
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccn1
cellular communication network factor 1
decreases expression
ISO
licochalcone A results in decreased expression of CCN1 mRNA
CTD
PMID:34845814
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
licochalcone A results in decreased expression of CCN2 mRNA
CTD
PMID:34845814
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccnb1
cyclin B1
decreases expression
ISO
licochalcone A results in decreased expression of CCNB1 mRNA
CTD
PMID:30055311
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
increases expression
ISO
licochalcone A results in increased expression of CCND1 mRNA
CTD
PMID:30055311
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
licochalcone A results in decreased expression of CDK1 mRNA
CTD
PMID:30055311
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
licochalcone A results in increased expression of CDKN1A mRNA
CTD
PMID:30055311
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
ISO
licochalcone A results in decreased activity of CYP1A2 protein
CTD
PMID:26100226
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
multiple interactions decreases expression
ISO
licochalcone A inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA]; licochalcone A inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] licochalcone A results in decreased expression of CYP1B1 mRNA
CTD
PMID:26134484
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases activity
ISO
licochalcone A results in decreased activity of CYP2C9 protein
CTD
PMID:26100226
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
licochalcone A results in decreased activity of CYP2C19 protein
CTD
PMID:26100226
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
decreases activity
ISO
licochalcone A results in decreased activity of CYP2C8 protein
CTD
PMID:26100226
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
affects activity
ISO
licochalcone A affects the activity of CYP2D6 protein
CTD
PMID:26100226
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
affects activity
ISO
licochalcone A affects the activity of CYP2E1 protein
CTD
PMID:26100226
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
decreases activity
ISO
licochalcone A results in decreased activity of CYP3A4 protein
CTD
PMID:26100226
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Dyrk1a
dual specificity tyrosine phosphorylation regulated kinase 1A
decreases activity
ISO
licochalcone A results in decreased activity of DYRK1A protein
CTD
PMID:31838052
NCBI chr11:33,890,706...34,009,420
Ensembl chr11:33,890,490...34,009,420
G
Fas
Fas cell surface death receptor
increases expression
ISO
licochalcone A results in increased expression of FAS mRNA
CTD
PMID:30055311
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Ifng
interferon gamma
multiple interactions
ISO
licochalcone A inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA]
CTD
PMID:26134484
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il1b
interleukin 1 beta
multiple interactions
ISO
licochalcone A inhibits the reaction [IL1B protein results in increased abundance of Dinoprost]; licochalcone A inhibits the reaction [IL1B protein results in increased abundance of Dinoprostone]
CTD
PMID:16354411
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Lats1
large tumor suppressor kinase 1
decreases expression increases expression
ISO
licochalcone A results in decreased expression of LATS1 protein licochalcone A results in increased expression of LATS1 protein modified form
CTD
PMID:34845814
NCBI chr 1:2,160,411...2,193,640
Ensembl chr 1:2,160,411...2,193,640
G
Map2k4
mitogen activated protein kinase kinase 4
decreases phosphorylation multiple interactions
ISO
licochalcone A results in decreased phosphorylation of MAP2K4 protein licochalcone A promotes the reaction [Sorafenib results in decreased phosphorylation of MAP2K4 protein]; Sorafenib promotes the reaction [licochalcone A results in decreased phosphorylation of MAP2K4 protein]
CTD
PMID:30187994
NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
licochalcone A results in increased phosphorylation of MAPK1 protein
CTD
PMID:30983163
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
licochalcone A results in increased phosphorylation of MAPK3 protein
CTD
PMID:30983163
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases expression decreases phosphorylation
ISO
licochalcone A promotes the reaction [Sorafenib results in decreased phosphorylation of MAPK8 protein]; Sorafenib promotes the reaction [licochalcone A results in decreased phosphorylation of MAPK8 protein] licochalcone A results in increased expression of MAPK8 mRNA
CTD
PMID:30055311 PMID:30187994
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
decreases phosphorylation multiple interactions
ISO
licochalcone A results in decreased phosphorylation of MAPK9 protein licochalcone A promotes the reaction [Sorafenib results in decreased phosphorylation of MAPK9 protein]; Sorafenib promotes the reaction [licochalcone A results in decreased phosphorylation of MAPK9 protein]
CTD
PMID:30187994
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
licochalcone A inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:26134484
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
licochalcone A results in increased expression of NQO1 protein
CTD
PMID:26473469
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
licochalcone A results in increased cleavage of PARP1 protein
CTD
PMID:30983163
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pes1
pescadillo ribosomal biogenesis factor 1
affects expression decreases expression multiple interactions
ISO
licochalcone A affects the expression of PES1 protein modified form licochalcone A results in decreased expression of PES1 mRNA licochalcone A results in decreased expression of and affects the localization of PES1 protein
CTD
PMID:34845814
NCBI chr14:78,850,754...78,867,134
Ensembl chr14:78,850,709...78,867,134
G
Plau
plasminogen activator, urokinase
multiple interactions decreases expression
ISO
licochalcone A promotes the reaction [Sorafenib results in decreased expression of PLAU protein]; Sorafenib promotes the reaction [licochalcone A results in decreased expression of PLAU protein]
CTD
PMID:30187994
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
licochalcone A results in decreased expression of PRKCE mRNA
CTD
PMID:30055311
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases expression
ISO
licochalcone A results in decreased expression of RPS6KB1 mRNA
CTD
PMID:30055311
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Slco1c1
solute carrier organic anion transporter family, member 1c1
multiple interactions decreases activity
EXP
[licochalcone A results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Bosentan; [licochalcone A results in decreased activity of SLCO1B1 protein] which results in decreased uptake of Methotrexate
CTD
PMID:32259555
NCBI chr 4:174,466,621...174,513,290
Ensembl chr 4:174,466,631...174,513,289
G
Stk4
serine/threonine kinase 4
increases expression decreases expression multiple interactions
ISO
licochalcone A results in increased expression of STK4 protein modified form licochalcone A results in decreased expression of STK4 protein XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of STK4 protein modified form]
CTD
PMID:34845814
NCBI chr 3:152,745,958...152,827,747
Ensembl chr 3:152,745,681...152,827,744
G
Tnf
tumor necrosis factor
multiple interactions
ISO
licochalcone A inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CYP1B1 mRNA]
CTD
PMID:26134484
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf25
TNF receptor superfamily member 25
increases expression
ISO
licochalcone A results in increased expression of TNFRSF25 mRNA
CTD
PMID:30055311
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT1A1 protein]
CTD
PMID:26875642
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT1A3 protein]
CTD
PMID:26875642
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a5
UDP glucuronosyltransferase family 1 member A5
multiple interactions
ISO
licochalcone A inhibits the reaction [Trifluoperazine results in increased activity of UGT1A4 protein]
CTD
PMID:26875642
NCBI chr 9:88,762,250...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a6
UDP glucuronosyltransferase family 1 member A6
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT1A6 protein]
CTD
PMID:26875642
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a9
UDP glucuronosyltransferase family 1 member A9
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT1A9 protein]; licochalcone A inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol]
CTD
PMID:26875642
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B17 protein]
CTD
PMID:26875642
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
multiple interactions
ISO
licochalcone A inhibits the reaction [Hymecromone results in increased activity of UGT2B7 protein]
CTD
PMID:26875642
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Wee1
WEE1 G2 checkpoint kinase
increases expression
ISO
licochalcone A results in increased expression of WEE1 mRNA
CTD
PMID:30055311
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
G
Wwtr1
WW domain containing transcription regulator 1
decreases expression
ISO
licochalcone A results in decreased expression of WWTR1 protein
CTD
PMID:34845814
NCBI chr 2:141,651,159...141,766,919
Ensembl chr 2:141,648,108...141,766,968
G
Yap1
Yes1 associated transcriptional regulator
decreases expression multiple interactions
ISO
licochalcone A results in decreased expression of YAP1 mRNA; licochalcone A results in decreased expression of YAP1 protein XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of YAP1 protein modified form]
CTD
PMID:34845814
NCBI chr 8:5,095,705...5,166,808
Ensembl chr 8:5,095,722...5,167,010
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression
ISO
licochalcone B results in decreased expression of ABCA1 mRNA
CTD
PMID:33647349
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abca8
ATP binding cassette subfamily A member 8
decreases expression
ISO
licochalcone B results in decreased expression of ABCA8 mRNA
CTD
PMID:33647349
NCBI chr10:94,917,520...94,991,199
Ensembl chr10:94,917,520...94,990,988
G
Abca8a
ATP-binding cassette, subfamily A (ABC1), member 8a
increases expression
ISO
licochalcone B results in increased expression of ABCA10 mRNA
CTD
PMID:33647349
NCBI chr10:95,002,334...95,072,315
Ensembl chr10:95,002,334...95,072,375
G
Abcb4
ATP binding cassette subfamily B member 4
increases expression
ISO
licochalcone B results in increased expression of ABCB4 mRNA
CTD
PMID:33647349
NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
G
Ache
acetylcholinesterase
increases expression
ISO
licochalcone B results in increased expression of ACHE mRNA
CTD
PMID:33647349
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acsbg1
acyl-CoA synthetase bubblegum family member 1
increases expression
ISO
licochalcone B results in increased expression of ACSBG1 mRNA
CTD
PMID:33647349
NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391
G
Acta1
actin, alpha 1, skeletal muscle
increases expression
ISO
licochalcone B results in increased expression of ACTA1 mRNA
CTD
PMID:33647349
NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742
G
Actn3
actinin alpha 3
increases expression
ISO
licochalcone B results in increased expression of ACTN3 mRNA
CTD
PMID:33647349
NCBI chr 1:202,159,081...202,175,012
Ensembl chr 1:202,159,082...202,175,012
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif, 5
decreases expression
ISO
licochalcone B results in decreased expression of ADAMTS5 mRNA
CTD
PMID:33647349
NCBI chr11:25,000,627...25,047,205
Ensembl chr11:25,000,637...25,047,205
G
Adap1
ArfGAP with dual PH domains 1
increases expression
ISO
licochalcone B results in increased expression of ADAP1 mRNA
CTD
PMID:33647349
NCBI chr12:15,323,913...15,376,110
Ensembl chr12:15,324,209...15,380,831
G
Adat3
adenosine deaminase, tRNA-specific 3
increases expression
ISO
licochalcone B results in increased expression of ADAT3 mRNA
CTD
PMID:33647349
NCBI chr 7:9,109,070...9,113,673
Ensembl chr 7:9,101,187...9,115,340
G
Adgrg3
adhesion G protein-coupled receptor G3
decreases expression
ISO
licochalcone B results in decreased expression of ADGRG3 mRNA
CTD
PMID:33647349
NCBI chr19:9,972,425...10,001,118
Ensembl chr19:9,972,430...10,001,123
G
Adgrl2
adhesion G protein-coupled receptor L2
decreases expression
ISO
licochalcone B results in decreased expression of ADGRL2 mRNA
CTD
PMID:33647349
NCBI chr 2:237,696,055...238,327,141
Ensembl chr 2:237,696,056...238,327,141
G
Adm
adrenomedullin
increases expression
ISO
licochalcone B results in increased expression of ADM mRNA
CTD
PMID:33647349
NCBI chr 1:164,745,484...164,747,655
Ensembl chr 1:164,745,466...164,747,654
G
Adra1d
adrenoceptor alpha 1D
increases expression
ISO
licochalcone B results in increased expression of ADRA1D mRNA
CTD
PMID:33647349
NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354
G
Adra2b
adrenoceptor alpha 2B
increases expression
ISO
licochalcone B results in increased expression of ADRA2B mRNA
CTD
PMID:33647349
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
G
Adrb2
adrenoceptor beta 2
increases expression
ISO
licochalcone B results in increased expression of ADRB2 mRNA
CTD
PMID:33647349
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Afmid
arylformamidase
increases expression
ISO
licochalcone B results in increased expression of AFMID mRNA
CTD
PMID:33647349
NCBI chr10:103,046,129...103,061,718
Ensembl chr10:103,046,180...103,061,718
G
Agl
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
decreases expression
ISO
licochalcone B results in decreased expression of AGL mRNA
CTD
PMID:33647349
NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828
G
Akap5
A-kinase anchoring protein 5
decreases expression
ISO
licochalcone B results in decreased expression of AKAP5 mRNA
CTD
PMID:33647349
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
licochalcone B results in increased expression of AKR1B10 mRNA
CTD
PMID:33647349
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
ISO
licochalcone B results in increased expression of ALDH1A1 mRNA
CTD
PMID:33647349
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Alg9
ALG9, alpha-1,2-mannosyltransferase
decreases expression
ISO
licochalcone B results in decreased expression of ALG9 mRNA
CTD
PMID:33647349
NCBI chr 8:51,117,057...51,188,790
Ensembl chr 8:51,119,365...51,182,261
G
Alkal2
ALK and LTK ligand 2
increases expression
ISO
licochalcone B results in increased expression of ALKAL2 mRNA
CTD
PMID:33647349
NCBI chr 6:47,495,645...47,505,235
Ensembl chr 6:47,495,782...47,505,234
G
Alox12
arachidonate 12-lipoxygenase, 12S type
increases expression
ISO
licochalcone B results in increased expression of ALOX12 mRNA
CTD
PMID:33647349
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Aloxe3
arachidonate lipoxygenase 3
increases expression
ISO
licochalcone B results in increased expression of ALOXE3 mRNA
CTD
PMID:33647349
NCBI chr10:53,830,219...53,854,328
Ensembl chr10:53,831,264...53,854,328
G
Ang
angiogenin
decreases expression
ISO
licochalcone B results in decreased expression of ANG mRNA
CTD
PMID:33647349
NCBI chr15:24,312,711...24,323,361
G
Ankrd1
ankyrin repeat domain 1
increases expression
ISO
licochalcone B results in increased expression of ANKRD1 mRNA
CTD
PMID:33647349
NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919
G
Ap3b2
adaptor related protein complex 3 subunit beta 2
increases expression
ISO
licochalcone B results in increased expression of AP3B2 mRNA
CTD
PMID:33647349
NCBI chr 1:135,412,580...135,445,191
Ensembl chr 1:135,412,580...135,445,191
G
Ap5z1
adaptor related protein complex 5 subunit zeta 1
increases expression
ISO
licochalcone B results in increased expression of AP5Z1 mRNA
CTD
PMID:33647349
NCBI chr12:12,093,834...12,109,043
Ensembl chr12:12,093,834...12,108,511
G
Apbb1
amyloid beta precursor protein binding family B member 1
increases expression
ISO
licochalcone B results in increased expression of APBB1 mRNA
CTD
PMID:33647349
NCBI chr 1:159,896,889...159,920,505
Ensembl chr 1:159,896,880...159,920,627
G
Apobr
apolipoprotein B receptor
decreases expression
ISO
licochalcone B results in decreased expression of APOBR mRNA
CTD
PMID:33647349
NCBI chr 1:181,169,019...181,173,206
Ensembl chr 1:181,168,916...181,173,528
G
Apoe
apolipoprotein E
increases expression
ISO
licochalcone B results in increased expression of APOE mRNA
CTD
PMID:33647349
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Arc
activity-regulated cytoskeleton-associated protein
increases expression
ISO
licochalcone B results in increased expression of ARC mRNA
CTD
PMID:33647349
NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
G
Arhgef33
Rho guanine nucleotide exchange factor 33
increases expression
ISO
licochalcone B results in increased expression of ARHGEF33 mRNA
CTD
PMID:33647349
NCBI chr 6:14,582,922...14,715,014
Ensembl chr 6:14,551,495...14,725,292
G
Arl4c
ADP ribosylation factor like GTPase 4C
increases expression
ISO
licochalcone B results in increased expression of ARL4C mRNA
CTD
PMID:33647349
NCBI chr 9:89,300,335...89,303,770
Ensembl chr 9:89,298,005...89,304,513
G
Arl4d
ADP-ribosylation factor like GTPase 4D
increases expression
ISO
licochalcone B results in increased expression of ARL4D mRNA
CTD
PMID:33647349
NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836
G
Arl6ip4
ADP-ribosylation factor like GTPase 6 interacting protein 4
increases expression
ISO
licochalcone B results in increased expression of ARL6IP4 mRNA
CTD
PMID:33647349
NCBI chr12:32,479,623...32,481,768
Ensembl chr12:32,479,625...32,481,799
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
decreases expression
ISO
licochalcone B results in decreased expression of ARNT2 mRNA
CTD
PMID:33647349
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
G
Arpin
actin-related protein 2/3 complex inhibitor
decreases expression
ISO
licochalcone B results in decreased expression of ARPIN mRNA
CTD
PMID:33647349
NCBI chr 1:133,864,288...133,873,124
Ensembl chr 1:133,864,265...133,873,124
G
Asic4
acid sensing ion channel subunit family member 4
increases expression
ISO
licochalcone B results in increased expression of ASIC4 mRNA
CTD
PMID:33647349
NCBI chr 9:76,941,532...76,962,900
Ensembl chr 9:76,941,532...76,962,900
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
licochalcone B results in increased expression of ASNS mRNA
CTD
PMID:33647349
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
G
Atcay
ATCAY kinesin light chain interacting caytaxin
increases expression
ISO
licochalcone B results in increased expression of ATCAY mRNA
CTD
PMID:33647349
NCBI chr 7:8,487,763...8,511,527
Ensembl chr 7:8,487,763...8,512,663
G
Atf3
activating transcription factor 3
increases expression
ISO
licochalcone B results in increased expression of ATF3 mRNA
CTD
PMID:33647349
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
G
Atg9b
autophagy related 9B
increases expression
ISO
licochalcone B results in increased expression of ATG9B mRNA
CTD
PMID:33647349
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
G
Atm
ATM serine/threonine kinase
increases phosphorylation
ISO
licochalcone B results in increased phosphorylation of ATM protein
CTD
PMID:35948134
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Atp13a4
ATPase 13A4
increases expression
ISO
licochalcone B results in increased expression of ATP13A4 mRNA
CTD
PMID:33647349
NCBI chr11:71,222,196...71,359,933
Ensembl chr11:71,226,161...71,359,933
G
Atp1a3
ATPase Na+/K+ transporting subunit alpha 3
increases expression
ISO
licochalcone B results in increased expression of ATP1A3 mRNA
CTD
PMID:33647349
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
G
Atp6v0c
ATPase H+ transporting V0 subunit C
increases expression
ISO
licochalcone B results in increased expression of ATP6V0C mRNA
CTD
PMID:33647349
NCBI chr10:13,196,204...13,202,580
Ensembl chr10:13,196,204...13,201,500
G
Atp9a
ATPase phospholipid transporting 9A (putative)
decreases expression
ISO
licochalcone B results in decreased expression of ATP9A mRNA
CTD
PMID:33647349
NCBI chr 3:157,360,354...157,467,628
Ensembl chr 3:157,360,359...157,467,818
G
Aurkc
aurora kinase C
increases expression
ISO
licochalcone B results in increased expression of AURKC mRNA
CTD
PMID:33647349
NCBI chr 1:66,843,653...66,849,775
Ensembl chr 1:66,843,653...66,864,386
G
B3gnt4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
increases expression
ISO
licochalcone B results in increased expression of B3GNT4 mRNA
CTD
PMID:33647349
NCBI chr12:33,070,221...33,073,904
Ensembl chr12:33,060,416...33,073,854
G
B4galnt3
beta-1,4-N-acetyl-galactosaminyl transferase 3
increases expression
ISO
licochalcone B results in increased expression of B4GALNT3 mRNA
CTD
PMID:33647349
NCBI chr 4:153,409,019...153,509,019
Ensembl chr 4:153,409,004...153,509,321
G
Bag3
BAG cochaperone 3
increases expression
ISO
licochalcone B results in increased expression of BAG3 mRNA
CTD
PMID:33647349
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
G
Baiap2
BAR/IMD domain containing adaptor protein 2
increases expression
ISO
licochalcone B results in increased expression of BAIAP2 mRNA
CTD
PMID:33647349
NCBI chr10:105,223,065...105,290,130
Ensembl chr10:105,223,090...105,290,134
G
Baiap3
BAI1-associated protein 3
increases expression
ISO
licochalcone B results in increased expression of BAIAP3 mRNA
CTD
PMID:33647349
NCBI chr10:14,260,269...14,273,019
Ensembl chr10:14,260,269...14,273,019
G
Bambi
BMP and activin membrane-bound inhibitor
increases expression
ISO
licochalcone B results in increased expression of BAMBI mRNA
CTD
PMID:33647349
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
licochalcone B results in increased expression of BAX protein
CTD
PMID:24384411
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression
ISO
licochalcone B results in increased expression of BBC3 mRNA
CTD
PMID:33647349
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
licochalcone B results in decreased expression of BCL2 protein
CTD
PMID:24384411
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bex1
brain expressed X-linked 1
increases expression
ISO
licochalcone B results in increased expression of BEX2 mRNA
CTD
PMID:33647349
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
G
Bicdl2
BICD family like cargo adaptor 2
increases expression
ISO
licochalcone B results in increased expression of BICDL2 mRNA
CTD
PMID:33647349
NCBI chr10:12,691,610...12,700,049
Ensembl chr10:12,691,610...12,700,049
G
Bik
BCL2-interacting killer
increases expression
ISO
licochalcone B results in increased expression of BIK mRNA
CTD
PMID:33647349
NCBI chr 7:114,672,277...114,691,296
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
licochalcone B results in decreased expression of BIRC5 protein
CTD
PMID:24384411
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Blvrb
biliverdin reductase B
increases expression
ISO
licochalcone B results in increased expression of BLVRB mRNA
CTD
PMID:33647349
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
G
Bmper
BMP-binding endothelial regulator
decreases expression
ISO
licochalcone B results in decreased expression of BMPER mRNA
CTD
PMID:33647349
NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
G
Bpgm
bisphosphoglycerate mutase
increases expression
ISO
licochalcone B results in increased expression of BPGM mRNA
CTD
PMID:33647349
NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581
G
Brms1
BRMS1, transcriptional repressor and anoikis regulator
increases expression
ISO
licochalcone B results in increased expression of BRMS1 mRNA
CTD
PMID:33647349
NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:202,345,704...202,355,028
G
Bst1
bone marrow stromal cell antigen 1
increases expression
ISO
licochalcone B results in increased expression of BST1 mRNA
CTD
PMID:33647349
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
Btbd8
BTB domain containing 8
decreases expression
ISO
licochalcone B results in decreased expression of BTBD8 mRNA
CTD
PMID:33647349
NCBI chr14:2,265,187...2,338,426
Ensembl chr14:2,266,454...2,334,393
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
licochalcone B results in increased expression of BTG2 mRNA
CTD
PMID:33647349
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
Btla
B and T lymphocyte associated
increases expression
ISO
licochalcone B results in increased expression of BTLA mRNA
CTD
PMID:33647349
NCBI chr11:55,563,683...55,588,187
Ensembl chr11:55,564,899...55,587,181
G
C16h13orf46
similar to human chromosome 13 open reading frame 46
decreases expression
ISO
licochalcone B results in decreased expression of C13ORF46 mRNA
CTD
PMID:33647349
NCBI chr16:75,974,501...75,987,629
Ensembl chr16:75,975,463...75,987,628
G
C1h10orf95
similar to human chromosome 10 open reading frame 95
decreases expression
ISO
licochalcone B results in decreased expression of C10ORF95 mRNA
CTD
PMID:33647349
NCBI chr 1:245,210,228...245,212,080
Ensembl chr 1:245,210,973...245,211,602
G
C1h11orf86
similar to human chromosome 11 open reading frame 86
decreases expression
ISO
licochalcone B results in decreased expression of C11ORF86 mRNA
CTD
PMID:33647349
NCBI chr 1:201,784,009...201,785,916
Ensembl chr 1:201,784,009...201,785,916
G
C1ql3
complement C1q like 3
increases expression
ISO
licochalcone B results in increased expression of C1QL3 mRNA
CTD
PMID:33647349
NCBI chr17:76,119,344...76,129,170
Ensembl chr17:76,119,447...76,128,530
G
C1qtnf4
C1q and TNF related 4
increases expression
ISO
licochalcone B results in increased expression of C1QTNF4 mRNA
CTD
PMID:33647349
NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139
G
C5ar2
complement C5a receptor 2
decreases expression
ISO
licochalcone B results in decreased expression of C5AR2 mRNA
CTD
PMID:33647349
NCBI chr 1:76,930,381...76,945,432
Ensembl chr 1:76,930,383...76,959,517
G
Cabp7
calcium binding protein 7
increases expression
ISO
licochalcone B results in increased expression of CABP7 mRNA
CTD
PMID:33647349
NCBI chr14:79,598,822...79,609,172
Ensembl chr14:79,598,827...79,609,240
G
Cacna2d2
calcium voltage-gated channel auxiliary subunit alpha2delta 2
increases expression
ISO
licochalcone B results in increased expression of CACNA2D2 mRNA
CTD
PMID:33647349
NCBI chr 8:108,072,208...108,203,516
Ensembl chr 8:108,072,454...108,203,173
G
Cacnb2
calcium voltage-gated channel auxiliary subunit beta 2
decreases expression
ISO
licochalcone B results in decreased expression of CACNB2 mRNA
CTD
PMID:33647349
NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106
G
Calb2
calbindin 2
increases expression
ISO
licochalcone B results in increased expression of CALB2 mRNA
CTD
PMID:33647349
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Card9
caspase recruitment domain family, member 9
increases expression
ISO
licochalcone B results in increased expression of CARD9 mRNA
CTD
PMID:33647349
NCBI chr 3:9,171,814...9,180,310
Ensembl chr 3:9,171,815...9,180,237
G
Carf
calcium responsive transcription factor
decreases expression
ISO
licochalcone B results in decreased expression of CARF mRNA
CTD
PMID:33647349
NCBI chr 9:61,502,368...61,552,433
Ensembl chr 9:61,506,956...61,550,462
G
Casp14
caspase 14
decreases expression
ISO
licochalcone B results in decreased expression of CASP14 mRNA
CTD
PMID:33647349
NCBI chr 7:10,929,759...10,932,591
Ensembl chr 7:10,926,725...10,933,405
G
Casp3
caspase 3
increases activity
ISO
licochalcone B results in increased activity of CASP3 protein
CTD
PMID:24384411
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases cleavage
ISO
TNFRSF10B protein promotes the reaction [licochalcone B results in increased cleavage of CASP8 protein]
CTD
PMID:35948134
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cass4
Cas scaffold protein family member 4
increases expression
ISO
licochalcone B results in increased expression of CASS4 mRNA
CTD
PMID:33647349
NCBI chr 3:161,162,520...161,202,523
Ensembl chr 3:161,163,436...161,202,186
G
Catsperg
cation channel sperm associated auxiliary subunit gamma
increases expression
ISO
licochalcone B results in increased expression of CATSPERG mRNA
CTD
PMID:33647349
NCBI chr 1:84,488,728...84,519,495
Ensembl chr 1:84,488,730...84,519,559
G
Cbarp
CACN subunit beta associated regulatory protein
increases expression
ISO
licochalcone B results in increased expression of CBARP mRNA
CTD
PMID:33647349
NCBI chr 7:9,566,637...9,575,204
Ensembl chr 7:9,566,364...9,575,204
G
Cbx4
chromobox 4
increases expression
ISO
licochalcone B results in increased expression of CBX4 mRNA
CTD
PMID:33647349
NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
G
Ccdc13
coiled-coil domain containing 13
increases expression
ISO
licochalcone B results in increased expression of CCDC13 mRNA
CTD
PMID:33647349
NCBI chr 8:121,455,202...121,507,487
Ensembl chr 8:121,457,697...121,502,337
G
Ccdc148
coiled-coil domain containing 148
increases expression
ISO
licochalcone B results in increased expression of CCDC148 mRNA
CTD
PMID:33647349
NCBI chr 3:43,356,885...43,631,999
Ensembl chr 3:43,356,892...43,631,991
G
Ccdc194
coiled-coil domain containing 194
increases expression
ISO
licochalcone B results in increased expression of CCDC194 mRNA
CTD
PMID:33647349
NCBI chr16:18,205,099...18,209,310
Ensembl chr16:18,205,095...18,209,283
G
Ccdc68
coiled-coil domain containing 68
decreases expression
ISO
licochalcone B results in decreased expression of CCDC68 mRNA
CTD
PMID:33647349
NCBI chr18:63,541,828...63,584,122
Ensembl chr18:63,541,896...63,584,119
G
Ccdc9
coiled-coil domain containing 9
increases expression
ISO
licochalcone B results in increased expression of CCDC9 mRNA
CTD
PMID:33647349
NCBI chr 1:76,978,312...76,991,673
Ensembl chr 1:76,974,091...76,991,607
G
Ccdc96
coiled-coil domain containing 96
increases expression
ISO
licochalcone B results in increased expression of CFAP184 mRNA
CTD
PMID:33647349
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
G
Ccm2l
CCM2 like scaffold protein
increases expression
ISO
licochalcone B results in increased expression of CCM2L mRNA
CTD
PMID:33647349
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
G
Ccn1
cellular communication network factor 1
increases expression
ISO
licochalcone B results in increased expression of CCN1 mRNA
CTD
PMID:33647349
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
increases expression
ISO
licochalcone B results in increased expression of CCN2 mRNA
CTD
PMID:33647349
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Ccna2
cyclin A2
decreases expression
ISO
licochalcone B results in decreased expression of CCNA2 mRNA
CTD
PMID:24384411
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
licochalcone B results in decreased expression of CCNB1 protein
CTD
PMID:35948134
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccne1
cyclin E1
increases expression
ISO
licochalcone B results in increased expression of CCNE1 mRNA
CTD
PMID:33647349
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Cd14
CD14 molecule
increases expression
ISO
licochalcone B results in increased expression of CD14 mRNA
CTD
PMID:33647349
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd247
Cd247 molecule
increases expression
ISO
licochalcone B results in increased expression of CD247 mRNA
CTD
PMID:33647349
NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263
G
Cd27
CD27 molecule
increases expression
ISO
licochalcone B results in increased expression of CD27 mRNA
CTD
PMID:33647349
NCBI chr 4:158,030,700...158,035,862
Ensembl chr 4:158,030,703...158,035,592
G
Cd4
Cd4 molecule
increases expression
ISO
licochalcone B results in increased expression of CD4 mRNA
CTD
PMID:33647349
NCBI chr 4:157,668,878...157,695,366
G
Cd79a
CD79a molecule
increases expression
ISO
licochalcone B results in increased expression of CD79A mRNA
CTD
PMID:33647349
NCBI chr 1:80,493,581...80,497,936
Ensembl chr 1:80,493,581...80,497,935
G
Cdc25a
cell division cycle 25A
decreases expression
ISO
licochalcone B results in decreased expression of CDC25A protein
CTD
PMID:24384411
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
licochalcone B results in decreased expression of CDC25B protein
CTD
PMID:24384411
NCBI chr 3:118,407,127...118,417,272
Ensembl chr 3:118,407,128...118,417,272
G
Cdc34
cell division cycle 34, ubiqiutin conjugating enzyme
increases expression
ISO
licochalcone B results in increased expression of CDC34 mRNA
CTD
PMID:33647349
NCBI chr 7:10,017,588...10,023,586
Ensembl chr 7:10,017,588...10,023,186
G
Cdc42ep2
CDC42 effector protein 2
increases expression
ISO
licochalcone B results in increased expression of CDC42EP2 mRNA
CTD
PMID:33647349
NCBI chr 1:203,202,000...203,210,891
Ensembl chr 1:203,201,873...203,210,897
G
Cdh23
cadherin-related 23
increases expression
ISO
licochalcone B results in increased expression of CDH23 mRNA
CTD
PMID:33647349
NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419
G
Cdk1
cyclin-dependent kinase 1
decreases expression multiple interactions
ISO
licochalcone B results in decreased expression of CDK1 mRNA licochalcone B results in decreased expression of and results in decreased phosphorylation of CDK1 protein
CTD
PMID:24384411 PMID:35948134
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
licochalcone B results in decreased expression of CDK2 mRNA
CTD
PMID:24384411
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk2ap2
cyclin-dependent kinase 2 associated protein 2
increases expression
ISO
licochalcone B results in increased expression of CDK2AP2 mRNA
CTD
PMID:33647349
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
G
Cdk5r1
cyclin-dependent kinase 5 regulatory subunit 1
increases expression
ISO
licochalcone B results in increased expression of CDK5R1 mRNA
CTD
PMID:33647349
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
G
Cdk5r2
cyclin-dependent kinase 5 regulatory subunit 2
decreases expression
ISO
licochalcone B results in decreased expression of CDK5R2 mRNA
CTD
PMID:33647349
NCBI chr 9:76,416,251...76,417,719
Ensembl chr 9:76,416,062...76,418,344
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
licochalcone B results in increased expression of CDKN1A mRNA
CTD
PMID:33647349
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
licochalcone B results in increased expression of CDKN1B protein
CTD
PMID:35948134
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
increases expression
ISO
licochalcone B results in increased expression of CDKN1C mRNA
CTD
PMID:33647349
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
increases expression
ISO
licochalcone B results in increased expression of CDKN2D mRNA
CTD
PMID:33647349
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Celf5
CUGBP, Elav-like family member 5
increases expression
ISO
licochalcone B results in increased expression of CELF5 mRNA
CTD
PMID:33647349
NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322
G
Cenpe
centromere protein E
decreases expression
ISO
licochalcone B results in decreased expression of CENPE mRNA
CTD
PMID:33647349
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
G
Cfap141
cilia and flagella associated protein 141
increases expression
ISO
licochalcone B results in increased expression of CFAP141 mRNA
CTD
PMID:33647349
NCBI chr 2:175,507,628...175,510,662
Ensembl chr 2:175,507,628...175,510,662
G
Cfap20
cilia and flagella associated protein 20
increases expression
ISO
licochalcone B results in increased expression of CFAP20 mRNA
CTD
PMID:33647349
NCBI chr19:9,608,867...9,622,558
Ensembl chr19:9,608,859...9,622,558
G
Cfap43
cilia and flagella associated protein 43
increases expression
ISO
licochalcone B results in increased expression of CFAP43 mRNA
CTD
PMID:33647349
NCBI chr 1:246,625,259...246,712,438
Ensembl chr 1:246,625,262...246,712,443
G
Cfap99
cilia and flagella associated protein 99
increases expression
ISO
licochalcone B results in increased expression of CFAP99 mRNA
CTD
PMID:33647349
NCBI chr14:76,423,923...76,468,170
Ensembl chr14:76,410,555...76,468,125
G
Cfp
complement factor properdin
increases expression
ISO
licochalcone B results in increased expression of CFP mRNA
CTD
PMID:33647349
NCBI chr X:1,162,014...1,167,576
Ensembl chr X:1,161,979...1,167,573
G
Chac1
ChaC glutathione-specific gamma-glutamylcyclotransferase 1
increases expression
ISO
licochalcone B results in increased expression of CHAC1 mRNA
CTD
PMID:33647349
NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526
G
Chchd7
coiled-coil-helix-coiled-coil-helix domain containing 7
increases expression
ISO
licochalcone B results in increased expression of CHCHD7 mRNA
CTD
PMID:33647349
NCBI chr 5:16,957,127...16,961,682
Ensembl chr 5:16,957,188...16,961,184
G
Chek2
checkpoint kinase 2
increases phosphorylation
ISO
licochalcone B results in increased phosphorylation of CHEK2 protein
CTD
PMID:35948134
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
G
Chrm3
cholinergic receptor, muscarinic 3
decreases expression
ISO
licochalcone B results in decreased expression of CHRM3 mRNA
CTD
PMID:33647349
NCBI chr17:60,005,137...60,467,250
Ensembl chr17:60,005,202...60,467,278
G
Chrm4
cholinergic receptor, muscarinic 4
increases expression
ISO
licochalcone B results in increased expression of CHRM4 mRNA
CTD
PMID:33647349
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Chrna3
cholinergic receptor nicotinic alpha 3 subunit
increases expression
ISO
licochalcone B results in increased expression of CHRNA3 mRNA
CTD
PMID:33647349
NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165
G
Chrna7
cholinergic receptor nicotinic alpha 7 subunit
increases expression
ISO
licochalcone B results in increased expression of CHRNA7 mRNA
CTD
PMID:33647349
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
G
Chrnd
cholinergic receptor nicotinic delta subunit
decreases expression
ISO
licochalcone B results in decreased expression of CHRND mRNA
CTD
PMID:33647349
NCBI chr 9:87,862,417...87,870,833
Ensembl chr 9:87,862,407...87,870,833
G
Chrng
cholinergic receptor nicotinic gamma subunit
decreases expression
ISO
licochalcone B results in decreased expression of CHRNG mRNA
CTD
PMID:33647349
NCBI chr 9:87,878,085...87,884,193
Ensembl chr 9:87,878,085...87,914,482
G
Cimip2a
ciliary microtubule inner protein 2A
increases expression
ISO
licochalcone B results in increased expression of CIMIP2A mRNA
CTD
PMID:33647349
NCBI chr 3:8,030,548...8,038,370
Ensembl chr 3:8,033,246...8,037,961
G
Cited2
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
increases expression
ISO
licochalcone B results in increased expression of CITED2 mRNA
CTD
PMID:33647349
NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897
G
Cks2
CDC28 protein kinase regulatory subunit 2
increases expression
ISO
licochalcone B results in increased expression of CKS2 mRNA
CTD
PMID:33647349
NCBI chr17:13,570,611...13,575,770
G
Cldn19
claudin 19
increases expression
ISO
licochalcone B results in increased expression of CLDN19 mRNA
CTD
PMID:33647349
NCBI chr 5:132,862,939...132,870,364
Ensembl chr 5:132,863,267...132,868,227
G
Cldn6
claudin 6
increases expression
ISO
licochalcone B results in increased expression of CLDN6 mRNA
CTD
PMID:33647349
NCBI chr10:12,710,302...12,713,987
Ensembl chr10:12,709,960...12,715,973
G
Cldn9
claudin 9
increases expression
ISO
licochalcone B results in increased expression of CLDN9 mRNA
CTD
PMID:33647349
NCBI chr10:12,714,137...12,715,568
G
Clu
clusterin
increases expression
ISO
licochalcone B results in increased expression of CLU mRNA
CTD
PMID:33647349
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cnih3
cornichon family AMPA receptor auxiliary protein 3
increases expression
ISO
licochalcone B results in increased expression of CNIH3 mRNA
CTD
PMID:33647349
NCBI chr13:93,016,707...93,208,168
Ensembl chr13:93,099,784...93,208,121
G
Cnnm4
cyclin and CBS domain divalent metal cation transport mediator 4
increases expression
ISO
licochalcone B results in increased expression of CNNM4 mRNA
CTD
PMID:33647349
NCBI chr 9:38,711,726...38,750,942
Ensembl chr 9:38,711,710...38,750,942
G
Cntn2
contactin 2
increases expression
ISO
licochalcone B results in increased expression of CNTN2 mRNA
CTD
PMID:33647349
NCBI chr13:43,942,868...43,975,973
Ensembl chr13:43,947,265...43,975,887
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
licochalcone B results in increased expression of COL6A2 mRNA
CTD
PMID:33647349
NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564
G
Cox8c
cytochrome c oxidase subunit 8C
increases expression
ISO
licochalcone B results in increased expression of COX8C mRNA
CTD
PMID:33647349
NCBI chr 6:122,028,566...122,029,889
Ensembl chr 6:122,028,566...122,029,889
G
Cplx2
complexin 2
increases expression
ISO
licochalcone B results in increased expression of CPLX2 mRNA
CTD
PMID:33647349
NCBI chr17:10,219,577...10,292,835
Ensembl chr17:10,222,347...10,293,855
G
Cps1
carbamoyl-phosphate synthase 1
decreases expression
ISO
licochalcone B results in decreased expression of CPS1 mRNA
CTD
PMID:33647349
NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
G
Crispld1
cysteine-rich secretory protein LCCL domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of CRISPLD1 mRNA
CTD
PMID:33647349
NCBI chr 5:1,267,347...1,314,926
Ensembl chr 5:1,274,647...1,314,926
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
increases expression
ISO
licochalcone B results in increased expression of CRISPLD2 mRNA
CTD
PMID:33647349
NCBI chr19:48,053,153...48,111,485
Ensembl chr19:48,053,287...48,110,465
G
Cryba1
crystallin, beta A1
increases expression
ISO
licochalcone B results in increased expression of CRYBA1 mRNA
CTD
PMID:33647349
NCBI chr10:62,608,373...62,614,726
Ensembl chr10:62,608,383...62,614,726
G
Crybg1
crystallin beta-gamma domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of CRYBG1 mRNA
CTD
PMID:33647349
NCBI chr20:47,425,030...47,496,918
Ensembl chr20:47,426,183...47,621,392
G
Crym
crystallin, mu
increases expression
ISO
licochalcone B results in increased expression of CRYM mRNA
CTD
PMID:33647349
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Csrnp1
cysteine and serine rich nuclear protein 1
increases expression
ISO
licochalcone B results in increased expression of CSRNP1 mRNA
CTD
PMID:33647349
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
G
Csrnp2
cysteine and serine rich nuclear protein 2
increases expression
ISO
licochalcone B results in increased expression of CSRNP2 mRNA
CTD
PMID:33647349
NCBI chr 7:131,594,232...131,610,075
Ensembl chr 7:131,594,232...131,610,075
G
Csrp2
cysteine and glycine-rich protein 2
increases expression
ISO
licochalcone B results in increased expression of CSRP2 mRNA
CTD
PMID:33647349
NCBI chr 7:46,349,109...46,367,743
Ensembl chr 7:46,348,686...46,367,745
G
Ctrc
chymotrypsin C
increases expression
ISO
licochalcone B results in increased expression of CTRC mRNA
CTD
PMID:33647349
NCBI chr 5:154,147,314...154,156,540
Ensembl chr 5:154,147,316...154,156,528
G
Cxxc4
CXXC finger protein 4
decreases expression
ISO
licochalcone B results in decreased expression of CXXC4 mRNA
CTD
PMID:33647349
NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365
G
Cygb
cytoglobin
decreases expression
ISO
licochalcone B results in decreased expression of CYGB mRNA
CTD
PMID:33647349
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
ISO
licochalcone B results in increased expression of CYP27A1 mRNA
CTD
PMID:33647349
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Dact3
dishevelled-binding antagonist of beta-catenin 3
increases expression
ISO
licochalcone B results in increased expression of DACT3 mRNA
CTD
PMID:33647349
NCBI chr 1:77,546,900...77,558,631
Ensembl chr 1:77,546,900...77,558,630
G
Dcxr
dicarbonyl and L-xylulose reductase
increases expression
ISO
licochalcone B results in increased expression of DCXR mRNA
CTD
PMID:33647349
NCBI chr10:106,006,404...106,008,293
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
licochalcone B results in increased expression of DDIT3 mRNA; licochalcone B results in increased expression of DDIT3 protein
CTD
PMID:33647349 PMID:35948134
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Ddr2
discoidin domain receptor tyrosine kinase 2
increases expression
ISO
licochalcone B results in increased expression of DDR2 mRNA
CTD
PMID:33647349
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
G
Ddx60
DEXD/H-box helicase 60
decreases expression
ISO
licochalcone B results in decreased expression of DDX60 mRNA
CTD
PMID:33647349
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dedd2
death effector domain containing 2
increases expression
ISO
licochalcone B results in increased expression of DEDD2 mRNA
CTD
PMID:33647349
NCBI chr 1:80,789,084...80,807,789
Ensembl chr 1:80,792,000...80,807,714
G
Dgat1
diacylglycerol O-acyltransferase 1
increases expression
ISO
licochalcone B results in increased expression of DGAT1 mRNA
CTD
PMID:33647349
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
G
Dhdh
dihydrodiol dehydrogenase
increases expression
ISO
licochalcone B results in increased expression of DHDH mRNA
CTD
PMID:33647349
NCBI chr 1:95,954,361...95,965,262
Ensembl chr 1:95,953,092...95,965,197
G
Dhx58
DEXH-box helicase 58
increases expression
ISO
licochalcone B results in increased expression of DHX58 mRNA
CTD
PMID:33647349
NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525
G
Dio2
iodothyronine deiodinase 2
decreases expression
ISO
licochalcone B results in decreased expression of DIO2 mRNA
CTD
PMID:33647349
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dio3
iodothyronine deiodinase 3
increases expression
ISO
licochalcone B results in increased expression of DIO3 mRNA
CTD
PMID:33647349
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
Disp3
dispatched RND transporter family member 3
increases expression
ISO
licochalcone B results in increased expression of DISP3 mRNA
CTD
PMID:33647349
NCBI chr 5:158,672,015...158,720,806
Ensembl chr 5:158,672,015...158,720,806
G
Dixdc1
DIX domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of DIXDC1 mRNA
CTD
PMID:33647349
NCBI chr 8:51,007,835...51,081,191
Ensembl chr 8:51,007,838...51,081,090
G
Dlg3
discs large MAGUK scaffold protein 3
decreases expression
ISO
licochalcone B results in decreased expression of DLG3 mRNA
CTD
PMID:33647349
NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322
G
Dll4
delta like canonical Notch ligand 4
increases expression
ISO
licochalcone B results in increased expression of DLL4 mRNA
CTD
PMID:33647349
NCBI chr 3:106,317,114...106,327,004
Ensembl chr 3:106,316,986...106,326,931
G
Dlx2
distal-less homeobox 2
increases expression
ISO
licochalcone B results in increased expression of DLX2 mRNA
CTD
PMID:33647349
NCBI chr 3:56,370,238...56,373,581
Ensembl chr 3:56,370,483...56,373,597
G
Dmbt1
deleted in malignant brain tumors 1
decreases expression
ISO
licochalcone B results in decreased expression of DMBT1 mRNA
CTD
PMID:33647349
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
G
Dnah3
dynein, axonemal, heavy chain 3
increases expression
ISO
licochalcone B results in increased expression of DNAH3 mRNA
CTD
PMID:33647349
NCBI chr 1:174,305,929...174,479,490
Ensembl chr 1:174,306,644...174,479,474
G
Dnaja4
DnaJ heat shock protein family (Hsp40) member A4
increases expression
ISO
licochalcone B results in increased expression of DNAJA4 mRNA
CTD
PMID:33647349
NCBI chr 8:55,085,246...55,102,715
Ensembl chr 8:55,085,464...55,101,207
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
increases expression
ISO
licochalcone B results in increased expression of DNAJB1 mRNA
CTD
PMID:33647349
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
G
Dnajc28
DnaJ heat shock protein family (Hsp40) member C28
decreases expression
ISO
licochalcone B results in decreased expression of DNAJC28 mRNA
CTD
PMID:33647349
NCBI chr11:30,855,566...30,858,386
Ensembl chr11:30,853,526...30,858,441
G
Dock3
dedicator of cyto-kinesis 3
increases expression
ISO
licochalcone B results in increased expression of DOCK3 mRNA
CTD
PMID:33647349
NCBI chr 8:107,552,462...107,903,527
Ensembl chr 8:107,552,463...107,903,514
G
Drap1
Dr1 associated protein 1
increases expression
ISO
licochalcone B results in increased expression of DRAP1 mRNA
CTD
PMID:33647349
NCBI chr 1:202,731,775...202,734,468
Ensembl chr 1:202,731,788...202,734,425
G
Drc1
dynein regulatory complex subunit 1
increases expression
ISO
licochalcone B results in increased expression of DRC1 mRNA
CTD
PMID:33647349
NCBI chr 6:26,025,004...26,059,438
Ensembl chr 6:26,025,005...26,059,414
G
Dtx3l
deltex E3 ubiquitin ligase 3L
decreases expression
ISO
licochalcone B results in decreased expression of DTX3L mRNA
CTD
PMID:33647349
NCBI chr11:64,814,926...64,824,539
Ensembl chr11:64,814,926...64,824,538
G
Dusp2
dual specificity phosphatase 2
increases expression
ISO
licochalcone B results in increased expression of DUSP2 mRNA
CTD
PMID:33647349
NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
licochalcone B results in increased expression of DUSP5 mRNA
CTD
PMID:33647349
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp7
dual specificity phosphatase 7
increases expression
ISO
licochalcone B results in increased expression of DUSP7 mRNA
CTD
PMID:33647349
NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404
G
Eddm13
epididymal protein 13
decreases expression
ISO
licochalcone B results in decreased expression of EDDM13 mRNA
CTD
PMID:33647349
NCBI chr 1:67,630,905...67,656,404
Ensembl chr 1:67,626,244...67,657,342
G
Ednra
endothelin receptor type A
decreases expression
ISO
licochalcone B results in decreased expression of EDNRA mRNA
CTD
PMID:33647349
NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049
G
Eeig1
estrogen-induced osteoclastogenesis regulator 1
increases expression
ISO
licochalcone B results in increased expression of EEIG1 mRNA
CTD
PMID:33647349
NCBI chr 3:15,822,441...15,854,651
Ensembl chr 3:15,823,144...15,854,643
G
Efnb2
ephrin B2
increases expression
ISO
licochalcone B results in increased expression of EFNB2 mRNA
CTD
PMID:33647349
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
G
Efnb3
ephrin B3
increases expression
ISO
licochalcone B results in increased expression of EFNB3 mRNA
CTD
PMID:33647349
NCBI chr10:54,274,506...54,281,951
Ensembl chr10:54,274,506...54,280,471
G
Egfl8
EGF-like-domain, multiple 8
decreases expression
ISO
licochalcone B results in decreased expression of EGFL8 mRNA
CTD
PMID:33647349
NCBI chr20:4,132,930...4,136,024
Ensembl chr20:4,133,629...4,136,018
G
Egr1
early growth response 1
increases expression
ISO
licochalcone B results in increased expression of EGR1 mRNA
CTD
PMID:33647349
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Egr3
early growth response 3
increases expression
ISO
licochalcone B results in increased expression of EGR3 mRNA
CTD
PMID:33647349
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
G
Ehd1
EH-domain containing 1
increases expression
ISO
licochalcone B results in increased expression of EHD1 mRNA
CTD
PMID:33647349
NCBI chr 1:203,579,850...203,602,226
Ensembl chr 1:203,579,869...203,602,212
G
Ehf
ets homologous factor
decreases expression
ISO
licochalcone B results in decreased expression of EHF mRNA
CTD
PMID:33647349
NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:89,641,833...89,679,997
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
decreases expression
ISO
licochalcone B results in decreased expression of EIF2AK3 protein
CTD
PMID:35948134
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
licochalcone B results in increased expression of EIF4A1 mRNA
CTD
PMID:33647349
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4a3
eukaryotic translation initiation factor 4A3
increases expression
ISO
licochalcone B results in increased expression of EIF4A3 mRNA
CTD
PMID:33647349
NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057
G
Emc9
ER membrane protein complex subunit 9
increases expression
ISO
licochalcone B results in increased expression of EMC9 mRNA
CTD
PMID:33647349
NCBI chr15:29,071,881...29,076,098
Ensembl chr15:29,071,883...29,076,098
G
Engase
endo-beta-N-acetylglucosaminidase
increases expression
ISO
licochalcone B results in increased expression of ENGASE mRNA
CTD
PMID:33647349
NCBI chr10:103,707,169...103,719,833
Ensembl chr10:103,707,169...103,719,819
G
Epha2
Eph receptor A2
increases expression
ISO
licochalcone B results in increased expression of EPHA2 mRNA
CTD
PMID:33647349
NCBI chr 5:153,605,644...153,634,115
Ensembl chr 5:153,605,644...153,634,117
G
Epha3
Eph receptor A3
decreases expression
ISO
licochalcone B results in decreased expression of EPHA3 mRNA
CTD
PMID:33647349
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
G
Eppk1
epiplakin 1
increases expression
ISO
licochalcone B results in increased expression of EPPK1 mRNA
CTD
PMID:33647349
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
G
Eras
ES cell expressed Ras
increases expression
ISO
licochalcone B results in increased expression of ERAS mRNA
CTD
PMID:33647349
NCBI chr X:14,573,987...14,578,455
Ensembl chr X:14,573,987...14,578,374
G
Erf
Ets2 repressor factor
increases expression
ISO
licochalcone B results in increased expression of ERF mRNA
CTD
PMID:33647349
NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388
G
Erlin2
ER lipid raft associated 2
decreases expression
ISO
licochalcone B results in decreased expression of ERLIN2 mRNA
CTD
PMID:33647349
NCBI chr16:65,017,654...65,034,184
Ensembl chr16:65,018,532...65,033,671
G
Espn
espin
increases expression
ISO
licochalcone B results in increased expression of ESPN mRNA
CTD
PMID:33647349
NCBI chr 5:162,626,560...162,660,439
Ensembl chr 5:162,626,560...162,660,256
G
Eva1b
eva-1 homolog B
increases expression
ISO
licochalcone B results in increased expression of EVA1B mRNA
CTD
PMID:33647349
NCBI chr 5:138,427,088...138,429,602
Ensembl chr 5:138,427,151...138,432,433
G
Exoc3l2
exocyst complex component 3-like 2
increases expression
ISO
licochalcone B results in increased expression of EXOC3L2 mRNA
CTD
PMID:33647349
NCBI chr 1:79,113,784...79,145,359
Ensembl chr 1:79,112,506...79,145,465
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
licochalcone B results in decreased expression of F2R mRNA
CTD
PMID:33647349
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
Fam117a
family with sequence similarity 117, member A
increases expression
ISO
licochalcone B results in increased expression of FAM117A mRNA
CTD
PMID:33647349
NCBI chr10:80,281,411...80,325,345
Ensembl chr10:80,281,408...80,325,343
G
Fam222a
family with sequence similarity 222, member A
increases expression
ISO
licochalcone B results in increased expression of FAM222A mRNA
CTD
PMID:33647349
NCBI chr12:41,982,064...42,033,085
Ensembl chr12:41,986,780...42,033,682
G
Fam228b
family with sequence similarity 228, member B
increases expression
ISO
licochalcone B results in increased expression of FAM228B mRNA
CTD
PMID:33647349
NCBI chr 6:27,754,505...27,786,578
Ensembl chr 6:27,754,506...27,786,537
G
Fam43a
family with sequence similarity 43, member A
increases expression
ISO
licochalcone B results in increased expression of FAM43A mRNA
CTD
PMID:33647349
NCBI chr11:70,128,253...70,131,401
Ensembl chr11:70,128,253...70,131,401
G
Fam78a
family with sequence similarity 78, member A
decreases expression
ISO
licochalcone B results in decreased expression of FAM78A mRNA
CTD
PMID:33647349
NCBI chr 3:15,355,958...15,376,330
Ensembl chr 3:15,355,955...15,373,812
G
Fam89b
family with sequence similarity 89, member B
increases expression
ISO
licochalcone B results in increased expression of FAM89B mRNA
CTD
PMID:33647349
NCBI chr 1:203,015,772...203,017,890
Ensembl chr 1:203,015,773...203,017,367
G
Fam90a1a
family with sequence similarity 90 member A1A
increases expression
ISO
licochalcone B results in increased expression of FAM90A1 mRNA
CTD
PMID:33647349
NCBI chr16:70,098,439...70,106,147
Ensembl chr16:70,098,740...70,101,241
G
Fbll1
fibrillarin-like 1
increases expression
ISO
licochalcone B results in increased expression of FBLL1 mRNA
CTD
PMID:33647349
NCBI chr10:20,258,656...20,260,299
Ensembl chr10:20,258,656...20,260,299
G
Fbxo32
F-box protein 32
increases expression
ISO
licochalcone B results in increased expression of FBXO32 mRNA
CTD
PMID:33647349
NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436
G
Fcgbp
Fc gamma binding protein
increases expression
ISO
licochalcone B results in increased expression of FCGBP mRNA
CTD
PMID:33647349
NCBI chr 1:83,374,979...83,413,082
Ensembl chr 1:83,372,127...83,413,083
G
Fcgr1a
Fc gamma receptor 1A
increases expression
ISO
licochalcone B results in increased expression of FCGR1A mRNA
CTD
PMID:33647349
NCBI chr 2:183,851,075...183,860,077
Ensembl chr 2:183,851,077...183,859,994
G
Fer1l5
fer-1-like family member 5
increases expression
ISO
licochalcone B results in increased expression of FER1L5 mRNA
CTD
PMID:33647349
NCBI chr 9:38,605,835...38,661,869
Ensembl chr 9:38,607,843...38,660,425
G
Fgf18
fibroblast growth factor 18
increases expression
ISO
licochalcone B results in increased expression of FGF18 mRNA
CTD
PMID:33647349
NCBI chr10:17,706,011...17,737,702
Ensembl chr10:17,706,174...17,736,818
G
Fgf22
fibroblast growth factor 22
increases expression
ISO
licochalcone B results in increased expression of FGF22 mRNA
CTD
PMID:33647349
NCBI chr 7:9,947,632...9,956,918
Ensembl chr 7:9,948,071...9,950,486
G
Fgfr3
fibroblast growth factor receptor 3
increases expression
ISO
licochalcone B results in increased expression of FGFR3 mRNA
CTD
PMID:33647349
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Fitm1
fat storage-inducing transmembrane protein 1
increases expression
ISO
licochalcone B results in increased expression of FITM1 mRNA
CTD
PMID:33647349
NCBI chr15:29,064,746...29,066,015
Ensembl chr15:29,064,707...29,066,015
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
licochalcone B results in increased expression of FOS mRNA licochalcone B analog inhibits the reaction [Lipopolysaccharides affects the localization of FOS protein]
CTD
PMID:25451593 PMID:33647349
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosb
FosB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
licochalcone B results in increased expression of FOSB mRNA
CTD
PMID:33647349
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
licochalcone B results in increased expression of FOSL1 mRNA
CTD
PMID:33647349
NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930
G
Foxa3
forkhead box A3
increases expression
ISO
licochalcone B results in increased expression of FOXA3 mRNA
CTD
PMID:33647349
NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155
G
Foxd1
forkhead box D1
increases expression
ISO
licochalcone B results in increased expression of FOXD1 mRNA
CTD
PMID:33647349
NCBI chr 2:29,702,558...29,704,978
Ensembl chr 2:29,702,558...29,704,978
G
Foxe3
forkhead box E3
increases expression
ISO
licochalcone B results in increased expression of FOXE3 mRNA
CTD
PMID:33647349
NCBI chr 5:128,444,912...128,446,494
Ensembl chr 5:128,445,594...128,446,454
G
Foxp4
forkhead box P4
increases expression
ISO
licochalcone B results in increased expression of FOXP4 mRNA
CTD
PMID:33647349
NCBI chr 9:13,058,506...13,115,406
Ensembl chr 9:13,058,476...13,114,879
G
Frey1
Frey regulator of sperm-oocyte fusion 1
increases expression
ISO
licochalcone B results in increased expression of FREY1 mRNA
CTD
PMID:33647349
NCBI chr 3:78,354,303...78,355,055
Ensembl chr 3:78,354,303...78,355,055
G
Frg2
FSHD region gene 2
increases expression
ISO
licochalcone B results in increased expression of FRG2 mRNA
CTD
PMID:33647349
NCBI chr14:80,427,260...80,429,560
Ensembl chr14:80,427,673...80,429,181
G
Fry
FRY microtubule binding protein
decreases expression
ISO
licochalcone B results in decreased expression of FRY mRNA
CTD
PMID:33647349
NCBI chr12:4,493,890...4,887,118
Ensembl chr12:4,493,891...4,799,116
G
Frzb
frizzled-related protein
increases expression
ISO
licochalcone B results in increased expression of FRZB mRNA
CTD
PMID:33647349
NCBI chr 3:65,332,274...65,365,208
Ensembl chr 3:65,332,277...65,365,208
G
Fut1
fucosyltransferase 1
decreases expression
ISO
licochalcone B results in decreased expression of FUT1 mRNA
CTD
PMID:33647349
NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
licochalcone B results in decreased expression of FYCO1 mRNA
CTD
PMID:33647349
NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021
G
Fzd7
frizzled class receptor 7
increases expression
ISO
licochalcone B results in increased expression of FZD7 mRNA
CTD
PMID:33647349
NCBI chr 9:60,931,433...60,934,252
Ensembl chr 9:60,930,875...60,935,781
G
Gabrr2
gamma-aminobutyric acid type A receptor subunit rho 2
increases expression
ISO
licochalcone B results in increased expression of GABRR2 mRNA
CTD
PMID:33647349
NCBI chr 5:47,445,280...47,489,929
Ensembl chr 5:47,452,150...47,489,809
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
licochalcone B results in increased expression of GADD45A mRNA
CTD
PMID:33647349
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
ISO
licochalcone B results in increased expression of GADD45B mRNA
CTD
PMID:33647349
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Galntl6
polypeptide N-acetylgalactosaminyltransferase-like 6
decreases expression
ISO
licochalcone B results in decreased expression of GALNTL6 mRNA
CTD
PMID:33647349
NCBI chr16:31,192,880...32,443,979
Ensembl chr16:31,186,462...32,441,960
G
Galr2
galanin receptor 2
increases expression
ISO
licochalcone B results in increased expression of GALR2 mRNA
CTD
PMID:33647349
NCBI chr10:101,513,689...101,517,176
Ensembl chr10:101,514,471...101,517,176
G
Gata2
GATA binding protein 2
increases expression
ISO
licochalcone B results in increased expression of GATA2 mRNA
CTD
PMID:33647349
NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761
G
Gata3
GATA binding protein 3
increases expression
ISO
licochalcone B results in increased expression of GATA3 mRNA
CTD
PMID:33647349
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gbx2
gastrulation brain homeobox 2
increases expression
ISO
licochalcone B results in increased expression of GBX2 mRNA
CTD
PMID:33647349
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
G
Gcm1
glial cells missing transcription factor 1
increases expression
ISO
licochalcone B results in increased expression of GCM1 mRNA
CTD
PMID:33647349
NCBI chr 8:78,925,687...78,938,924
Ensembl chr 8:78,925,687...78,938,924
G
Gem
GTP binding protein overexpressed in skeletal muscle
increases expression
ISO
licochalcone B results in increased expression of GEM mRNA
CTD
PMID:33647349
NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222
G
Get4
guided entry of tail-anchored proteins factor 4
increases expression
ISO
licochalcone B results in increased expression of GET4 mRNA
CTD
PMID:33647349
NCBI chr12:15,377,009...15,394,238
Ensembl chr12:15,377,009...15,394,053
G
Gfi1
growth factor independent 1 transcriptional repressor
decreases expression
ISO
licochalcone B results in decreased expression of GFI1 mRNA
CTD
PMID:33647349
NCBI chr14:2,040,576...2,056,874
Ensembl chr14:2,042,434...2,051,814
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
licochalcone B results in increased expression of GFPT2 mRNA
CTD
PMID:33647349
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Gfra3
GDNF family receptor alpha 3
increases expression
ISO
licochalcone B results in increased expression of GFRA3 mRNA
CTD
PMID:33647349
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Gipc2
GIPC PDZ domain containing family, member 2
increases expression
ISO
licochalcone B results in increased expression of GIPC2 mRNA
CTD
PMID:33647349
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
G
Gng13
G protein subunit gamma 13
increases expression
ISO
licochalcone B results in increased expression of GNG13 mRNA
CTD
PMID:33647349
NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083
G
Gstm5l
glutathione S-transferase, mu 5-like
increases expression
ISO
licochalcone B results in increased expression of GSTM5 mRNA
CTD
PMID:33647349
NCBI chr 2:195,544,424...195,549,895
Ensembl chr 2:195,544,426...195,628,961
G
Gzmm
granzyme M
increases expression
ISO
licochalcone B results in increased expression of GZMM mRNA
CTD
PMID:33647349
NCBI chr 7:10,011,065...10,016,841
Ensembl chr 7:10,011,066...10,016,665
G
H1f4
H1.4 linker histone, cluster member
increases expression
ISO
licochalcone B results in increased expression of H1-4 mRNA
CTD
PMID:33647349
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
G
H2ac12
H2A clustered histone 12
increases expression
ISO
licochalcone B results in increased expression of H2AC12 mRNA
CTD
PMID:33647349
NCBI chr17:42,486,415...42,486,880
Ensembl chr17:42,486,415...42,486,941
G
H2ac21
H2A clustered histone 21
increases expression
ISO
licochalcone B results in increased expression of H2AC21 mRNA
CTD
PMID:33647349
NCBI chr 2:183,779,355...183,779,788
G
H2ax
H2A.X variant histone
increases expression increases phosphorylation
ISO
licochalcone B results in increased expression of H2AX mRNA licochalcone B results in increased phosphorylation of H2AX protein
CTD
PMID:33647349 PMID:35948134
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H2bc12
H2B clustered histone 12
increases expression
ISO
licochalcone B results in increased expression of H2BC12 mRNA
CTD
PMID:33647349
NCBI chr17:42,485,699...42,486,162
G
H2bc18
H2B clustered histone 18
increases expression
ISO
licochalcone B results in increased expression of H2BC18 mRNA
CTD
PMID:33647349
NCBI chr 2:183,838,331...183,842,769
Ensembl chr 2:183,838,334...183,841,529
G
H2bc6
H2B clustered histone 6
increases expression
ISO
licochalcone B results in increased expression of H2BC6 mRNA
CTD
PMID:33647349
NCBI chr17:41,520,775...41,521,238
G
H2bc8
H2B clustered histone 8
increases expression
ISO
licochalcone B results in increased expression of H2BC8 mRNA
CTD
PMID:33647349
NCBI chr17:42,708,658...42,709,408
G
H2bc9
H2B clustered histone 9
increases expression
ISO
licochalcone B results in increased expression of H2BC9 mRNA
CTD
PMID:33647349
NCBI chr17:42,470,593...42,478,590
G
H3c1
H3 clustered histone 1
increases expression
ISO
licochalcone B results in increased expression of H3C1 mRNA
CTD
PMID:33647349
NCBI chr17:41,368,379...41,368,902
Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856 Ensembl chr17:41,368,386...41,368,856
G
H3c13
H3 clustered histone 13
increases expression
ISO
licochalcone B results in increased expression of H3C13 mRNA
CTD
PMID:33647349
NCBI chr17:41,531,502...41,531,971
Ensembl chr 2:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr 2:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr17:183,795,504...183,809,469 Ensembl chr 2:183,795,504...183,809,469
G
H4c3
H4 clustered histone 3
increases expression
ISO
licochalcone B results in increased expression of H4C3 mRNA
CTD
PMID:33647349
G
Hamp
hepcidin antimicrobial peptide
increases expression
ISO
licochalcone B results in increased expression of HAMP mRNA
CTD
PMID:33647349
NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
G
Hapln2
hyaluronan and proteoglycan link protein 2
increases expression
ISO
licochalcone B results in increased expression of HAPLN2 mRNA
CTD
PMID:33647349
NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588
G
Hapln3
hyaluronan and proteoglycan link protein 3
increases expression
ISO
licochalcone B results in increased expression of HAPLN3 mRNA
CTD
PMID:33647349
NCBI chr 1:133,046,465...133,064,665
Ensembl chr 1:133,046,467...133,080,177
G
Has1
hyaluronan synthase 1
increases expression
ISO
licochalcone B results in increased expression of HAS1 mRNA
CTD
PMID:33647349
NCBI chr 1:58,693,411...58,705,653
Ensembl chr 1:58,693,411...58,705,397
G
Has3
hyaluronan synthase 3
increases expression
ISO
licochalcone B results in increased expression of HAS3 mRNA
CTD
PMID:33647349
NCBI chr19:34,768,421...34,782,170
Ensembl chr19:34,771,982...34,782,592
G
Hba-a2
hemoglobin alpha, adult chain 2
increases expression
ISO
licochalcone B results in increased expression of HBA1 mRNA
CTD
PMID:33647349
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
G
Hbegf
heparin-binding EGF-like growth factor
increases expression
ISO
licochalcone B results in increased expression of HBEGF mRNA
CTD
PMID:33647349
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
licochalcone B results in increased expression of HERPUD1 mRNA
CTD
PMID:33647349
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hes6
hes family bHLH transcription factor 6
increases expression
ISO
licochalcone B results in increased expression of HES6 mRNA
CTD
PMID:33647349
NCBI chr 9:92,001,849...92,003,562
Ensembl chr 9:92,001,841...92,003,559
G
Hes7
hes family bHLH transcription factor 7
increases expression
ISO
licochalcone B results in increased expression of HES7 mRNA
CTD
PMID:33647349
NCBI chr10:53,824,124...53,828,934
Ensembl chr10:53,825,574...53,828,097
G
Hic2
HIC ZBTB transcriptional repressor 2
increases expression
ISO
licochalcone B results in increased expression of HIC2 mRNA
CTD
PMID:33647349
NCBI chr11:83,737,075...83,789,554
Ensembl chr11:83,738,874...83,767,484
G
Hipk4
homeodomain interacting protein kinase 4
increases expression
ISO
licochalcone B results in increased expression of HIPK4 mRNA
CTD
PMID:33647349
NCBI chr 1:82,810,708...82,821,080
Ensembl chr 1:82,810,708...82,821,077
G
Hist1h2af
histone cluster 1 H2A family member F
increases expression
ISO
licochalcone B results in increased expression of H2AC8 mRNA
CTD
PMID:33647349
NCBI chr17:41,379,404...41,379,796
Ensembl chr17:41,379,404...41,379,796
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
licochalcone B results in increased expression of H2BC5 mRNA
CTD
PMID:33647349
NCBI chr17:42,792,887...42,793,268
G
Hist1h2bq
histone cluster 1 H2B family member Q
increases expression
ISO
licochalcone B results in increased expression of H2BC7 mRNA
CTD
PMID:33647349
NCBI chr17:41,432,100...41,441,487
Ensembl chr17:41,429,164...41,442,153
G
Hist1h4b
histone cluster 1 H4 family member B
increases expression
ISO
licochalcone B results in increased expression of H4C9 mRNA
CTD
PMID:33647349
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
G
Hist1h4m
histone cluster 1, H4m
increases expression
ISO
licochalcone B results in increased expression of H4C1 mRNA
CTD
PMID:33647349
NCBI chr17:42,698,016...42,698,420
Ensembl chr17:42,698,025...42,698,958
G
Hist2h2be
histone cluster 2 H2B family member E
increases expression
ISO
licochalcone B results in increased expression of H2BC11 mRNA
CTD
PMID:33647349
NCBI chr 2:183,780,583...183,783,030
G
Hist2h4a
histone cluster 2 H4 family member A
increases expression
ISO
licochalcone B results in increased expression of H4C4 mRNA
CTD
PMID:33647349
G
Hmox1
heme oxygenase 1
increases expression
ISO
licochalcone B results in increased expression of HMOX1 mRNA
CTD
PMID:33647349
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Homer2
homer scaffold protein 2
increases expression
ISO
licochalcone B results in increased expression of HOMER2 mRNA
CTD
PMID:33647349
NCBI chr 1:135,558,977...135,659,780
Ensembl chr 1:135,567,414...135,659,772
G
Hoxc4
homeo box C4
decreases expression
ISO
licochalcone B results in decreased expression of HOXC4 mRNA
CTD
PMID:33647349
NCBI chr 7:134,135,279...134,173,133
Ensembl chr 7:134,170,591...134,173,133
G
Hpx
hemopexin
increases expression
ISO
licochalcone B results in increased expression of HPX mRNA
CTD
PMID:33647349
NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
licochalcone B results in increased expression of HSPA1A mRNA
CTD
PMID:33647349
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
licochalcone B results in increased expression of HSPA1B mRNA
CTD
PMID:33647349
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
increases expression
ISO
licochalcone B results in increased expression of HSPA1L mRNA
CTD
PMID:33647349
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
licochalcone B results in increased expression of HSPA6 mRNA
CTD
PMID:33647349
NCBI chr13:83,273,176...83,274,317
G
Hspa8
heat shock protein family A (Hsp70) member 8
increases expression
ISO
licochalcone B results in increased expression of HSPA8 mRNA
CTD
PMID:33647349
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
licochalcone B results in increased expression of HSPB8 mRNA
CTD
PMID:33647349
NCBI chr12:40,176,405...40,205,002
Ensembl chr12:40,176,532...40,191,185
G
Hspb9
heat shock protein family B (small) member 9
increases expression
ISO
licochalcone B results in increased expression of HSPB9 mRNA
CTD
PMID:33647349
NCBI chr10:85,641,284...85,641,929
Ensembl chr10:85,641,284...85,641,929
G
Hsph1
heat shock protein family H (Hsp110) member 1
increases expression
ISO
licochalcone B results in increased expression of HSPH1 mRNA
CTD
PMID:33647349
NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224
G
Hus1b
HUS1 checkpoint clamp component B
increases expression
ISO
licochalcone B results in increased expression of HUS1B mRNA
CTD
PMID:33647349
NCBI chr17:33,534,032...33,535,199
G
Id2
inhibitor of DNA binding 2
increases expression
ISO
licochalcone B results in increased expression of ID2 mRNA
CTD
PMID:33647349
NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400
G
Ier5
immediate early response 5
increases expression
ISO
licochalcone B results in increased expression of IER5 mRNA
CTD
PMID:33647349
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ier5l
immediate early response 5-like
increases expression
ISO
licochalcone B results in increased expression of IER5L mRNA
CTD
PMID:33647349
NCBI chr 3:13,744,056...13,745,647
Ensembl chr 3:13,744,078...13,745,647
G
Ifi30
IFI30, lysosomal thiol reductase
increases expression
ISO
licochalcone B results in increased expression of IFI30 mRNA
CTD
PMID:33647349
NCBI chr16:18,675,590...18,679,655
Ensembl chr16:18,675,613...18,681,175
G
Ifih1
interferon induced with helicase C domain 1
decreases expression
ISO
licochalcone B results in decreased expression of IFIH1 mRNA
CTD
PMID:33647349
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Igsf11
immunoglobulin superfamily, member 11
increases expression
ISO
licochalcone B results in increased expression of IGSF11 mRNA
CTD
PMID:33647349
NCBI chr11:61,733,139...61,884,059
Ensembl chr11:61,733,144...61,868,348
G
Il1a
interleukin 1 alpha
decreases expression
ISO
licochalcone B results in decreased expression of IL1A mRNA
CTD
PMID:33647349
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
decreases expression multiple interactions
ISO
licochalcone B results in decreased expression of IL1B mRNA licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
CTD
PMID:25451593 PMID:33647349
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
decreases expression
ISO
licochalcone B results in decreased expression of IL1R1 mRNA
CTD
PMID:33647349
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il2rb
interleukin 2 receptor subunit beta
decreases expression
ISO
licochalcone B results in decreased expression of IL2RB mRNA
CTD
PMID:33647349
NCBI chr 7:110,033,341...110,048,054
Ensembl chr 7:110,033,341...110,048,054
G
Il6
interleukin 6
multiple interactions decreases expression
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] licochalcone B results in decreased expression of IL6 mRNA
CTD
PMID:25451593 PMID:33647349
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inafm1
InaF-motif containing 1
increases expression
ISO
licochalcone B results in increased expression of INAFM1 mRNA
CTD
PMID:33647349
NCBI chr 1:76,976,808...76,978,292
G
Inhbe
inhibin subunit beta E
decreases expression
ISO
licochalcone B results in decreased expression of INHBE mRNA
CTD
PMID:33647349
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inka1
inka box actin regulator 1
increases expression
ISO
licochalcone B results in increased expression of INKA1 mRNA
CTD
PMID:33647349
NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953
G
Insm2
INSM transcriptional repressor 2
increases expression
ISO
licochalcone B results in increased expression of INSM2 mRNA
CTD
PMID:33647349
NCBI chr 6:72,973,861...72,976,453
G
Irf7
interferon regulatory factor 7
increases expression
ISO
licochalcone B results in increased expression of IRF7 mRNA
CTD
PMID:33647349
NCBI chr 1:196,367,380...196,370,943
Ensembl chr 1:196,367,361...196,370,832
G
Irgc
immunity related GTPase cinema
increases expression
ISO
licochalcone B results in increased expression of IRGC mRNA
CTD
PMID:33647349
NCBI chr 1:80,020,114...80,025,797
Ensembl chr 1:80,020,079...80,025,802
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression
ISO
licochalcone B results in increased expression of JMJD6 mRNA
CTD
PMID:33647349
NCBI chr10:102,041,131...102,047,182
Ensembl chr10:102,041,120...102,047,182
G
Jph4
junctophilin 4
increases expression
ISO
licochalcone B results in increased expression of JPH4 mRNA
CTD
PMID:33647349
NCBI chr15:28,579,579...28,588,903
Ensembl chr15:28,571,568...28,587,573
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO
licochalcone B results in increased expression of JUN mRNA licochalcone B analog inhibits the reaction [Lipopolysaccharides affects the localization of JUN protein]
CTD
PMID:25451593 PMID:33647349
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Junb
JunB proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
licochalcone B results in increased expression of JUNB mRNA
CTD
PMID:33647349
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
licochalcone B results in increased expression of JUND mRNA
CTD
PMID:33647349
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Kank3
KN motif and ankyrin repeat domains 3
increases expression
ISO
licochalcone B results in increased expression of KANK3 mRNA
CTD
PMID:33647349
NCBI chr 7:14,594,358...14,607,675
Ensembl chr 7:14,594,422...14,607,675
G
Kbtbd8
kelch repeat and BTB domain containing 8
increases expression
ISO
licochalcone B results in increased expression of KBTBD8 mRNA
CTD
PMID:33647349
NCBI chr 4:127,675,967...127,688,785
Ensembl chr 4:127,676,141...127,687,697
G
Kcnb1
potassium voltage-gated channel subfamily B member 1
increases expression
ISO
licochalcone B results in increased expression of KCNB1 mRNA
CTD
PMID:33647349
NCBI chr 3:155,820,255...155,913,383
Ensembl chr 3:155,822,963...155,916,194
G
Kcng2
potassium voltage-gated channel modifier subfamily G member 2
increases expression
ISO
licochalcone B results in increased expression of KCNG2 mRNA
CTD
PMID:33647349
NCBI chr18:73,742,224...73,810,420
Ensembl chr18:73,743,074...73,808,723
G
Kcnh5
potassium voltage-gated channel subfamily H member 5
decreases expression
ISO
licochalcone B results in decreased expression of KCNH5 mRNA
CTD
PMID:33647349
NCBI chr 6:93,615,174...93,908,107
Ensembl chr 6:93,624,529...93,908,107
G
Kcnk3
potassium two pore domain channel subfamily K member 3
decreases expression
ISO
licochalcone B results in decreased expression of KCNK3 mRNA
CTD
PMID:33647349
NCBI chr 6:25,761,487...25,799,153
Ensembl chr 6:25,763,228...25,799,153
G
Kcnk4
potassium two pore domain channel subfamily K member 4
increases expression
ISO
licochalcone B results in increased expression of KCNK4 mRNA
CTD
PMID:33647349
NCBI chr 1:204,117,941...204,129,494
Ensembl chr 1:204,114,572...204,125,925
G
Kctd5
potassium channel tetramerization domain containing 5
increases expression
ISO
licochalcone B results in increased expression of KCTD5 mRNA
CTD
PMID:33647349
NCBI chr10:13,079,216...13,105,197
Ensembl chr10:13,079,214...13,105,209
G
Kdf1
keratinocyte differentiation factor 1
increases expression
ISO
licochalcone B results in increased expression of KDF1 mRNA
CTD
PMID:33647349
NCBI chr 5:145,744,753...145,758,150
Ensembl chr 5:145,745,099...145,755,878
G
Kiaa0825
KIAA0825 homolog
decreases expression
ISO
licochalcone B results in decreased expression of KIAA0825 mRNA
CTD
PMID:33647349
NCBI chr 2:6,874,474...7,437,032
Ensembl chr 2:6,874,539...7,434,521
G
Kif5a
kinesin family member 5A
increases expression
ISO
licochalcone B results in increased expression of KIF5A mRNA
CTD
PMID:33647349
NCBI chr 7:63,051,894...63,089,024
Ensembl chr 7:63,049,424...63,092,858
G
Kirrel2
kirre like nephrin family adhesion molecule 2
increases expression
ISO
licochalcone B results in increased expression of KIRREL2 mRNA
CTD
PMID:33647349
NCBI chr 1:85,708,793...85,718,670
Ensembl chr 1:85,708,793...85,718,670
G
Klf2
KLF transcription factor 2
increases expression
ISO
licochalcone B results in increased expression of KLF2 mRNA
CTD
PMID:33647349
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
G
Klf4
KLF transcription factor 4
increases expression
ISO
licochalcone B results in increased expression of KLF4 mRNA
CTD
PMID:33647349
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Klhl13
kelch-like family member 13
decreases expression
ISO
licochalcone B results in decreased expression of KLHL13 mRNA
CTD
PMID:33647349
NCBI chr X:113,942,309...114,107,299
Ensembl chr X:113,942,309...114,107,321
G
Klhl21
kelch-like family member 21
increases expression
ISO
licochalcone B results in increased expression of KLHL21 mRNA
CTD
PMID:33647349
NCBI chr 5:162,514,888...162,523,545
Ensembl chr 5:162,514,765...162,523,545
G
Klhl25
kelch-like family member 25
increases expression
ISO
licochalcone B results in increased expression of KLHL25 mRNA
CTD
PMID:33647349
NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227
G
Kndc1
kinase non-catalytic C-lobe domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of KNDC1 mRNA
CTD
PMID:33647349
NCBI chr 1:194,689,962...194,738,353
Ensembl chr 1:194,690,135...194,738,362
G
Krt16
keratin 16
increases expression
ISO
licochalcone B results in increased expression of KRT16 mRNA
CTD
PMID:33647349
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Lag3
lymphocyte activating 3
increases expression
ISO
licochalcone B results in increased expression of LAG3 mRNA
CTD
PMID:33647349
NCBI chr 4:157,712,665...157,722,229
Ensembl chr 4:157,712,667...157,720,404
G
Ldlrad2
low density lipoprotein receptor class A domain containing 2
increases expression
ISO
licochalcone B results in increased expression of LDLRAD2 mRNA
CTD
PMID:33647349
NCBI chr 5:149,778,795...149,788,335
Ensembl chr 5:149,779,675...149,787,140
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
increases expression
ISO
licochalcone B results in increased expression of LDLRAD4 mRNA
CTD
PMID:33647349
NCBI chr18:61,519,253...61,848,403
Ensembl chr18:61,521,428...61,843,238
G
Leng1
leukocyte receptor cluster member 1
increases expression
ISO
licochalcone B results in increased expression of LENG1 mRNA
CTD
PMID:33647349
NCBI chr 1:65,551,983...65,556,915
Ensembl chr 1:65,551,983...65,556,915
G
Lgals4
galectin 4
increases expression
ISO
licochalcone B results in increased expression of LGALS4 mRNA
CTD
PMID:33647349
NCBI chr 1:84,124,766...84,132,481
Ensembl chr 1:84,124,764...84,132,481
G
Lgi4
leucine-rich repeat LGI family, member 4
increases expression
ISO
licochalcone B results in increased expression of LGI4 mRNA
CTD
PMID:33647349
NCBI chr 1:86,294,539...86,305,909
Ensembl chr 1:86,295,074...86,304,874
G
Lgsn
lengsin, lens protein with glutamine synthetase domain
decreases expression
ISO
licochalcone B results in decreased expression of LGSN mRNA
CTD
PMID:33647349
NCBI chr 9:33,416,362...33,447,919
Ensembl chr 9:33,420,484...33,447,907
G
Lhb
luteinizing hormone subunit beta
increases expression
ISO
licochalcone B results in increased expression of LHB mRNA
CTD
PMID:33647349
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Lnx1
ligand of numb-protein X 1
decreases expression
ISO
licochalcone B results in decreased expression of LNX1 mRNA
CTD
PMID:33647349
NCBI chr14:33,514,429...33,617,086
Ensembl chr14:33,514,436...33,617,086
G
LOC120095693
small ubiquitin-related modifier 2-like
increases expression
ISO
licochalcone B results in increased expression of SUMO4 mRNA
CTD
PMID:33647349
NCBI chr11:79,163,457...79,164,088
Ensembl chr11:79,163,634...79,163,960
G
Lrfn1
leucine rich repeat and fibronectin type III domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of LRFN1 mRNA
CTD
PMID:33647349
NCBI chr 1:83,742,442...83,761,450
Ensembl chr 1:83,682,964...83,761,449
G
Lrguk
leucine-rich repeats and guanylate kinase domain containing
decreases expression
ISO
licochalcone B results in decreased expression of LRGUK mRNA
CTD
PMID:33647349
NCBI chr 4:62,647,222...62,770,268
Ensembl chr 4:62,647,264...62,770,319
G
Lrrc15
leucine rich repeat containing 15
increases expression
ISO
licochalcone B results in increased expression of LRRC15 mRNA
CTD
PMID:33647349
NCBI chr11:70,469,817...70,484,268
Ensembl chr11:70,469,804...70,484,267
G
Lrrc43
leucine rich repeat containing 43
increases expression
ISO
licochalcone B results in increased expression of LRRC43 mRNA
CTD
PMID:33647349
NCBI chr12:33,074,149...33,092,257
Ensembl chr12:33,074,150...33,095,082
G
Lrrc8a
leucine rich repeat containing 8 VRAC subunit A
increases expression
ISO
licochalcone B results in increased expression of LRRC8A mRNA
CTD
PMID:33647349
NCBI chr 3:13,509,577...13,537,174
Ensembl chr 3:13,510,513...13,536,202
G
Lrriq3
leucine-rich repeats and IQ motif containing 3
decreases expression
ISO
licochalcone B results in decreased expression of LRRIQ3 mRNA
CTD
PMID:33647349
NCBI chr 2:244,119,975...244,214,590
Ensembl chr 2:244,126,200...244,212,339
G
Lrrn4
leucine rich repeat neuronal 4
increases expression
ISO
licochalcone B results in increased expression of LRRN4 mRNA
CTD
PMID:33647349
NCBI chr 3:120,138,093...120,150,877
Ensembl chr 3:120,139,410...120,150,831
G
Lsmem1
leucine-rich single-pass membrane protein 1
increases expression
ISO
licochalcone B results in increased expression of LSMEM1 mRNA
CTD
PMID:33647349
NCBI chr 6:57,251,720...57,261,590
Ensembl chr 6:57,252,056...57,261,653
G
Ltbp1
latent transforming growth factor beta binding protein 1
decreases expression
ISO
licochalcone B results in decreased expression of LTBP1 mRNA
CTD
PMID:33647349
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Ly6g6c
lymphocyte antigen 6 family member G6C
increases expression
ISO
licochalcone B results in increased expression of LY6G6C mRNA
CTD
PMID:33647349
NCBI chr20:3,753,632...3,757,205
Ensembl chr20:3,753,632...3,758,867
G
Mafa
MAF bZIP transcription factor A
increases expression
ISO
licochalcone B results in increased expression of MAFA mRNA
CTD
PMID:33647349
NCBI chr 7:107,432,292...107,435,084
Ensembl chr 7:107,433,605...107,434,690
G
Mafb
MAF bZIP transcription factor B
increases expression
ISO
licochalcone B results in increased expression of MAFB mRNA
CTD
PMID:33647349
NCBI chr 3:148,998,111...149,000,031
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
licochalcone B results in increased expression of MAFF mRNA
CTD
PMID:33647349
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Mageb3
MAGE family member B3
increases expression
ISO
licochalcone B results in increased expression of MAGEB3 mRNA
CTD
PMID:33647349
NCBI chr X:50,865,484...50,866,479
Ensembl chr X:50,865,484...50,866,479
G
Maml2
mastermind-like transcriptional coactivator 2
decreases expression
ISO
licochalcone B results in decreased expression of MAML2 mRNA
CTD
PMID:33647349
NCBI chr 8:10,268,611...10,588,307
Ensembl chr 8:10,268,665...10,587,107
G
Man1c1
mannosidase, alpha, class 1C, member 1
increases expression
ISO
licochalcone B results in increased expression of MAN1C1 mRNA
CTD
PMID:33647349
NCBI chr 5:146,774,282...146,913,257
Ensembl chr 5:146,775,842...146,913,421
G
Mansc1
MANSC domain containing 1
decreases expression
ISO
licochalcone B results in decreased expression of MANSC1 mRNA
CTD
PMID:33647349
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
G
Map1a
microtubule-associated protein 1A
increases expression
ISO
licochalcone B results in increased expression of MAP1A mRNA
CTD
PMID:33647349
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression
ISO
licochalcone B results in increased expression of MAP2K3 mRNA
CTD
PMID:33647349
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map3k14
mitogen-activated protein kinase kinase kinase 14
increases expression
ISO
licochalcone B results in increased expression of MAP3K14 mRNA
CTD
PMID:33647349
NCBI chr10:88,165,349...88,215,558
Ensembl chr10:88,165,351...88,215,523
G
Map7d2
MAP7 domain containing 2
increases expression
ISO
licochalcone B results in increased expression of MAP7D2 mRNA
CTD
PMID:33647349
NCBI chr X:35,372,453...35,488,073
Ensembl chr X:35,372,700...35,488,091
G
Mapk1
mitogen activated protein kinase 1
multiple interactions increases phosphorylation
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] licochalcone B results in increased phosphorylation of MAPK1 protein
CTD
PMID:25451593 PMID:35948134
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] licochalcone B results in increased phosphorylation of MAPK3 protein
CTD
PMID:25451593 PMID:35948134
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein] licochalcone B results in increased phosphorylation of MAPK8 protein
CTD
PMID:25451593 PMID:35948134
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk8ip1
mitogen-activated protein kinase 8 interacting protein 1
increases expression
ISO
licochalcone B results in increased expression of MAPK8IP1 mRNA
CTD
PMID:33647349
NCBI chr 3:78,355,051...78,372,946
Ensembl chr 3:78,355,048...78,372,884
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK9 protein] licochalcone B results in increased phosphorylation of MAPK9 protein
CTD
PMID:25451593 PMID:35948134
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Marchf1
membrane associated ring-CH-type finger 1
decreases expression
ISO
licochalcone B results in decreased expression of MARCHF1 mRNA
CTD
PMID:33647349
NCBI chr16:23,255,551...24,114,290
Ensembl chr16:23,258,799...24,114,277
G
Marcksl1
MARCKS-like 1
increases expression
ISO
licochalcone B results in increased expression of MARCKSL1 mRNA
CTD
PMID:33647349
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Marcol
MARCO like
decreases expression
ISO
licochalcone B results in decreased expression of MARCOL mRNA
CTD
PMID:33647349
NCBI chr18:36,448,714...36,455,171
G
Masp1
MBL associated serine protease 1
decreases expression
ISO
licochalcone B results in decreased expression of MASP1 mRNA
CTD
PMID:33647349
NCBI chr11:77,334,794...77,405,271
Ensembl chr11:77,334,859...77,402,974
G
Mc5r
melanocortin 5 receptor
increases expression
ISO
licochalcone B results in increased expression of MC5R mRNA
CTD
PMID:33647349
NCBI chr18:61,915,188...61,920,229
Ensembl chr18:61,915,188...61,920,229
G
Mcoln1
mucolipin TRP cation channel 1
increases expression
ISO
licochalcone B results in increased expression of MCOLN1 mRNA
CTD
PMID:33647349
NCBI chr12:1,560,341...1,574,252
Ensembl chr12:1,560,359...1,574,252
G
Mdfi
MyoD family inhibitor
increases expression
ISO
licochalcone B results in increased expression of MDFI mRNA
CTD
PMID:33647349
NCBI chr 9:13,156,806...13,175,218
Ensembl chr 9:13,156,866...13,175,217
G
Mdga1
MAM domain containing glycosylphosphatidylinositol anchor 1
increases expression
ISO
licochalcone B results in increased expression of MDGA1 mRNA
CTD
PMID:33647349
NCBI chr20:7,900,327...7,964,309
Ensembl chr20:7,904,358...7,963,471
G
Meis1
Meis homeobox 1
decreases expression
ISO
licochalcone B results in decreased expression of MEIS1 mRNA
CTD
PMID:33647349
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Meox1
mesenchyme homeobox 1
decreases expression
ISO
licochalcone B results in decreased expression of MEOX1 mRNA
CTD
PMID:33647349
NCBI chr10:86,818,450...86,837,563
Ensembl chr10:86,818,478...86,837,660
G
Metrnl
meteorin-like, glial cell differentiation regulator
increases expression
ISO
licochalcone B results in increased expression of METRNL mRNA
CTD
PMID:33647349
NCBI chr10:106,963,880...106,977,875
Ensembl chr10:106,963,880...106,977,869
G
Mettl7a
methyltransferase like 7A
decreases expression
ISO
licochalcone B results in decreased expression of TMT1A mRNA
CTD
PMID:33647349
NCBI chr 7:131,452,099...131,460,154
Ensembl chr 7:131,451,641...131,460,154
G
Mex3a
mex-3 RNA binding family member A
decreases expression
ISO
licochalcone B results in decreased expression of MEX3A mRNA
CTD
PMID:33647349
NCBI chr 2:173,990,098...173,999,567
Ensembl chr 2:173,989,856...173,997,377
G
Mex3b
mex-3 RNA binding family member B
increases expression
ISO
licochalcone B results in increased expression of MEX3B mRNA
CTD
PMID:33647349
NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:136,855,130...136,859,354
G
Mex3d
mex-3 RNA binding family member D
increases expression
ISO
licochalcone B results in increased expression of MEX3D mRNA
CTD
PMID:33647349
NCBI chr 7:9,325,575...9,332,705
Ensembl chr 7:9,325,488...9,332,096
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
increases expression
ISO
licochalcone B results in increased expression of MFGE8 mRNA
CTD
PMID:33647349
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mgarp
mitochondria-localized glutamic acid-rich protein
increases expression
ISO
licochalcone B results in increased expression of MGARP mRNA
CTD
PMID:33647349
NCBI chr 2:135,431,283...135,439,425
Ensembl chr 2:135,431,283...135,439,612
G
Micall2
MICAL-like 2
increases expression
ISO
licochalcone B results in increased expression of MICALL2 mRNA
CTD
PMID:33647349
NCBI chr12:14,899,188...14,927,949
Ensembl chr12:14,899,157...14,927,946
G
Mir125b1
microRNA 125b-1
decreases expression
ISO
licochalcone B results in decreased expression of MIR125B1 mRNA
CTD
PMID:33647349
NCBI chr 8:41,952,966...41,953,052
Ensembl chr 8:41,952,966...41,953,052
G
Mir126a
microRNA 126a
decreases expression
ISO
licochalcone B results in decreased expression of MIR126 mRNA
CTD
PMID:33647349
NCBI chr 3:9,415,063...9,415,180
Ensembl chr 3:9,415,063...9,415,180
G
Mir127
microRNA 127
increases expression
ISO
licochalcone B results in increased expression of MIR127 mRNA
CTD
PMID:33647349
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
G
Mir143
microRNA 143
increases expression
ISO
licochalcone B results in increased expression of MIR143 mRNA
CTD
PMID:33647349
NCBI chr18:55,101,006...55,101,110
Ensembl chr18:55,101,006...55,101,110
G
Mir146a
microRNA 146a
increases expression
ISO
licochalcone B results in increased expression of MIR146A mRNA
CTD
PMID:33647349
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
G
Mir148a
microRNA 148a
decreases expression
ISO
licochalcone B results in decreased expression of MIR148A mRNA
CTD
PMID:33647349
NCBI chr 4:80,333,762...80,333,858
Ensembl chr 4:80,333,762...80,333,858
G
Mir181b1
microRNA 181b-1
decreases expression
ISO
licochalcone B results in decreased expression of MIR181B1 mRNA
CTD
PMID:33647349
NCBI chr13:49,485,688...49,485,797
Ensembl chr13:49,485,688...49,485,797
G
Mir191
microRNA 191
decreases expression
ISO
licochalcone B results in decreased expression of MIR191 mRNA
CTD
PMID:33647349
NCBI chr 8:109,264,098...109,264,188
G
Mir193a
microRNA 193a
increases expression
ISO
licochalcone B results in increased expression of MIR193A mRNA
CTD
PMID:33647349
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
G
Mir19a
microRNA 19a
increases expression
ISO
licochalcone B results in increased expression of MIR19A mRNA
CTD
PMID:33647349
NCBI chr15:92,180,912...92,180,993
Ensembl chr15:92,180,912...92,180,993
G
Mir200a
microRNA 200a
increases expression
ISO
licochalcone B results in increased expression of MIR200A mRNA
CTD
PMID:33647349
NCBI chr 5:166,648,494...166,648,582
G
Mir206
microRNA 206
increases expression
ISO
licochalcone B results in increased expression of MIR206 mRNA
CTD
PMID:33647349
NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
G
Mir210
microRNA 210
decreases expression
ISO
licochalcone B results in decreased expression of MIR210 mRNA
CTD
PMID:33647349
NCBI chr 1:196,326,343...196,326,452
Ensembl chr 1:196,326,337...196,326,454
G
Mir222
microRNA 222
decreases expression
ISO
licochalcone B results in decreased expression of MIR222 mRNA
CTD
PMID:33647349
NCBI chr X:3,428,904...3,429,006
Ensembl chr X:3,428,904...3,429,006
G
Mir23b
microRNA 23b
decreases expression
ISO
licochalcone B results in decreased expression of MIR23B mRNA
CTD
PMID:33647349
NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
G
Mir25
microRNA 25
decreases expression
ISO
licochalcone B results in decreased expression of MIR25 mRNA
CTD
PMID:33647349
NCBI chr12:17,042,932...17,043,015
Ensembl chr12:17,042,932...17,043,015
G
Mir27a
microRNA 27a
decreases expression
ISO
licochalcone B results in decreased expression of MIR27A mRNA
CTD
PMID:33647349
NCBI chr19:23,954,831...23,954,917
Ensembl chr19:23,954,831...23,954,917
G
Mir27b
microRNA 27b
decreases expression
ISO
licochalcone B results in decreased expression of MIR27B mRNA
CTD
PMID:33647349
NCBI chr17:1,813,427...1,813,523
Ensembl chr17:1,813,426...1,813,529
G
Mir296
microRNA 296
decreases expression
ISO
licochalcone B results in decreased expression of MIR296 mRNA
CTD
PMID:33647349
NCBI chr 3:163,051,838...163,051,915
Ensembl chr 3:163,051,838...163,051,915
G
Mir301a
microRNA 301a
decreases expression
ISO
licochalcone B results in decreased expression of MIR301A mRNA
CTD
PMID:33647349
NCBI chr10:71,925,336...71,925,435
Ensembl chr10:71,925,336...71,925,435
G
Mir301b
microRNA 301b
increases expression
ISO
licochalcone B results in increased expression of MIR301B mRNA
CTD
PMID:33647349
NCBI chr11:83,879,816...83,879,893
Ensembl chr11:83,879,816...83,879,893
G
Mir30b
microRNA 30b
decreases expression
ISO
licochalcone B results in decreased expression of MIR30B mRNA
CTD
PMID:33647349
NCBI chr 7:100,132,589...100,132,675
Ensembl chr 7:100,132,589...100,132,675
G
Mir30c1
microRNA 30c-1
decreases expression
ISO
licochalcone B results in decreased expression of MIR30C1 mRNA
CTD
PMID:33647349
NCBI chr 5:134,349,237...134,349,325
Ensembl chr 5:134,349,237...134,349,325
G
Mir30d
microRNA 30d
decreases expression
ISO
licochalcone B results in decreased expression of MIR30D mRNA
CTD
PMID:33647349
NCBI chr 7:100,136,391...100,136,472
Ensembl chr 7:100,136,391...100,136,472
G
Mir322
microRNA 322
decreases expression
ISO
licochalcone B results in decreased expression of MIR424 mRNA
CTD
PMID:33647349
NCBI chr X:132,806,594...132,806,688
Ensembl chr X:132,806,594...132,806,688
G
Mir33
microRNA 33
decreases expression
ISO
licochalcone B results in decreased expression of MIR33A mRNA
CTD
PMID:33647349
NCBI chr 7:113,713,855...113,713,923
Ensembl chr 7:113,713,855...113,713,923
G
Mir374b
microRNA 374b
decreases expression
ISO
licochalcone B results in decreased expression of MIR374B mRNA
CTD
PMID:33647349
NCBI chr X:68,591,732...68,591,799
Ensembl chr X:68,591,732...68,591,799
G
Mir451a
microRNA 451a
increases expression
ISO
licochalcone B results in increased expression of MIR451A mRNA
CTD
PMID:33647349
NCBI chr10:62,961,520...62,961,591
Ensembl chr10:62,961,520...62,961,591
G
Mir484
microRNA 484
decreases expression
ISO
licochalcone B results in decreased expression of MIR484 mRNA
CTD
PMID:33647349
NCBI chr10:887,684...887,760
Ensembl chr10:887,684...887,760
G
Mir615
microRNA 615
decreases expression
ISO
licochalcone B results in decreased expression of MIR615 mRNA
CTD
PMID:33647349
NCBI chr 7:134,151,887...134,151,978
Ensembl chr 7:134,151,887...134,151,978
G
Mir671
microRNA 671
decreases expression
ISO
licochalcone B results in decreased expression of MIR671 mRNA
CTD
PMID:33647349
NCBI chr 4:10,580,747...10,580,827
Ensembl chr 4:10,580,738...10,580,835
G
Mir675
microRNA 675
decreases expression
ISO
licochalcone B results in decreased expression of MIR675 mRNA
CTD
PMID:33647349
NCBI chr 1:197,732,275...197,732,358
Ensembl chr 1:197,732,275...197,732,358
G
Mir760
microRNA 760
decreases expression
ISO
licochalcone B results in decreased expression of MIR760 mRNA
CTD
PMID:33647349
NCBI chr 2:210,392,616...210,392,695
Ensembl chr 2:210,392,616...210,392,695
G
Mir874
microRNA 874
decreases expression
ISO
licochalcone B results in decreased expression of MIR874 mRNA
CTD
PMID:33647349
NCBI chr17:6,620,649...6,620,724
Ensembl chr17:6,620,649...6,620,724
G
Mir92a1
microRNA 92a-1
decreases expression
ISO
licochalcone B results in decreased expression of MIR92A1 mRNA
CTD
PMID:33647349
NCBI chr15:92,181,336...92,181,413
Ensembl chr15:92,181,336...92,181,413
G
Mir96
microRNA 96
increases expression
ISO
licochalcone B results in increased expression of MIR96 mRNA
CTD
PMID:33647349
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
G
Mirlet7c1
microRNA let-7c-1
decreases expression
ISO
licochalcone B results in decreased expression of MIRLET7C mRNA
CTD
PMID:33647349
NCBI chr11:16,201,163...16,201,256
Ensembl chr11:16,201,158...16,201,265
G
Mkrn2os
MKRN2 opposite strand
decreases expression
ISO
licochalcone B results in decreased expression of MKRN2OS mRNA
CTD
PMID:33647349
NCBI chr 4:148,644,489...148,653,396
Ensembl chr 4:148,644,609...148,652,712
G
Mn1
MN1 proto-oncogene, transcriptional regulator
decreases expression
ISO
licochalcone B results in decreased expression of MN1 mRNA
CTD
PMID:33647349
NCBI chr12:45,181,794...45,220,959
Ensembl chr12:45,183,085...45,221,651
G
Mns1
meiosis-specific nuclear structural 1
decreases expression
ISO
licochalcone B results in decreased expression of MNS1 mRNA
CTD
PMID:33647349
NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925
G
Mpig6b
megakaryocyte and platelet inhibitory receptor G6b
increases expression
ISO
licochalcone B results in increased expression of MPIG6B mRNA
CTD
PMID:33647349
NCBI chr20:3,757,396...3,761,024
Ensembl chr20:3,757,536...3,760,735
G
Mrpl18
mitochondrial ribosomal protein L18
increases expression
ISO
licochalcone B results in increased expression of MRPL18 mRNA
CTD
PMID:33647349
NCBI chr 1:47,837,169...47,841,987
Ensembl chr 1:47,836,561...47,841,987
G
Mrps24
mitochondrial ribosomal protein S24
increases expression
ISO
licochalcone B results in increased expression of MRPS24 mRNA
CTD
PMID:33647349
NCBI chr14:80,584,671...80,588,801
Ensembl chr14:80,584,673...80,588,871
G
Mrtfb
myocardin related transcription factor B
decreases expression
ISO
licochalcone B results in decreased expression of MRTFB mRNA
CTD
PMID:33647349
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
G
Msx1
msh homeobox 1
increases expression
ISO
licochalcone B results in increased expression of MSX1 mRNA
CTD
PMID:33647349
NCBI chr14:72,961,036...72,964,970
Ensembl chr14:72,961,148...72,964,966
G
Mt-atp8
mitochondrially encoded ATP synthase membrane subunit 8
decreases expression
ISO
licochalcone B results in decreased expression of ATP8 mRNA
CTD
PMID:33647349
NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961 NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
decreases expression
ISO
licochalcone B results in decreased expression of COX1 mRNA
CTD
PMID:33647349
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mt-co3
mitochondrially encoded cytochrome c oxidase III
decreases expression
ISO
licochalcone B results in decreased expression of COX3 mRNA
CTD
PMID:33647349
NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382 NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
G
Mt-nd2
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
decreases expression
ISO
licochalcone B results in decreased expression of ND2 mRNA
CTD
PMID:33647349
NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942 NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
G
Mt-nd3
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3
decreases expression
ISO
licochalcone B results in decreased expression of ND3 mRNA
CTD
PMID:33647349
NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798 NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
G
Mt-nd4
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4
decreases expression
ISO
licochalcone B results in decreased expression of ND4 mRNA
CTD
PMID:33647349
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
G
Mt-nd4l
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L
decreases expression
ISO
licochalcone B results in decreased expression of ND4L mRNA
CTD
PMID:33647349
NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166 NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
G
Mt-nd5
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5
decreases expression
ISO
licochalcone B results in decreased expression of ND5 mRNA
CTD
PMID:33647349
NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
G
Mt-nd6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
ISO
licochalcone B results in decreased expression of ND6 mRNA
CTD
PMID:33647349
NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061 NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
G
Muc20
mucin 20, cell surface associated
increases expression
ISO
licochalcone B results in increased expression of MUC20 mRNA
CTD
PMID:33647349
NCBI chr11:67,987,816...68,001,496
Ensembl chr11:67,987,800...68,001,495
G
Muc6
mucin 6, oligomeric mucus/gel-forming
decreases expression
ISO
licochalcone B results in decreased expression of MUC6 mRNA
CTD
PMID:33647349
NCBI chr 1:196,726,678...196,764,842
Ensembl chr 1:196,726,807...196,764,842
G
Mug2
murinoglobulin 2
decreases expression
ISO
licochalcone B results in decreased expression of PZP mRNA
CTD
PMID:33647349
NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
G
Mxd1
max dimerization protein 1
increases expression
ISO
licochalcone B results in increased expression of MXD1 mRNA
CTD
PMID:33647349
NCBI chr 4:119,097,353...119,118,080
Ensembl chr 4:119,097,353...119,117,751
G
Mycl
MYCL proto-oncogene, bHLH transcription factor
increases expression
ISO
licochalcone B results in increased expression of MYCL mRNA
CTD
PMID:33647349
NCBI chr 5:135,274,713...135,281,584
Ensembl chr 5:135,274,748...135,281,582
G
Mylip
myosin regulatory light chain interacting protein
increases expression
ISO
licochalcone B results in increased expression of MYLIP mRNA
CTD
PMID:33647349
NCBI chr17:19,286,649...19,308,295
Ensembl chr17:19,286,650...19,308,295
G
Myo15a
myosin XVA
increases expression
ISO
licochalcone B results in increased expression of MYO15A mRNA
CTD
PMID:33647349
NCBI chr10:45,277,619...45,335,953
Ensembl chr10:45,278,737...45,335,340
G
Myt1l
myelin transcription factor 1-like
decreases expression
ISO
licochalcone B results in decreased expression of MYT1L mRNA
CTD
PMID:33647349
NCBI chr 6:46,164,742...46,564,234
Ensembl chr 6:46,428,150...46,561,671
G
N4bp2l1
NEDD4 binding protein 2-like 1
increases expression
ISO
licochalcone B results in increased expression of N4BP2L1 mRNA
CTD
PMID:33647349
NCBI chr12:102,572...128,352
Ensembl chr12:102,573...127,257
G
Naif1
nuclear apoptosis inducing factor 1
increases expression
ISO
licochalcone B results in increased expression of NAIF1 mRNA
CTD
PMID:33647349
NCBI chr 3:15,741,239...15,747,672
Ensembl chr 3:15,742,919...15,747,669
G
Nanos1
nanos C2HC-type zinc finger 1
increases expression
ISO
licochalcone B results in increased expression of NANOS1 mRNA
CTD
PMID:33647349
NCBI chr 1:259,897,663...259,901,561
Ensembl chr 1:259,897,939...259,898,730
G
Nccrp1
NCCRP1, F-box associated domain containing
decreases expression
ISO
licochalcone B results in decreased expression of NCCRP1 mRNA
CTD
PMID:33647349
NCBI chr 1:83,835,083...83,838,620
Ensembl chr 1:83,835,083...83,838,676
G
Nckap5l
NCK-associated protein 5-like
increases expression
ISO
licochalcone B results in increased expression of NCKAP5L mRNA
CTD
PMID:33647349
NCBI chr 7:130,553,683...130,591,886
Ensembl chr 7:130,555,368...130,591,857
G
Necab1
N-terminal EF-hand calcium binding protein 1
increases expression
ISO
licochalcone B results in increased expression of NECAB1 mRNA
CTD
PMID:33647349
NCBI chr 5:28,357,859...28,578,642
Ensembl chr 5:28,357,859...28,578,642 Ensembl chr 5:28,357,859...28,578,642
G
Neu1
neuraminidase 1
increases expression
ISO
licochalcone B results in increased expression of NEU1 mRNA
CTD
PMID:33647349
NCBI chr20:3,897,480...3,901,745
Ensembl chr20:3,897,480...3,901,745
G
Neu4
neuraminidase 4
decreases expression
ISO
licochalcone B results in decreased expression of NEU4 mRNA
CTD
PMID:33647349
NCBI chr 9:94,396,920...94,402,576
Ensembl chr 9:94,396,920...94,402,576
G
Neurl1b
neuralized E3 ubiquitin protein ligase 1B
decreases expression
ISO
licochalcone B results in decreased expression of NEURL1B mRNA
CTD
PMID:33647349
NCBI chr10:16,754,002...16,785,049
Ensembl chr10:16,757,208...16,785,119
G
Nfatc1
nuclear factor of activated T-cells 1
increases expression
ISO
licochalcone B results in increased expression of NFATC1 mRNA
CTD
PMID:33647349
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]
CTD
PMID:25451593
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbid
NFKB inhibitor delta
increases expression
ISO
licochalcone B results in increased expression of NFKBID mRNA
CTD
PMID:33647349
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
G
Nfkbiz
NFKB inhibitor zeta
increases expression
ISO
licochalcone B results in increased expression of NFKBIZ mRNA
CTD
PMID:33647349
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Ngfr
nerve growth factor receptor
increases expression
ISO
licochalcone B results in increased expression of NGFR mRNA
CTD
PMID:33647349
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
G
Nhlh1
nescient helix loop helix 1
increases expression
ISO
licochalcone B results in increased expression of NHLH1 mRNA
CTD
PMID:33647349
NCBI chr13:84,517,347...84,522,548
Ensembl chr13:84,517,289...84,525,094
G
Niban3
niban apoptosis regulator 3
increases expression
ISO
licochalcone B results in increased expression of NIBAN3 mRNA
CTD
PMID:33647349
NCBI chr16:18,307,122...18,318,589
Ensembl chr16:18,307,221...18,318,585
G
Nid2
nidogen 2
increases expression
ISO
licochalcone B results in increased expression of NID2 mRNA
CTD
PMID:33647349
NCBI chr15:4,458,082...4,513,808
Ensembl chr15:4,458,084...4,513,843
G
Nkx2-5
NK2 homeobox 5
increases expression
ISO
licochalcone B results in increased expression of NKX2-5 mRNA
CTD
PMID:33647349
NCBI chr10:16,340,428...16,347,004
Ensembl chr10:16,344,159...16,346,934
G
Nkx3-1
NK3 homeobox 1
increases expression
ISO
licochalcone B results in increased expression of NKX3-1 mRNA
CTD
PMID:33647349
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
G
Nlrc3
NLR family, CARD domain containing 3
decreases expression
ISO
licochalcone B results in decreased expression of NLRC3 mRNA
CTD
PMID:33647349
NCBI chr10:11,551,378...11,585,027
Ensembl chr10:11,551,356...11,584,398
G
Nmb
neuromedin B
increases expression
ISO
licochalcone B results in increased expression of NMB mRNA
CTD
PMID:33647349
NCBI chr 1:134,869,446...134,875,507
Ensembl chr 1:134,869,446...134,872,190
G
Nmrk2
nicotinamide riboside kinase 2
increases expression
ISO
licochalcone B results in increased expression of NMRK2 mRNA
CTD
PMID:33647349
NCBI chr 7:8,514,855...8,517,916
Ensembl chr 7:8,514,927...8,517,922
G
Nnat
neuronatin
increases expression
ISO
licochalcone B results in increased expression of NNAT mRNA
CTD
PMID:33647349
NCBI chr 3:146,225,941...146,228,868
Ensembl chr 3:146,226,407...146,228,834
G
Noct
nocturnin
increases expression
ISO
licochalcone B results in increased expression of NOCT mRNA
CTD
PMID:33647349
NCBI chr 2:135,271,189...135,291,407
Ensembl chr 2:135,271,189...135,291,400
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:25451593
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Notch1
notch receptor 1
increases expression
ISO
licochalcone B results in increased expression of NOTCH1 mRNA
CTD
PMID:33647349
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Notch4
notch receptor 4
increases expression
ISO
licochalcone B results in increased expression of NOTCH4 mRNA
CTD
PMID:33647349
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
Npy4r
neuropeptide Y receptor Y4
decreases expression
ISO
licochalcone B results in decreased expression of NPY4R mRNA
CTD
PMID:33647349
NCBI chr16:9,467,801...9,469,057
Ensembl chr16:9,467,801...9,469,057
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
ISO
licochalcone B results in decreased expression of NR1I3 mRNA
CTD
PMID:33647349
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrarp
Notch-regulated ankyrin repeat protein
increases expression
ISO
licochalcone B results in increased expression of NRARP mRNA
CTD
PMID:33647349
NCBI chr 3:7,992,582...7,995,136
Ensembl chr 3:7,992,552...7,995,133
G
Nrep
neuronal regeneration related protein
decreases expression
ISO
licochalcone B results in decreased expression of NREP mRNA
CTD
PMID:33647349
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Ntsr1
neurotensin receptor 1
decreases expression
ISO
licochalcone B results in decreased expression of NTSR1 mRNA
CTD
PMID:33647349
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
Nudt12
nudix hydrolase 12
decreases expression
ISO
licochalcone B results in decreased expression of NUDT12 mRNA
CTD
PMID:33647349
NCBI chr 9:98,741,627...98,755,039
Ensembl chr 9:98,742,360...98,755,039
G
Nuggc
nuclear GTPase, germinal center associated
increases expression
ISO
licochalcone B results in increased expression of NUGGC mRNA
CTD
PMID:33647349
NCBI chr15:39,821,851...39,866,122
Ensembl chr15:39,821,855...39,866,122
G
Nxf1
nuclear RNA export factor 1
increases expression
ISO
licochalcone B results in increased expression of NXF1 mRNA
CTD
PMID:33647349
NCBI chr 1:205,655,442...205,668,637
Ensembl chr 1:205,655,375...205,668,636
G
Oat
ornithine aminotransferase
increases expression
ISO
licochalcone B results in increased expression of OAT mRNA
CTD
PMID:33647349
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Oser1
oxidative stress responsive serine-rich 1
increases expression
ISO
licochalcone B results in increased expression of OSER1 mRNA
CTD
PMID:33647349
NCBI chr 3:152,066,975...152,085,180
Ensembl chr 3:152,066,975...152,085,149
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression
ISO
licochalcone B results in increased expression of OSGIN1 mRNA
CTD
PMID:33647349
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
Osr2
odd-skipped related transciption factor 2
increases expression
ISO
licochalcone B results in increased expression of OSR2 mRNA
CTD
PMID:33647349
NCBI chr 7:66,487,841...66,495,003
Ensembl chr 7:66,487,839...66,495,224
G
Otud5
OTU deubiquitinase 5
increases expression
ISO
licochalcone B results in increased expression of OTUD5 mRNA
CTD
PMID:33647349
NCBI chr X:14,626,173...14,659,331
Ensembl chr X:14,626,164...14,659,573
G
Otulinl
OTU deubiquitinase with linear linkage specificity like
decreases expression
ISO
licochalcone B results in decreased expression of OTULINL mRNA
CTD
PMID:33647349
NCBI chr 2:78,405,994...78,433,860
Ensembl chr 2:78,408,593...78,433,838
G
P2ry6
pyrimidinergic receptor P2Y6
decreases expression
ISO
licochalcone B results in decreased expression of P2RY6 mRNA
CTD
PMID:33647349
NCBI chr 1:155,295,110...155,330,610
Ensembl chr 1:155,295,111...155,330,808
G
Pabpc4l
poly(A) binding protein, cytoplasmic 4-like
decreases expression
ISO
licochalcone B results in decreased expression of PABPC4L mRNA
CTD
PMID:33647349
NCBI chr 2:129,807,755...129,809,745
Ensembl chr 2:129,807,755...129,809,745
G
Padi2
peptidyl arginine deiminase 2
decreases expression
ISO
licochalcone B results in decreased expression of PADI2 mRNA
CTD
PMID:33647349
NCBI chr 5:153,209,053...153,251,632
Ensembl chr 5:153,209,053...153,251,632
G
Palmd
palmdelphin
decreases expression
ISO
licochalcone B results in decreased expression of PALMD mRNA
CTD
PMID:33647349
NCBI chr 2:204,889,526...204,941,355
Ensembl chr 2:204,889,533...204,941,519
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [licochalcone B results in increased cleavage of PARP1 protein]; pyrazolanthrone inhibits the reaction [licochalcone B results in increased expression of PARP1 protein]; TNFRSF10B protein promotes the reaction [licochalcone B results in increased cleavage of PARP1 protein]
CTD
PMID:35948134
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp9
poly (ADP-ribose) polymerase family, member 9
decreases expression
ISO
licochalcone B results in decreased expression of PARP9 mRNA
CTD
PMID:33647349
NCBI chr11:64,780,977...64,814,995
Ensembl chr11:64,780,981...64,815,455
G
Pcdhb16
protocadherin beta 16
decreases expression
ISO
licochalcone B results in decreased expression of PCDHB16 mRNA
CTD
PMID:33647349
NCBI chr18:29,192,260...29,195,669
Ensembl chr18:29,192,124...29,200,539
G
Pcdhb19
protocadherin beta 19
decreases expression
ISO
licochalcone B results in decreased expression of PCDHB12 mRNA
CTD
PMID:33647349
NCBI chr18:29,204,838...29,207,646
G
Pcdhga1
protocadherin gamma subfamily A, 1
decreases expression
ISO
licochalcone B results in decreased expression of PCDHGA1 mRNA
CTD
PMID:33647349
NCBI chr18:29,487,404...29,667,865
Ensembl chr18:29,487,482...29,492,857 Ensembl chr18:29,487,482...29,492,857
G
Pcdhga10
protocadherin gamma subfamily A, 10
decreases expression
ISO
licochalcone B results in decreased expression of PCDHGA10 mRNA
CTD
PMID:33647349
NCBI chr18:29,574,693...29,667,865
Ensembl chr18:29,493,954...29,667,868
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
decreases expression
ISO
licochalcone B results in decreased expression of PCSK1 mRNA
CTD
PMID:33647349
NCBI chr 2:4,395,543...4,442,434
Ensembl chr 2:4,395,543...4,442,434
G
Pde3a
phosphodiesterase 3A
decreases expression
ISO
licochalcone B results in decreased expression of PDE3A mRNA
CTD
PMID:33647349
NCBI chr 4:174,172,804...174,443,944
Ensembl chr 4:174,172,868...174,438,274
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
licochalcone B results in increased expression of PDGFA mRNA
CTD
PMID:33647349
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
decreases expression
ISO
licochalcone B results in decreased expression of PDGFB mRNA
CTD
PMID:33647349
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pea15
proliferation and apoptosis adaptor protein 15
increases expression
ISO
licochalcone B results in increased expression of PEA15 mRNA
CTD
PMID:33647349
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pgbd2
piggyBac transposable element derived 2
increases expression
ISO
licochalcone B results in increased expression of PGBD2 mRNA
CTD
PMID:33647349
G
Pgf
placental growth factor
increases expression
ISO
licochalcone B results in increased expression of PGF mRNA
CTD
PMID:33647349
NCBI chr 6:104,816,102...104,826,685
Ensembl chr 6:104,816,104...104,826,685
G
Pheta1
PH domain containing endocytic trafficking adaptor 1
increases expression
ISO
licochalcone B results in increased expression of PHETA1 mRNA
CTD
PMID:33647349
NCBI chr12:34,711,831...34,717,601
Ensembl chr12:34,711,810...34,717,081
G
Phkg1
phosphorylase kinase catalytic subunit gamma 1
increases expression
ISO
licochalcone B results in increased expression of PHKG1 mRNA
CTD
PMID:33647349
NCBI chr12:26,838,822...26,854,547
Ensembl chr12:26,838,968...26,852,850
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression
ISO
licochalcone B results in increased expression of PHLDA2 mRNA
CTD
PMID:33647349
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
G
Phldb2
pleckstrin homology-like domain, family B, member 2
decreases expression
ISO
licochalcone B results in decreased expression of PHLDB2 mRNA
CTD
PMID:33647349
NCBI chr11:54,859,173...55,078,212
Ensembl chr11:54,859,135...55,078,467
G
Phyhd1
phytanoyl-CoA dioxygenase domain containing 1
increases expression
ISO
licochalcone B results in increased expression of PHYHD1 mRNA
CTD
PMID:33647349
NCBI chr 3:13,535,670...13,553,797
Ensembl chr 3:13,540,056...13,553,797
G
Pilra
paired immunoglobin-like type 2 receptor alpha
increases expression
ISO
licochalcone B results in increased expression of PILRA mRNA
CTD
PMID:33647349
NCBI chr12:17,787,169...17,798,149
Ensembl chr12:17,787,127...17,798,094
G
Pilrb1
paired immunoglobin-like type 2 receptor beta 1
increases expression
ISO
licochalcone B results in increased expression of PILRB mRNA
CTD
PMID:33647349
NCBI chr12:18,516,161...18,525,375
Ensembl chr12:18,516,156...18,525,346
G
Pithd1
PITH domain containing 1
increases expression
ISO
licochalcone B results in increased expression of PITHD1 mRNA
CTD
PMID:33647349
NCBI chr 5:148,205,995...148,216,490
Ensembl chr 5:148,205,998...148,217,080
G
Pkd1l1
polycystin 1 like 1, transient receptor potential channel interacting
increases expression
ISO
licochalcone B results in increased expression of PKD1L1 mRNA
CTD
PMID:33647349
NCBI chr14:83,552,964...83,670,062
Ensembl chr14:83,545,469...83,638,498
G
Pkd1l3
polycystin 1 like 3, transient receptor potential channel interacting
increases expression
ISO
licochalcone B results in increased expression of PKD1L3 mRNA
CTD
PMID:33647349
NCBI chr19:37,585,564...37,650,083
Ensembl chr19:37,585,725...37,650,155
G
Pla2g4a
phospholipase A2 group IVA
decreases expression
ISO
licochalcone B results in decreased expression of PLA2G4A mRNA
CTD
PMID:33647349
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Plac8l1
PLAC8-like 1
increases expression
ISO
licochalcone B results in increased expression of PLAC8L1 mRNA
CTD
PMID:33647349
NCBI chr18:34,167,667...34,192,137
Ensembl chr18:34,168,864...34,190,800
G
Plcxd1
phosphatidylinositol-specific phospholipase C, X domain containing 1
increases expression
ISO
licochalcone B results in increased expression of PLCXD1 mRNA
CTD
PMID:33647349
NCBI chr12:46,578,917...46,582,181
Ensembl chr12:46,579,225...46,582,392
G
Pld1
phospholipase D1
decreases expression
ISO
licochalcone B results in decreased expression of PLD1 mRNA
CTD
PMID:33647349
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
G
Plek
pleckstrin
increases expression
ISO
licochalcone B results in increased expression of PLEK mRNA
CTD
PMID:33647349
NCBI chr14:91,397,015...91,429,693
Ensembl chr14:91,397,019...91,454,131
G
Plekha2
pleckstrin homology domain containing A2
decreases expression
ISO
licochalcone B results in decreased expression of PLEKHA2 mRNA
CTD
PMID:33647349
NCBI chr16:66,938,684...67,000,661
Ensembl chr16:66,939,109...66,999,395
G
Plekhg6
pleckstrin homology and RhoGEF domain containing G6
decreases expression
ISO
licochalcone B results in decreased expression of PLEKHG6 mRNA
CTD
PMID:33647349
NCBI chr 4:158,163,443...158,182,628
Ensembl chr 4:158,162,969...158,182,271
G
Plekho2
pleckstrin homology domain containing O2
increases expression
ISO
licochalcone B results in increased expression of PLEKHO2 mRNA
CTD
PMID:33647349
NCBI chr 8:66,079,106...66,105,283
Ensembl chr 8:66,078,448...66,105,266
G
Plin2
perilipin 2
increases expression
ISO
licochalcone B results in increased expression of PLIN2 mRNA
CTD
PMID:33647349
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plin5
perilipin 5
increases expression
ISO
licochalcone B results in increased expression of PLIN5 mRNA
CTD
PMID:33647349
NCBI chr 9:939,745...946,188
Ensembl chr 9:939,747...946,120
G
Plk2
polo-like kinase 2
increases expression
ISO
licochalcone B results in increased expression of PLK2 mRNA
CTD
PMID:33647349
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Plk3
polo-like kinase 3
increases expression
ISO
licochalcone B results in increased expression of PLK3 mRNA
CTD
PMID:33647349
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
G
Plk5
polo-like kinase 5
increases expression
ISO
licochalcone B results in increased expression of PLK5 mRNA
CTD
PMID:33647349
NCBI chr 7:9,346,777...9,367,923
Ensembl chr 7:9,346,777...9,355,196
G
Plppr3
phospholipid phosphatase related 3
increases expression
ISO
licochalcone B results in increased expression of PLPPR3 mRNA
CTD
PMID:33647349
NCBI chr 7:9,831,162...9,842,434
Ensembl chr 7:9,831,162...9,845,296
G
Plvap
plasmalemma vesicle associated protein
increases expression
ISO
licochalcone B results in increased expression of PLVAP mRNA
CTD
PMID:33647349
NCBI chr16:18,184,985...18,197,301
Ensembl chr16:18,184,975...18,197,301
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression
ISO
licochalcone B results in increased expression of PMAIP1 mRNA
CTD
PMID:33647349
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pnck
pregnancy up-regulated nonubiquitous CaM kinase
increases expression
ISO
licochalcone B results in increased expression of PNCK mRNA
CTD
PMID:33647349
NCBI chr X:151,369,406...151,373,508
Ensembl chr X:151,369,410...151,373,446
G
Pnldc1
PARN like ribonuclease domain containing exonuclease 1
increases expression
ISO
licochalcone B results in increased expression of PNLDC1 mRNA
CTD
PMID:33647349
NCBI chr 1:47,843,224...47,861,675
Ensembl chr 1:47,843,224...47,861,674
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
ISO
licochalcone B results in increased expression of PNPLA2 mRNA
CTD
PMID:33647349
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
G
Pnrc1
proline-rich nuclear receptor coactivator 1
increases expression
ISO
licochalcone B results in increased expression of PNRC1 mRNA
CTD
PMID:33647349
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
G
Podnl1
podocan-like 1
increases expression
ISO
licochalcone B results in increased expression of PODNL1 mRNA
CTD
PMID:33647349
NCBI chr19:24,027,261...24,033,867
Ensembl chr19:24,027,297...24,033,846
G
Potef
POTE ankyrin domain family, member F
decreases expression
ISO
licochalcone B results in decreased expression of POTEF mRNA
CTD
PMID:33647349
NCBI chr18:23,626,518...23,629,132
Ensembl chr 3:72,977,767...72,979,694
G
Pou3f1
POU class 3 homeobox 1
increases expression
ISO
licochalcone B results in increased expression of POU3F1 mRNA
CTD
PMID:33647349
NCBI chr 5:136,910,391...136,913,371
Ensembl chr 5:136,910,391...136,913,371
G
Ppef1
protein phosphatase with EF-hand domain 1
decreases expression
ISO
licochalcone B results in decreased expression of PPEF1 mRNA
CTD
PMID:33647349
NCBI chr X:33,994,503...34,151,704
Ensembl chr X:34,021,350...34,151,701
G
Ppp1r13b
protein phosphatase 1, regulatory subunit 13B
increases expression
ISO
licochalcone B results in increased expression of PPP1R13B mRNA
CTD
PMID:33647349
NCBI chr 6:130,890,682...130,963,845
Ensembl chr 6:130,890,679...130,963,330
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
licochalcone B results in increased expression of PPP1R15A mRNA
CTD
PMID:33647349
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r27
protein phosphatase 1, regulatory subunit 27
increases expression
ISO
licochalcone B results in increased expression of PPP1R27 mRNA
CTD
PMID:33647349
NCBI chr10:105,828,364...105,829,533
Ensembl chr10:105,828,364...105,829,533
G
Prr18
proline rich 18
increases expression
ISO
licochalcone B results in increased expression of PRR18 mRNA
CTD
PMID:33647349
NCBI chr 1:52,400,215...52,403,998
Ensembl chr 1:52,400,215...52,404,309
G
Ptger1
prostaglandin E receptor 1
increases expression
ISO
licochalcone B results in increased expression of PTGER1 mRNA
CTD
PMID:33647349
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Pxdc1
PX domain containing 1
increases expression
ISO
licochalcone B results in increased expression of PXDC1 mRNA
CTD
PMID:33647349
NCBI chr17:30,275,998...30,304,971
Ensembl chr17:30,276,377...30,304,973
G
Pygm
glycogen phosphorylase, muscle associated
increases expression
ISO
licochalcone B results in increased expression of PYGM mRNA
CTD
PMID:33647349
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
G
Rab33a
RAB33A, member RAS oncogene family
increases expression
ISO
licochalcone B results in increased expression of RAB33A mRNA
CTD
PMID:33647349
NCBI chr X:127,694,219...127,706,378
Ensembl chr X:127,694,964...127,706,378
G
Rad9b
RAD9 checkpoint clamp component B
increases expression
ISO
licochalcone B results in increased expression of RAD9B mRNA
CTD
PMID:33647349
NCBI chr12:34,217,868...34,248,380
Ensembl chr12:34,218,024...34,248,372
G
Radil
Rap associating with DIL domain
increases expression
ISO
licochalcone B results in increased expression of RADIL mRNA
CTD
PMID:33647349
NCBI chr12:12,024,395...12,088,540
Ensembl chr12:12,024,395...12,088,540
G
Rarres2
retinoic acid receptor responder 2
decreases expression
ISO
licochalcone B results in decreased expression of RARRES2 mRNA
CTD
PMID:33647349
NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
licochalcone B results in increased expression of RASD1 mRNA
CTD
PMID:33647349
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rasl10a
RAS-like, family 10, member A
increases expression
ISO
licochalcone B results in increased expression of RASL10A mRNA
CTD
PMID:33647349
NCBI chr14:79,955,093...79,956,471
Ensembl chr14:79,954,398...79,956,468
G
Rasl11a
RAS-like family 11 member A
increases expression
ISO
licochalcone B results in increased expression of RASL11A mRNA
CTD
PMID:33647349
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
G
Rassf2
Ras association domain family member 2
decreases expression
ISO
licochalcone B results in decreased expression of RASSF2 mRNA
CTD
PMID:33647349
NCBI chr 3:119,244,288...119,280,462
Ensembl chr 3:119,245,821...119,280,431
G
Rassf9
Ras association domain family member 9
decreases expression
ISO
licochalcone B results in decreased expression of RASSF9 mRNA
CTD
PMID:33647349
NCBI chr 7:37,599,720...37,631,553
Ensembl chr 7:37,599,720...37,635,245
G
Rbfox3
RNA binding fox-1 homolog 3
increases expression
ISO
licochalcone B results in increased expression of RBFOX3 mRNA
CTD
PMID:33647349
NCBI chr10:103,720,355...104,157,277
Ensembl chr10:103,720,636...104,156,935
G
Rbm38
RNA binding motif protein 38
increases expression
ISO
licochalcone B results in increased expression of RBM38 mRNA
CTD
PMID:33647349
NCBI chr 3:161,801,577...161,814,381
Ensembl chr 3:161,801,577...161,814,381
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:25451593
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
licochalcone B results in increased expression of RELB mRNA
CTD
PMID:33647349
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rell2
RELT-like 2
increases expression
ISO
licochalcone B results in increased expression of RELL2 mRNA
CTD
PMID:33647349
NCBI chr18:29,789,996...29,793,986
Ensembl chr18:29,790,415...29,793,986
G
Relt
RELT, TNF receptor
increases expression
ISO
licochalcone B results in increased expression of RELT mRNA
CTD
PMID:33647349
NCBI chr 1:155,206,976...155,224,609
Ensembl chr 1:155,206,976...155,214,196
G
Rftn2
raftlin family member 2
increases expression
ISO
licochalcone B results in increased expression of RFTN2 mRNA
CTD
PMID:33647349
NCBI chr 9:56,651,617...56,707,830
Ensembl chr 9:56,630,460...56,707,810
G
Rgcc
regulator of cell cycle
increases expression
ISO
licochalcone B results in increased expression of RGCC mRNA
CTD
PMID:33647349
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
G
Rgma
repulsive guidance molecule BMP co-receptor a
increases expression
ISO
licochalcone B results in increased expression of RGMA mRNA
CTD
PMID:33647349
NCBI chr 1:127,128,934...127,172,918
Ensembl chr 1:127,128,934...127,172,918
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
licochalcone B results in increased expression of RGS16 mRNA
CTD
PMID:33647349
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rgs9bp
regulator of G protein signaling 9 binding protein
decreases expression
ISO
licochalcone B results in decreased expression of RGS9BP mRNA
CTD
PMID:33647349
NCBI chr 1:88,249,438...88,250,151
Ensembl chr 1:88,249,438...88,250,151
G
Ribc2
RIB43A domain with coiled-coils 2
decreases expression
ISO
licochalcone B results in decreased expression of RIBC2 mRNA
CTD
PMID:33647349
NCBI chr 7:116,242,863...116,257,868
Ensembl chr 7:116,242,863...116,257,863
G
Ripor3
RIPOR family member 3
increases expression
ISO
licochalcone B results in increased expression of RIPOR3 mRNA
CTD
PMID:33647349
NCBI chr 3:156,687,253...156,760,524
Ensembl chr 3:156,687,517...156,715,061
G
Rnd1
Rho family GTPase 1
increases expression
ISO
licochalcone B results in increased expression of RND1 mRNA
CTD
PMID:33647349
NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399
G
Rnf150
ring finger protein 150
decreases expression
ISO
licochalcone B results in decreased expression of RNF150 mRNA
CTD
PMID:33647349
NCBI chr19:25,006,978...25,229,273
Ensembl chr19:25,006,611...25,228,678
G
Rnf19b
ring finger protein 19B
increases expression
ISO
licochalcone B results in increased expression of RNF19B mRNA
CTD
PMID:33647349
NCBI chr 5:141,406,085...141,431,376
Ensembl chr 5:141,406,118...141,431,380
G
Rnf225
ring finger protein 225
increases expression
ISO
licochalcone B results in increased expression of RNF225 mRNA
CTD
PMID:33647349
NCBI chr 1:73,543,598...73,546,269
Ensembl chr 1:73,543,598...73,546,269
G
Rnf227
ring finger protein 227
increases expression
ISO
licochalcone B results in increased expression of RNF227 mRNA
CTD
PMID:33647349
NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010
G
Rnf31
ring finger protein 31
increases expression
ISO
licochalcone B results in increased expression of RNF31 mRNA
CTD
PMID:33647349
NCBI chr15:29,083,047...29,095,328
Ensembl chr15:29,083,631...29,101,915
G
Rorb
RAR-related orphan receptor B
decreases expression
ISO
licochalcone B results in decreased expression of RORB mRNA
CTD
PMID:33647349
NCBI chr 1:216,363,629...216,544,390
Ensembl chr 1:216,363,629...216,544,390
G
Rp1l1
RP1 like 1
decreases expression
ISO
licochalcone B results in decreased expression of RP1L1 mRNA
CTD
PMID:33647349
NCBI chr15:38,259,907...38,271,269
Ensembl chr15:38,259,928...38,270,316
G
Rps6ka2
ribosomal protein S6 kinase A2
decreases expression
ISO
licochalcone B results in decreased expression of RPS6KA2 mRNA
CTD
PMID:33647349
NCBI chr 1:52,631,582...52,906,739
Ensembl chr 1:52,631,736...52,906,739
G
Rps6kb1
ribosomal protein S6 kinase B1
decreases phosphorylation
ISO
licochalcone B results in decreased phosphorylation of RPS6KB1 protein
CTD
PMID:35948134
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
licochalcone B results in increased expression of RRAD mRNA
CTD
PMID:33647349
NCBI chr19:354,184...357,424
Ensembl chr19:354,198...357,417
G
Rsph6a
radial spoke head 6 homolog A
increases expression
ISO
licochalcone B results in increased expression of RSPH6A mRNA
CTD
PMID:33647349
NCBI chr 1:78,700,801...78,720,444
Ensembl chr 1:78,700,814...78,720,431
G
Rsrp1
arginine and serine rich protein 1
increases expression
ISO
licochalcone B results in increased expression of RSRP1 mRNA
CTD
PMID:33647349
NCBI chr 5:147,147,774...147,151,523
Ensembl chr 5:147,147,784...147,151,523
G
Runx2
RUNX family transcription factor 2
decreases expression
ISO
licochalcone B results in decreased expression of RUNX2 mRNA
CTD
PMID:33647349
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
S100a1
S100 calcium binding protein A1
increases expression
ISO
licochalcone B results in increased expression of S100A1 mRNA
CTD
PMID:33647349
NCBI chr 2:175,993,922...175,998,765
Ensembl chr 2:175,993,922...175,999,544
G
Samd5
sterile alpha motif domain containing 5
decreases expression
ISO
licochalcone B results in decreased expression of SAMD5 mRNA
CTD
PMID:33647349
NCBI chr 1:4,041,547...4,090,909
Ensembl chr 1:3,677,784...4,091,120
G
Samd9
sterile alpha motif domain containing 9
decreases expression
ISO
licochalcone B results in decreased expression of SAMD9 mRNA
CTD
PMID:33647349
NCBI chr 4:31,164,639...31,184,278
Ensembl chr 4:31,164,510...31,184,322
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
licochalcone B results in increased expression of SAT1 mRNA
CTD
PMID:33647349
NCBI chr X:40,158,354...40,161,641
Ensembl chr X:40,157,046...40,196,813
G
Saxo4
stabilizer of axonemal microtubules 4
increases expression
ISO
licochalcone B results in increased expression of SAXO4 mRNA
CTD
PMID:33647349
NCBI chr 1:207,113,807...207,122,378
Ensembl chr 1:207,113,809...207,122,358
G
Sbsn
suprabasin
increases expression
ISO
licochalcone B results in increased expression of SBSN mRNA
CTD
PMID:33647349
NCBI chr 1:85,978,970...86,006,034
Ensembl chr 1:86,001,567...86,006,034
G
Scn3b
sodium voltage-gated channel beta subunit 3
decreases expression
ISO
licochalcone B results in decreased expression of SCN3B mRNA
CTD
PMID:33647349
NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868
G
Scrt1
scratch family transcriptional repressor 1
increases expression
ISO
licochalcone B results in increased expression of SCRT1 mRNA
CTD
PMID:33647349
NCBI chr 7:108,240,986...108,244,636
Ensembl chr 7:108,240,986...108,244,636
G
Sdc4
syndecan 4
increases expression
ISO
licochalcone B results in increased expression of SDC4 mRNA
CTD
PMID:33647349
NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
G
Sdcbp2
syndecan binding protein 2
increases expression
ISO
licochalcone B results in increased expression of SDCBP2 mRNA
CTD
PMID:33647349
NCBI chr 3:140,060,746...140,098,063
Ensembl chr 3:140,070,540...140,098,057
G
Sema4a
semaphorin 4A
increases expression
ISO
licochalcone B results in increased expression of SEMA4A mRNA
CTD
PMID:33647349
NCBI chr 2:173,896,432...173,917,903
Ensembl chr 2:173,896,439...173,914,442
G
Sema5a
semaphorin 5A
decreases expression
ISO
licochalcone B results in decreased expression of SEMA5A mRNA
CTD
PMID:33647349
NCBI chr 2:83,309,843...83,741,084
Ensembl chr 2:83,309,843...83,741,084
G
Senp3
SUMO specific peptidase 3
increases expression
ISO
licochalcone B results in increased expression of SENP3 mRNA
CTD
PMID:33647349
NCBI chr10:54,390,698...54,399,590
Ensembl chr10:54,390,694...54,399,593
G
Serpinb8
serpin family B member 8
increases expression
ISO
licochalcone B results in increased expression of SERPINB8 mRNA
CTD
PMID:33647349
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpinc1
serpin family C member 1
increases expression
ISO
licochalcone B results in increased expression of SERPINC1 mRNA
CTD
PMID:33647349
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Sertad1
SERTA domain containing 1
increases expression
ISO
licochalcone B results in increased expression of SERTAD1 mRNA
CTD
PMID:33647349
NCBI chr 1:82,775,692...82,778,961
Ensembl chr 1:82,775,252...82,779,091
G
Sesn2
sestrin 2
increases expression
ISO
licochalcone B results in increased expression of SESN2 mRNA
CTD
PMID:33647349
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Sesn3
sestrin 3
increases expression
ISO
licochalcone B results in increased expression of SESN3 mRNA
CTD
PMID:33647349
NCBI chr 8:11,133,822...11,189,436
Ensembl chr 8:11,133,678...11,185,842
G
Sfn
stratifin
increases expression
ISO
licochalcone B results in increased expression of SFN mRNA
CTD
PMID:33647349
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sfrp5
secreted frizzled-related protein 5
increases expression
ISO
licochalcone B results in increased expression of SFRP5 mRNA
CTD
PMID:33647349
NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:241,006,762...241,011,224
G
Sgk2
serum/glucocorticoid regulated kinase 2
increases expression
ISO
licochalcone B results in increased expression of SGK2 mRNA
CTD
PMID:33647349
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sgsm3
small G protein signaling modulator 3
increases expression
ISO
licochalcone B results in increased expression of SGSM3 mRNA
CTD
PMID:33647349
NCBI chr 7:112,514,453...112,544,109
Ensembl chr 7:112,514,630...112,544,108
G
Sh3d21
SH3 domain containing 21
increases expression
ISO
licochalcone B results in increased expression of SH3D21 mRNA
CTD
PMID:33647349
NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407
G
Sh3pxd2a
SH3 and PX domains 2A
decreases expression
ISO
licochalcone B results in decreased expression of SH3PXD2A mRNA
CTD
PMID:33647349
NCBI chr 1:246,153,660...246,359,806
Ensembl chr 1:246,160,502...246,360,166
G
Shbg
sex hormone binding globulin
increases expression
ISO
licochalcone B results in increased expression of SHBG mRNA
CTD
PMID:33647349
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Sirt7
sirtuin 7
increases expression
ISO
licochalcone B results in increased expression of SIRT7 mRNA
CTD
PMID:33647349
NCBI chr10:105,896,476...105,903,301
Ensembl chr10:105,896,476...105,903,172
G
Slc12a7
solute carrier family 12 member 7
decreases expression
ISO
licochalcone B results in decreased expression of SLC12A7 mRNA
CTD
PMID:33647349
NCBI chr 1:29,472,692...29,554,246
Ensembl chr 1:29,472,692...29,554,302
G
Slc13a4
solute carrier family 13 member 4
decreases expression
ISO
licochalcone B results in decreased expression of SLC13A4 mRNA
CTD
PMID:33647349
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc16a11
solute carrier family 16, member 11
increases expression
ISO
licochalcone B results in increased expression of SLC16A11 mRNA
CTD
PMID:33647349
NCBI chr10:54,929,129...54,933,021
Ensembl chr10:54,927,725...54,942,915
G
Slc16a6
solute carrier family 16, member 6
decreases expression
ISO
licochalcone B results in decreased expression of SLC16A6 mRNA
CTD
PMID:33647349
NCBI chr10:94,424,377...94,447,482
Ensembl chr10:94,426,244...94,448,779
G
Slc16a7
solute carrier family 16 member 7
decreases expression
ISO
licochalcone B results in decreased expression of SLC16A7 mRNA
CTD
PMID:33647349
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc16a9
solute carrier family 16, member 9
decreases expression
ISO
licochalcone B results in decreased expression of SLC16A9 mRNA
CTD
PMID:33647349
NCBI chr20:18,335,862...18,377,125
Ensembl chr20:18,335,862...18,377,022
G
Slc17a7
solute carrier family 17 member 7
increases expression
ISO
licochalcone B results in increased expression of SLC17A7 mRNA
CTD
PMID:33647349
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc22a2
solute carrier family 22 member 2
decreases expression
ISO
licochalcone B results in decreased expression of SLC22A2 mRNA
CTD
PMID:33647349
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc25a25
solute carrier family 25 member 25
increases expression
ISO
licochalcone B results in increased expression of SLC25A25 mRNA
CTD
PMID:33647349
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
G
Slc39a4
solute carrier family 39 member 4
increases expression
ISO
licochalcone B results in increased expression of SLC39A4 mRNA
CTD
PMID:33647349
NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553
G
Slc44a4
solute carrier family 44, member 4
increases expression
ISO
licochalcone B results in increased expression of SLC44A4 mRNA
CTD
PMID:33647349
NCBI chr20:3,903,099...3,919,215
Ensembl chr20:3,903,099...3,919,215
G
Slc5a5
solute carrier family 5 member 5
increases expression
ISO
licochalcone B results in increased expression of SLC5A5 mRNA
CTD
PMID:33647349
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Slc6a13
solute carrier family 6 member 13
increases expression
ISO
licochalcone B results in increased expression of SLC6A13 mRNA
CTD
PMID:33647349
NCBI chr 4:154,539,246...154,577,784
Ensembl chr 4:154,540,468...154,576,152
G
Slc6a15
solute carrier family 6 member 15
decreases expression
ISO
licochalcone B results in decreased expression of SLC6A15 mRNA
CTD
PMID:33647349
NCBI chr 7:38,553,055...38,607,239
Ensembl chr 7:38,553,196...38,607,239
G
Slc7a8
solute carrier family 7 member 8
decreases expression
ISO
licochalcone B results in decreased expression of SLC7A8 mRNA
CTD
PMID:33647349
NCBI chr15:28,183,013...28,242,717
Ensembl chr15:28,183,015...28,242,717
G
Slc9a1
solute carrier family 9 member A1
increases expression
ISO
licochalcone B results in increased expression of SLC9A1 mRNA
CTD
PMID:33647349
NCBI chr 5:145,576,341...145,629,630
Ensembl chr 5:145,576,334...145,629,624
G
Slitrk5
SLIT and NTRK-like family, member 5
decreases expression
ISO
licochalcone B results in decreased expression of SLITRK5 mRNA
CTD
PMID:33647349
NCBI chr15:88,848,123...88,858,809
Ensembl chr15:88,847,535...88,856,836
G
Slitrk6
SLIT and NTRK-like family, member 6
decreases expression
ISO
licochalcone B results in decreased expression of SLITRK6 mRNA
CTD
PMID:33647349
NCBI chr15:87,563,506...87,570,125
Ensembl chr15:87,563,322...87,570,393
G
Smad7
SMAD family member 7
increases expression
ISO
licochalcone B results in increased expression of SMAD7 mRNA
CTD
PMID:33647349
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
G
Smarcad1
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1`
decreases expression
ISO
licochalcone B results in decreased expression of SMARCAD1 mRNA
CTD
PMID:33647349
NCBI chr 4:94,311,441...94,379,184
Ensembl chr 4:94,311,489...94,372,563
G
Snai1
snail family transcriptional repressor 1
increases expression
ISO
licochalcone B results in increased expression of SNAI1 mRNA
CTD
PMID:33647349
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
licochalcone B results in increased expression of SOCS1 mRNA
CTD
PMID:33647349
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
increases expression
ISO
licochalcone B results in increased expression of SOCS3 mRNA
CTD
PMID:33647349
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sorbs1
sorbin and SH3 domain containing 1
increases expression
ISO
licochalcone B results in increased expression of SORBS1 mRNA
CTD
PMID:33647349
NCBI chr 1:239,107,882...239,330,276
Ensembl chr 1:239,108,777...239,330,169
G
Sorbs2
sorbin and SH3 domain containing 2
decreases expression
ISO
licochalcone B results in decreased expression of SORBS2 mRNA
CTD
PMID:33647349
NCBI chr16:46,435,220...46,748,743
Ensembl chr16:46,435,237...46,626,514
G
Sowahd
sosondowah ankyrin repeat domain family member D
increases expression
ISO
licochalcone B results in increased expression of SOWAHD mRNA
CTD
PMID:33647349
NCBI chr X:116,292,030...116,293,660
Ensembl chr X:116,292,030...116,293,660
G
Sox17
SRY-box transcription factor 17
increases expression
ISO
licochalcone B results in increased expression of SOX17 mRNA
CTD
PMID:33647349
NCBI chr 5:15,016,660...15,022,228
Ensembl chr 5:15,016,731...15,022,228
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
licochalcone B results in increased expression of SOX9 mRNA
CTD
PMID:33647349
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Sp6
Sp6 transcription factor
increases expression
ISO
licochalcone B results in increased expression of SP6 mRNA
CTD
PMID:33647349
NCBI chr10:82,005,518...82,009,699
Ensembl chr10:82,005,294...82,011,013
G
Spacdr
sperm acrosome developmental regulator
increases expression
ISO
licochalcone B results in increased expression of SPACDR mRNA
CTD
PMID:33647349
NCBI chr12:18,930,608...18,936,787
Ensembl chr12:18,914,398...18,952,008
G
Spata2L
spermatogenesis associated 2-like
increases expression
ISO
licochalcone B results in increased expression of SPATA2L mRNA
CTD
PMID:33647349
NCBI chr19:51,269,078...51,273,605
Ensembl chr19:51,269,078...51,273,510
G
Spata31f1
SPATA31 subfamily F member 1
increases expression
ISO
licochalcone B results in increased expression of SPATA31F1 mRNA
CTD
PMID:33647349
NCBI chr 5:57,065,743...57,071,880
Ensembl chr 5:57,065,747...57,071,738
G
Spata31h1
SPATA31 subfamily H member 1
decreases expression
ISO
licochalcone B results in decreased expression of SPATA31H1 mRNA
CTD
PMID:33647349
NCBI chr 6:25,023,718...25,040,928
G
Spdya
speedy/RINGO cell cycle regulator family member A
increases expression
ISO
licochalcone B results in increased expression of SPDYA mRNA
CTD
PMID:33647349
NCBI chr 6:23,905,574...23,954,926
Ensembl chr 6:23,910,223...23,954,850
G
Sphk1
sphingosine kinase 1
increases expression
ISO
licochalcone B results in increased expression of SPHK1 mRNA
CTD
PMID:33647349
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
G
Spindoc
spindlin interactor and repressor of chromatin binding
increases expression
ISO
licochalcone B results in increased expression of SPINDOC mRNA
CTD
PMID:33647349
NCBI chr 1:204,541,647...204,565,109
Ensembl chr 1:204,542,335...204,564,144
G
Spon1
spondin 1
increases expression
ISO
licochalcone B results in increased expression of SPON1 mRNA
CTD
PMID:33647349
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spry4
sprouty RTK signaling antagonist 4
increases expression
ISO
licochalcone B results in increased expression of SPRY4 mRNA
CTD
PMID:33647349
NCBI chr18:30,436,513...30,451,426
Ensembl chr18:30,436,443...30,453,004
G
Spsb1
splA/ryanodine receptor domain and SOCS box containing 1
increases expression
ISO
licochalcone B results in increased expression of SPSB1 mRNA
CTD
PMID:33647349
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
G
Spsb3
splA/ryanodine receptor domain and SOCS box containing 3
increases expression
ISO
licochalcone B results in increased expression of SPSB3 mRNA
CTD
PMID:33647349
NCBI chr10:13,907,175...13,912,841
Ensembl chr10:13,907,253...13,912,841
G
Srsf12
serine and arginine rich splicing factor 12
increases expression
ISO
licochalcone B results in increased expression of SRSF12 mRNA
CTD
PMID:33647349
NCBI chr 5:47,606,526...47,631,509
Ensembl chr 5:47,606,285...47,629,778
G
Sstr1
somatostatin receptor 1
decreases expression
ISO
licochalcone B results in decreased expression of SSTR1 mRNA
CTD
PMID:33647349
NCBI chr 6:75,832,292...75,836,806
Ensembl chr 6:75,832,530...75,836,802
G
Stc1
stanniocalcin 1
decreases expression
ISO
licochalcone B results in decreased expression of STC1 mRNA
CTD
PMID:33647349
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Steap4
STEAP4 metalloreductase
decreases expression
ISO
licochalcone B results in decreased expression of STEAP4 mRNA
CTD
PMID:33647349
NCBI chr 4:26,077,182...26,099,859
Ensembl chr 4:26,054,671...26,099,859
G
Stx11
syntaxin 11
increases expression
ISO
licochalcone B results in increased expression of STX11 mRNA
CTD
PMID:33647349
NCBI chr 1:7,293,427...7,320,060
Ensembl chr 1:7,289,976...7,320,164
G
Sv2a
synaptic vesicle glycoprotein 2a
increases expression
ISO
licochalcone B results in increased expression of SV2A mRNA
CTD
PMID:33647349
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Sv2b
synaptic vesicle glycoprotein 2b
decreases expression
ISO
licochalcone B results in decreased expression of SV2B mRNA
CTD
PMID:33647349
NCBI chr 1:128,978,471...129,152,479
Ensembl chr 1:128,978,473...129,152,479
G
Syndig1l
synapse differentiation inducing 1-like
increases expression
ISO
licochalcone B results in increased expression of SYNDIG1L mRNA
CTD
PMID:33647349
NCBI chr 6:104,318,096...104,344,989
Ensembl chr 6:104,323,424...104,344,891
G
Syt11
synaptotagmin 11
increases expression
ISO
licochalcone B results in increased expression of SYT11 mRNA
CTD
PMID:33647349
NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964
G
Sytl5
synaptotagmin-like 5
decreases expression
ISO
licochalcone B results in decreased expression of SYTL5 mRNA
CTD
PMID:33647349
NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175
G
Tacstd2
tumor-associated calcium signal transducer 2
increases expression
ISO
licochalcone B results in increased expression of TACSTD2 mRNA
CTD
PMID:33647349
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
G
Tapbpl
TAP binding protein-like
increases expression
ISO
licochalcone B results in increased expression of TAPBPL mRNA
CTD
PMID:33647349
NCBI chr 4:158,021,454...158,028,905
G
Tas1r1
taste 1 receptor member 1
increases expression
ISO
licochalcone B results in increased expression of TAS1R1 mRNA
CTD
PMID:33647349
NCBI chr 5:162,533,838...162,546,408
Ensembl chr 5:162,533,841...162,545,562
G
Tax1bp3
Tax1 binding protein 3
increases expression
ISO
licochalcone B results in increased expression of TAX1BP3 mRNA
CTD
PMID:33647349
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tbr1
T-box brain transcription factor 1
increases expression
ISO
licochalcone B results in increased expression of TBR1 mRNA
CTD
PMID:33647349
NCBI chr 3:46,350,237...46,368,397
Ensembl chr 3:46,351,213...46,361,041
G
Tcap
titin-cap
increases expression
ISO
licochalcone B results in increased expression of TCAP mRNA
CTD
PMID:33647349
NCBI chr10:83,381,719...83,382,887
Ensembl chr10:83,381,719...83,382,887
G
Tcim
transcriptional and immune response regulator
decreases expression
ISO
licochalcone B results in decreased expression of TCIM mRNA
CTD
PMID:33647349
NCBI chr16:67,595,762...67,597,055
Ensembl chr16:67,593,410...67,597,581
G
Tekt2
tektin 2
increases expression
ISO
licochalcone B results in increased expression of TEKT2 mRNA
CTD
PMID:33647349
NCBI chr 5:138,619,665...138,623,301
Ensembl chr 5:138,619,667...138,623,204
G
Tent5b
terminal nucleotidyltransferase 5B
increases expression
ISO
licochalcone B results in increased expression of TENT5B mRNA
CTD
PMID:33647349
NCBI chr 5:145,695,358...145,702,668
Ensembl chr 5:145,695,362...145,706,073
G
Tent5c
terminal nucleotidyltransferase 5C
increases expression
ISO
licochalcone B results in increased expression of TENT5C mRNA
CTD
PMID:33647349
NCBI chr 2:187,853,026...187,875,260
Ensembl chr 2:187,853,024...187,894,744
G
Tf
transferrin
increases expression
ISO
licochalcone B results in increased expression of TF mRNA
CTD
PMID:33647349
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb2
transforming growth factor, beta 2
decreases expression
ISO
licochalcone B results in decreased expression of TGFB2 mRNA
CTD
PMID:33647349
NCBI chr13:98,160,075...98,261,771
Ensembl chr13:98,160,087...98,261,405
G
Thbs1
thrombospondin 1
increases expression
ISO
licochalcone B results in increased expression of THBS1 mRNA
CTD
PMID:33647349
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Tigd3
tigger transposable element derived 3
increases expression
ISO
licochalcone B results in increased expression of TIGD3 mRNA
CTD
PMID:33647349
NCBI chr 1:203,178,456...203,182,775
Ensembl chr 1:203,178,460...203,181,272
G
Tmem178b
transmembrane protein 178B
decreases expression
ISO
licochalcone B results in decreased expression of TMEM178B mRNA
CTD
PMID:33647349
NCBI chr 4:68,659,425...69,035,690
Ensembl chr 4:68,657,343...69,035,690
G
Tmem191c
transmembrane protein 191C
increases expression
ISO
licochalcone B results in increased expression of TMEM191C mRNA
CTD
PMID:33647349
NCBI chr11:83,726,155...83,728,926
Ensembl chr11:83,725,185...83,730,172
G
Tmem61
transmembrane protein 61
decreases expression
ISO
licochalcone B results in decreased expression of TMEM61 mRNA
CTD
PMID:33647349
NCBI chr 5:121,266,799...121,276,426
Ensembl chr 5:121,266,799...121,276,057
G
Tmem92
transmembrane protein 92
decreases expression
ISO
licochalcone B results in decreased expression of TMEM92 mRNA
CTD
PMID:33647349
NCBI chr10:79,749,242...79,760,807
G
Tnf
tumor necrosis factor
multiple interactions
ISO
licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; licochalcone B analog inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:25451593
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
increases expression
ISO
licochalcone B results in increased expression of TNFRSF10A protein
CTD
PMID:35948134
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfrsf12a
TNF receptor superfamily member 12A
increases expression
ISO
licochalcone B results in increased expression of TNFRSF12A mRNA
CTD
PMID:33647349
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfsf15
TNF superfamily member 15
decreases expression
ISO
licochalcone B results in decreased expression of TNFSF15 mRNA
CTD
PMID:33647349
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnfsf9
TNF superfamily member 9
increases expression
ISO
licochalcone B results in increased expression of TNFSF9 mRNA
CTD
PMID:33647349
NCBI chr 9:1,944,017...1,946,351
Ensembl chr 9:1,944,017...1,946,345
G
Tnk1
tyrosine kinase, non-receptor, 1
increases expression
ISO
licochalcone B results in increased expression of TNK1 mRNA
CTD
PMID:33647349
NCBI chr10:54,571,396...54,580,547
Ensembl chr10:54,571,117...54,579,940
G
Tnnc2
troponin C2, fast skeletal type
increases expression
ISO
licochalcone B results in increased expression of TNNC2 mRNA
CTD
PMID:33647349
NCBI chr 3:153,513,272...153,516,033
Ensembl chr 3:153,513,271...153,516,029
G
Tns1
tensin 1
decreases expression
ISO
licochalcone B results in decreased expression of TNS1 mRNA
CTD
PMID:33647349
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
G
Tprn
taperin
increases expression
ISO
licochalcone B results in increased expression of TPRN mRNA
CTD
PMID:33647349
NCBI chr 3:8,076,164...8,083,642
Ensembl chr 3:8,075,137...8,083,642
G
Trappc14
trafficking protein particle complex subunit 14
increases expression
ISO
licochalcone B results in increased expression of TRAPPC14 mRNA
CTD
PMID:33647349
NCBI chr12:17,262,748...17,267,093
Ensembl chr12:17,262,750...17,267,084
G
Trappc3l
trafficking protein particle complex subunit 3L
decreases expression
ISO
licochalcone B results in decreased expression of TRAPPC3L mRNA
CTD
PMID:33647349
NCBI chr20:25,992,835...26,084,938
Ensembl chr20:25,967,502...26,078,989
G
Trim26
tripartite motif-containing 26
increases expression
ISO
licochalcone B results in increased expression of TRIM26 mRNA
CTD
PMID:33647349
NCBI chr20:1,708,297...1,731,176
Ensembl chr20:1,709,788...1,731,120
G
Trim36
tripartite motif-containing 36
increases expression
ISO
licochalcone B results in increased expression of TRIM36 mRNA
CTD
PMID:33647349
NCBI chr18:38,859,604...38,912,859
Ensembl chr18:38,861,018...38,912,859
G
Trnp1
TMF1-regulated nuclear protein 1
increases expression
ISO
licochalcone B results in increased expression of TRNP1 mRNA
CTD
PMID:33647349
NCBI chr 5:145,706,427...145,713,279
Ensembl chr 5:145,706,094...145,713,272
G
Tsc22d2
TSC22 domain family, member 2
increases expression
ISO
licochalcone B results in increased expression of TSC22D2 mRNA
CTD
PMID:33647349
NCBI chr 2:142,646,778...142,697,977
Ensembl chr 2:142,644,744...142,693,606
G
Tspan5
tetraspanin 5
decreases expression
ISO
licochalcone B results in decreased expression of TSPAN5 mRNA
CTD
PMID:33647349
NCBI chr 2:227,294,180...227,469,361
Ensembl chr 2:227,294,217...227,465,664
G
Tspoap1
TSPO associated protein 1
increases expression
ISO
licochalcone B results in increased expression of TSPOAP1 mRNA
CTD
PMID:33647349
NCBI chr10:72,554,220...72,586,402
Ensembl chr10:72,560,980...72,586,412
G
Ttc23l
tetratricopeptide repeat domain 23-like
increases expression
ISO
licochalcone B results in increased expression of TTC23L mRNA
CTD
PMID:33647349
NCBI chr 2:59,476,666...59,538,313
Ensembl chr 2:59,476,669...59,538,282
G
Ttc39b
tetratricopeptide repeat domain 39B
decreases expression
ISO
licochalcone B results in decreased expression of TTC39B mRNA
CTD
PMID:33647349
NCBI chr 5:97,603,329...97,708,103
Ensembl chr 5:97,609,392...97,736,270
G
Tubb2a
tubulin, beta 2A class IIa
increases expression
ISO
licochalcone B results in increased expression of TUBB2A mRNA
CTD
PMID:33647349
NCBI chr17:30,796,842...30,800,713
Ensembl chr17:30,747,503...30,800,714
G
Tubb3
tubulin, beta 3 class III
increases expression
ISO
licochalcone B results in increased expression of TUBB3 mRNA
CTD
PMID:33647349
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
ISO
licochalcone B results in increased expression of TUBB4B mRNA
CTD
PMID:33647349
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:8,037,799...8,040,296
G
Tulp2
TUB like protein 2
increases expression
ISO
licochalcone B results in increased expression of TULP2 mRNA
CTD
PMID:33647349
NCBI chr 1:95,962,496...95,999,775
Ensembl chr 1:95,962,496...96,000,628
G
Txnip
thioredoxin interacting protein
decreases expression
ISO
licochalcone B results in decreased expression of TXNIP mRNA
CTD
PMID:33647349
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Uap1
UDP-N-acetylglucosamine pyrophosphorylase 1
increases expression
ISO
licochalcone B results in increased expression of UAP1 mRNA
CTD
PMID:33647349
NCBI chr13:82,342,946...82,377,558
Ensembl chr13:82,342,946...82,377,469
G
Uba7
ubiquitin-like modifier activating enzyme 7
increases expression
ISO
licochalcone B results in increased expression of UBA7 mRNA
CTD
PMID:33647349
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ubald2
UBA-like domain containing 2
increases expression
ISO
licochalcone B results in increased expression of UBALD2 mRNA
CTD
PMID:33647349
NCBI chr10:101,662,507...101,667,089
Ensembl chr10:101,658,127...101,667,061
G
Ubb
ubiquitin B
increases expression
ISO
licochalcone B results in increased expression of UBB mRNA
CTD
PMID:33647349
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
G
Ubc
ubiquitin C
increases expression
ISO
licochalcone B results in increased expression of UBC mRNA
CTD
PMID:33647349
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
G
Ube2s
ubiquitin-conjugating enzyme E2S
increases expression
ISO
licochalcone B results in increased expression of UBE2S mRNA
CTD
PMID:33647349
NCBI chr 1:69,028,853...69,032,914
Ensembl chr 1:69,028,750...69,032,914
G
Uchl1
ubiquitin C-terminal hydrolase L1
increases expression
ISO
licochalcone B results in increased expression of UCHL1 mRNA
CTD
PMID:33647349
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
G
Ucp3
uncoupling protein 3
increases expression
ISO
licochalcone B results in increased expression of UCP3 mRNA
CTD
PMID:33647349
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Ugcg
UDP-glucose ceramide glucosyltransferase
increases expression
ISO
licochalcone B results in increased expression of UGCG mRNA
CTD
PMID:33647349
NCBI chr 5:74,032,978...74,065,701
Ensembl chr 5:74,032,978...74,065,393
G
Ulbp1
UL16 binding protein 1
increases expression
ISO
licochalcone B results in increased expression of ULBP1 mRNA
CTD
PMID:33647349
NCBI chr 1:1,694,255...1,716,160
G
Unc80
unc-80 homolog, NALCN channel complex subunit
increases expression
ISO
licochalcone B results in increased expression of UNC80 mRNA
CTD
PMID:33647349
NCBI chr 9:68,011,940...68,190,135
Ensembl chr 9:68,011,728...68,187,659
G
Upp1
uridine phosphorylase 1
increases expression
ISO
licochalcone B results in increased expression of UPP1 mRNA
CTD
PMID:33647349
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
G
Vasn
vasorin
increases expression
ISO
licochalcone B results in increased expression of VASN mRNA
CTD
PMID:33647349
NCBI chr10:10,917,750...10,928,259
Ensembl chr10:10,917,605...10,928,357
G
Vav1
vav guanine nucleotide exchange factor 1
increases expression
ISO
licochalcone B results in increased expression of VAV1 mRNA
CTD
PMID:33647349
NCBI chr 9:2,161,985...2,209,951
Ensembl chr 9:2,157,900...2,208,937
G
Vegfd
vascular endothelial growth factor D
increases expression
ISO
licochalcone B results in increased expression of VEGFD mRNA
CTD
PMID:33647349
NCBI chr X:30,073,122...30,108,413
Ensembl chr X:30,074,163...30,108,295
G
Vgf
VGF nerve growth factor inducible
increases expression
ISO
licochalcone B results in increased expression of VGF mRNA
CTD
PMID:33647349
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
G
Vmo1
vitelline membrane outer layer 1 homolog
increases expression
ISO
licochalcone B results in increased expression of VMO1 mRNA
CTD
PMID:33647349
NCBI chr10:55,227,944...55,234,794
Ensembl chr10:55,227,944...55,229,289
G
Vpreb3
V-set pre-B cell surrogate light chain 3
increases expression
ISO
licochalcone B results in increased expression of VPREB3 mRNA
CTD
PMID:33647349
NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520
G
Vwa3a
von Willebrand factor A domain containing 3A
increases expression
ISO
licochalcone B results in increased expression of VWA3A mRNA
CTD
PMID:33647349
NCBI chr 1:175,293,782...175,355,588
Ensembl chr 1:175,293,873...175,355,602
G
Vwa5b2
von Willebrand factor A domain containing 5B2
increases expression
ISO
licochalcone B results in increased expression of VWA5B2 mRNA
CTD
PMID:33647349
NCBI chr11:80,306,067...80,323,220
Ensembl chr11:80,306,350...80,323,220
G
Wdr38
WD repeat domain 38
increases expression
ISO
licochalcone B results in increased expression of WDR38 mRNA
CTD
PMID:33647349
NCBI chr 3:22,750,150...22,753,260
Ensembl chr 3:22,749,396...22,753,259
G
Wdr47
WD repeat domain 47
increases expression
ISO
licochalcone B results in increased expression of WDR47 mRNA
CTD
PMID:33647349
NCBI chr 2:196,226,757...196,287,739
Ensembl chr 2:196,205,238...196,287,739
G
Wdr49
WD repeat domain 49
increases expression
ISO
licochalcone B results in increased expression of WDR49 mRNA
CTD
PMID:33647349
NCBI chr 2:160,049,478...160,264,581
Ensembl chr 2:160,051,458...160,264,511
G
Wnt4
Wnt family member 4
increases expression
ISO
licochalcone B results in increased expression of WNT4 mRNA
CTD
PMID:33647349
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Wnt9a
Wnt family member 9A
increases expression
ISO
licochalcone B results in increased expression of WNT9A mRNA
CTD
PMID:33647349
NCBI chr10:44,094,140...44,121,134
Ensembl chr10:44,094,140...44,121,133
G
Wtip
WT1 interacting protein
increases expression
ISO
licochalcone B results in increased expression of WTIP mRNA
CTD
PMID:33647349
NCBI chr 1:86,731,214...86,764,939
Ensembl chr 1:86,731,265...86,765,014
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
licochalcone B results in increased expression of ZC3H12A mRNA
CTD
PMID:33647349
NCBI chr 5:137,376,562...137,385,351
Ensembl chr 5:137,376,564...137,385,351
G
Zfand2a
zinc finger AN1-type containing 2A
increases expression
ISO
licochalcone B results in increased expression of ZFAND2A mRNA
CTD
PMID:33647349
NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677
G
Zfp296
zinc finger protein 296
increases expression
ISO
licochalcone B results in increased expression of ZNF296 mRNA
CTD
PMID:33647349
NCBI chr 1:79,228,649...79,231,866
Ensembl chr 1:79,228,401...79,231,866
G
Zfp36
zinc finger protein 36
increases expression
ISO
licochalcone B results in increased expression of ZFP36 mRNA
CTD
PMID:33647349
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
G
Zfp382
zinc finger protein 382
increases expression
ISO
licochalcone B results in increased expression of ZNF382 mRNA
CTD
PMID:33647349
NCBI chr 1:85,377,614...85,400,832
Ensembl chr 1:85,377,484...85,399,667
G
Zfp473
zinc finger protein 473
increases expression
ISO
licochalcone B results in increased expression of ZNF473 mRNA
CTD
PMID:33647349
NCBI chr 1:95,222,683...95,243,328
Ensembl chr 1:95,223,433...95,243,325
G
Zfp518a
zinc finger protein 518A
decreases expression
ISO
licochalcone B results in decreased expression of ZNF518A mRNA
CTD
PMID:33647349
NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
G
Zfp622
zinc finger protein 622
increases expression
ISO
licochalcone B results in increased expression of ZNF622 mRNA
CTD
PMID:33647349
NCBI chr 2:76,479,605...76,494,405
Ensembl chr 2:76,335,609...76,493,898
G
Zfp628
zinc finger protein 628
increases expression
ISO
licochalcone B results in increased expression of ZNF628 mRNA
CTD
PMID:33647349
NCBI chr 1:68,913,600...68,921,186
Ensembl chr 1:68,910,401...68,921,243
G
Zfp703
zinc finger protein 703
increases expression
ISO
licochalcone B results in increased expression of ZNF703 mRNA
CTD
PMID:33647349
NCBI chr16:65,076,507...65,080,677
Ensembl chr16:65,076,507...65,080,677
G
Zfp827
zinc finger protein 827
decreases expression
ISO
licochalcone B results in decreased expression of ZNF827 mRNA
CTD
PMID:33647349
NCBI chr19:28,720,568...28,887,381
Ensembl chr19:28,721,021...28,887,191
G
Zfp831
zinc finger protein 831
decreases expression
ISO
licochalcone B results in decreased expression of ZNF831 mRNA
CTD
PMID:33647349
NCBI chr 3:163,393,787...163,510,654
Ensembl chr 3:163,438,006...163,509,095
G
Zfp853
zinc finger protein 853
increases expression
ISO
licochalcone B results in increased expression of ZNF853 mRNA
CTD
PMID:33647349
NCBI chr12:11,266,124...11,276,492
Ensembl chr12:11,269,414...11,275,731
G
Zmat5
zinc finger, matrin type 5
increases expression
ISO
licochalcone B results in increased expression of ZMAT5 mRNA
CTD
PMID:33647349
NCBI chr14:79,568,644...79,599,595
Ensembl chr14:79,568,758...79,599,594
G
Zmym3
zinc finger MYM-type containing 3
decreases expression
ISO
licochalcone B results in decreased expression of ZMYM3 mRNA
CTD
PMID:33647349
NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782
G
Zmynd15
zinc finger, MYND-type containing 15
increases expression
ISO
licochalcone B results in increased expression of ZMYND15 mRNA
CTD
PMID:33647349
NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
decreases activity
ISO
okanin results in decreased activity of CYP1A2 protein
CTD
PMID:29753067
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
decreases activity
ISO
okanin results in decreased activity of CYP2C9 protein
CTD
PMID:29753067
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases activity
ISO
okanin results in decreased activity of CYP2C19 protein
CTD
PMID:29753067
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Hmox1
heme oxygenase 1
increases expression
ISO
isosalipurposide results in increased expression of HMOX1 protein
CTD
PMID:26028482
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
MAPK1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]
CTD
PMID:26028482
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]
CTD
PMID:26028482
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions
ISO
isosalipurposide affects the localization of NFE2L2 protein MAPK1 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]; MAPK3 protein affects the reaction [isosalipurposide affects the localization of NFE2L2 protein]
CTD
PMID:26028482
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
affects localization
ISO
sappanchalcone affects the localization of AIFM1 protein
CTD
PMID:32590072
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
ISO
sappanchalcone results in increased expression of BAX protein
CTD
PMID:21963806 PMID:32590072
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
sappanchalcone results in decreased expression of BCL2 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity increases cleavage
ISO
sappanchalcone results in increased activity of CASP3 protein sappanchalcone results in increased cleavage of CASP3 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases cleavage
ISO
sappanchalcone results in increased cleavage of CASP7 protein
CTD
PMID:32590072
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
increases cleavage
ISO
sappanchalcone results in increased cleavage of CASP8 protein
CTD
PMID:32590072
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases activity increases cleavage
ISO
sappanchalcone results in increased activity of CASP9 protein sappanchalcone results in increased cleavage of CASP9 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
sappanchalcone results in increased phosphorylation of MAPK8 protein
CTD
PMID:21963806
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
sappanchalcone results in increased degradation of and results in increased phosphorylation of NFKBIA protein
CTD
PMID:21963806
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
sappanchalcone results in increased cleavage of PARP1 protein
CTD
PMID:32590072
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Rela
RELA proto-oncogene, NF-kB subunit
affects localization
ISO
sappanchalcone affects the localization of RELA protein
CTD
PMID:21963806
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tp53
tumor protein p53
increases expression multiple interactions
ISO
sappanchalcone results in increased expression of TP53 protein sappanchalcone results in increased expression of and results in increased phosphorylation of TP53 protein
CTD
PMID:21963806 PMID:32590072
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Afp
alpha-fetoprotein
affects binding
EXP
Chalcone binds to AFP protein
CTD
PMID:23013281 PMID:25349334
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Ar
androgen receptor
affects binding
EXP
Chalcone binds to AR protein
CTD
PMID:14565775
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Car1
carbonic anhydrase 1
decreases activity
ISO
Chalcone results in decreased activity of CA1 protein
CTD
PMID:30431690
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
decreases activity
ISO
Chalcone results in decreased activity of CA2 protein
CTD
PMID:30431690
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
multiple interactions increases cleavage
ISO
MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP3 protein]
CTD
PMID:20620131
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions increases cleavage
ISO
MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP8 protein]
CTD
PMID:20620131
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of CASP9 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein]
CTD
PMID:20620131
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases hydroxylation
EXP
CYP1A1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases hydroxylation
EXP
CYP1A2 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases hydroxylation
EXP
CYP2C6V1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases hydroxylation
EXP
CYP3A23-3A1 protein results in increased hydroxylation of Chalcone
CTD
PMID:15863696
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
Chalcone analog results in increased expression of GCLM mRNA; Chalcone analog results in increased expression of GCLM protein
CTD
PMID:31299238
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Hat1
histone acetyltransferase 1
decreases activity
ISO
Chalcone analog results in decreased activity of HAT1 protein
CTD
PMID:22155221
NCBI chr 3:56,217,344...56,265,021
Ensembl chr 3:56,217,342...56,275,517
G
Il6
interleukin 6
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:22155221
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:22155221
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk14
mitogen activated protein kinase 14
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]
CTD
PMID:22155221
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
CTD
PMID:22155221
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK8 protein]
CTD
PMID:22155221
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions affects response to substance
ISO
Chalcone promotes the reaction [MYC protein results in increased abundance of Reactive Oxygen Species]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP3 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP8 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of CASP9 protein]; MYC protein affects the susceptibility to [Chalcone results in increased cleavage of PARP1 protein] MYC protein affects the susceptibility to Chalcone
CTD
PMID:20620131
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
Chalcone analog results in decreased ubiquitination of and results in decreased degradation of and affects the localization of NFE2L2 protein; NFE2L2 promotes the reaction [Chalcone analog results in increased abundance of Glutathione]
CTD
PMID:31299238
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:22155221
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2] which results in increased abundance of Nitric Oxide]; Chalcone analog inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:22155221
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression
ISO
Chalcone analog results in increased expression of NQO1 mRNA; Chalcone analog results in increased expression of NQO1 protein
CTD
PMID:31299238
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage multiple interactions
ISO
Chalcone results in increased cleavage of PARP1 protein MYC protein affects the susceptibility to [Chalcone results in increased cleavage of PARP1 protein]
CTD
PMID:20620131
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
Chalcone analog results in increased expression of PPARG mRNA
CTD
PMID:28528971
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgr1
prostaglandin reductase 1
multiple interactions
EXP
[PTGR1 protein co-treated with NADP] affects the reduction of Chalcone
CTD
PMID:11524419
NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Chalcone analog inhibits the reaction [[Lipopolysaccharides results in increased phosphorylation of RELA protein] which results in increased acetylation of RELA protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides promotes the reaction [RELA protein binds to NOS2 promoter]]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of RELA mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
CTD
PMID:22155221
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Shbg
sex hormone binding globulin
affects binding
ISO
Chalcone binds to SHBG protein
CTD
PMID:25349334
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
G
Tnf
tumor necrosis factor
multiple interactions
ISO
Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; Chalcone analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:22155221
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Abcc5
ATP binding cassette subfamily C member 5
multiple interactions
ISO
[xanthohumol binds to and results in decreased activity of ABCC5 protein] which results in decreased export of Hyaluronic Acid; xanthohumol binds to and results in decreased activity of ABCC5 protein; xanthohumol inhibits the reaction [ABCC5 protein results in increased export of Hyaluronic Acid]
CTD
PMID:23978416
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
G
Abcg1
ATP binding cassette subfamily G member 1
increases expression
ISO
xanthohumol increases expression of Abcg1 protein in liver
RGD
PMID:23650230
RGD:401842363
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
xanthohumol results in decreased phosphorylation of AKT1 protein AKT1 protein modified form inhibits the reaction [xanthohumol results in increased expression of BBC3 protein]
CTD
PMID:35229981 PMID:35259468
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
multiple interactions decreases phosphorylation
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of AKT2 mRNA] xanthohumol results in decreased phosphorylation of AKT2 protein
CTD
PMID:23994090 PMID:35229981
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Akt3
AKT serine/threonine kinase 3
decreases phosphorylation
ISO
xanthohumol results in decreased phosphorylation of AKT3 protein
CTD
PMID:35229981
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
G
Alpl
alkaline phosphatase, biomineralization associated
increases activity increases expression
ISO
xanthohumol results in increased activity of ALPL protein xanthohumol results in increased expression of ALPL mRNA
CTD
PMID:16019205
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
xanthohumol results in increased expression of BAK1 protein
CTD
PMID:35229981
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
EXP
xanthohumol inhibits the reaction [Azoxymethane results in decreased expression of BAX protein]
CTD
PMID:31714664
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbc3
Bcl-2 binding component 3
increases expression multiple interactions
ISO
xanthohumol results in increased expression of BBC3 mRNA; xanthohumol results in increased expression of BBC3 protein AKT1 protein modified form inhibits the reaction [xanthohumol results in increased expression of BBC3 protein]; BBC3 protein affects the reaction [xanthohumol results in increased cleavage of CASP3 protein]; BBC3 protein affects the reaction [xanthohumol results in increased cleavage of CASP9 protein]; FOXO3 protein affects the reaction [xanthohumol results in increased expression of BBC3 protein]; xanthohumol promotes the reaction [Cisplatin results in increased expression of BBC3 protein]; xanthohumol promotes the reaction [Pemetrexed results in increased expression of BBC3 protein]
CTD
PMID:35259468
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO EXP
xanthohumol results in decreased expression of BCL2; xanthohumol results in decreased expression of BCL2 protein xanthohumol inhibits the reaction [Azoxymethane results in increased expression of BCL2 protein]
CTD
PMID:15995977 PMID:23562496 PMID:26297991 PMID:31714664 PMID:35229981
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
xanthohumol results in increased expression of BCL2L11 alternative form
CTD
PMID:35229981
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Car2
carbonic anhydrase 2
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]
CTD
PMID:23994090
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
multiple interactions increases activity decreases activity increases cleavage
ISO EXP
BBC3 protein affects the reaction [xanthohumol results in increased cleavage of CASP3 protein]; FOXO3 protein affects the reaction [xanthohumol results in increased cleavage of CASP3 protein]; xanthohumol results in increased cleavage of and results in increased activity of CASP3 protein xanthohumol results in increased activity of CASP3 protein xanthohumol results in decreased activity of CASP3 protein xanthohumol inhibits the reaction [Azoxymethane results in decreased expression of CASP3 protein]
CTD
PMID:15995977 PMID:26297991 PMID:27317025 PMID:30240731 PMID:31714664 PMID:35229981 PMID:35259468 More...
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions increases activity
ISO
xanthohumol results in increased cleavage of and results in increased activity of CASP7 protein xanthohumol results in increased activity of CASP7 protein
CTD
PMID:15995977 PMID:30240731
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions increases cleavage increases activity
ISO
xanthohumol results in increased cleavage of and results in increased activity of CASP8 protein xanthohumol results in increased cleavage of CASP8 protein xanthohumol results in increased activity of CASP8 protein
CTD
PMID:15995977 PMID:26297991 PMID:35229981
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases cleavage increases activity
ISO
BBC3 protein affects the reaction [xanthohumol results in increased cleavage of CASP9 protein]; xanthohumol results in increased cleavage of and results in increased activity of CASP9 protein xanthohumol results in increased activity of CASP9 protein
CTD
PMID:15995977 PMID:26297991 PMID:35229981 PMID:35259468
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cbr1
carbonyl reductase 1
multiple interactions
ISO
xanthohumol inhibits the reaction [CBR1 protein results in increased metabolism of Daunorubicin]; xanthohumol inhibits the reaction [CBR1 protein results in increased reduction of 2,3-hexanedione]
CTD
PMID:30849340
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
xanthohumol decreases expression of Ccl2 protein in blood serum
RGD
PMID:23650230
RGD:401842363
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccna2
cyclin A2
decreases expression
ISO
xanthohumol results in decreased expression of CCNA2 protein
CTD
PMID:35229981
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
decreases expression
ISO
xanthohumol results in decreased expression of CCNB1 protein
CTD
PMID:35229981
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO EXP
xanthohumol results in decreased expression of CCND1 xanthohumol inhibits the reaction [Azoxymethane results in increased expression of CCND1 protein]
CTD
PMID:26297991 PMID:27317025 PMID:31714664
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk1
cyclin-dependent kinase 1
decreases expression
ISO
xanthohumol results in decreased expression of CDK1 protein
CTD
PMID:35229981
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
xanthohumol results in increased expression of CDKN1A
CTD
PMID:26297991 PMID:27317025
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cftr
CF transmembrane conductance regulator
multiple interactions
ISO
xanthohumol inhibits the reaction [CFTR protein results in increased export of Hyaluronic Acid]
CTD
PMID:23978416
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
Clcn7
chloride voltage-gated channel 7
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CLCN7 mRNA]
CTD
PMID:23994090
NCBI chr10:14,151,758...14,177,130
Ensembl chr10:14,151,758...14,177,130
G
Cpt1a
carnitine palmitoyltransferase 1A
increases expression
ISO
xanthohumol increases expression of Cpt1a mRNA in liver
RGD
PMID:23650230
RGD:401842363
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
ISO
xanthohumol results in decreased activity of and results in decreased phosphorylation of CREB1 protein
CTD
PMID:27317025
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
G
Cryz
crystallin zeta
increases activity
ISO
xanthohumol results in increased activity of CRYZ protein
CTD
PMID:17590382
NCBI chr 2:243,552,037...243,580,369
Ensembl chr 2:243,552,119...243,579,758
G
Ctnnb1
catenin beta 1
multiple interactions
EXP
xanthohumol inhibits the reaction [Azoxymethane results in decreased phosphorylation of and results in increased activity of CTNNB1 protein]
CTD
PMID:31714664
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Ctsk
cathepsin K
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]
CTD
PMID:23994090
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions increases expression decreases activity
ISO
xanthohumol promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CYP1A1 mRNA] xanthohumol results in increased expression of CYP1A1 mRNA xanthohumol results in decreased activity of CYP1A1 protein
CTD
PMID:22138251 PMID:23503627
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression multiple interactions
ISO
xanthohumol results in increased expression of CYP1A2 mRNA xanthohumol inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]
CTD
PMID:22138251
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Dio1
iodothyronine deiodinase 1
multiple interactions
ISO
[xanthohumol results in decreased activity of DIO1 protein] which affects the metabolism of Triiodothyronine, Reverse
CTD
PMID:25962824
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dio2
iodothyronine deiodinase 2
decreases activity multiple interactions
ISO
xanthohumol results in decreased activity of DIO2 protein [xanthohumol results in decreased activity of DIO2 protein] which affects the metabolism of Thyroxine
CTD
PMID:25962824 PMID:30561685
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dio3
iodothyronine deiodinase 3
decreases activity multiple interactions
ISO
xanthohumol results in decreased activity of DIO3 protein [xanthohumol results in decreased activity of DIO3 protein] which affects the metabolism of Triiodothyronine
CTD
PMID:25962824 PMID:30561685
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
Esr1
estrogen receptor 1
multiple interactions decreases expression
ISO
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [xanthohumol results in decreased expression of ESR1 protein]; xanthohumol promotes the reaction [Estradiol results in decreased expression of ESR1 protein]
CTD
PMID:32986415
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]
CTD
PMID:23994090
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Foxo3
forkhead box O3
multiple interactions decreases phosphorylation
ISO
FOXO3 protein affects the reaction [xanthohumol results in increased cleavage of CASP3 protein]; FOXO3 protein affects the reaction [xanthohumol results in increased expression of BBC3 protein] xanthohumol results in decreased phosphorylation of FOXO3 protein
CTD
PMID:35259468
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
G
Gab2
GRB2-associated binding protein 2
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]
CTD
PMID:23994090
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
G
Gsta1
glutathione S-transferase alpha 1
decreases expression multiple interactions
ISO
xanthohumol results in decreased expression of GSTA1 mRNA [xanthohumol co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] results in increased expression of GSTA1 mRNA
CTD
PMID:22138251
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gstp1
glutathione S-transferase pi 1
increases expression multiple interactions
ISO
xanthohumol results in increased expression of GSTP1 mRNA; xanthohumol results in increased expression of GSTP1 protein [indole-3-carbinol co-treated with xanthohumol] results in increased expression of GSTP1 mRNA; [phenethyl isothiocyanate co-treated with xanthohumol] results in increased expression of GSTP1 mRNA; [phenethyl isothiocyanate co-treated with xanthohumol] results in increased expression of GSTP1 protein; [Resveratrol co-treated with xanthohumol] results in increased expression of GSTP1 mRNA
CTD
PMID:23085367 PMID:32070777
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
increases expression
ISO
xanthohumol results in increased expression of GSTT1 mRNA; xanthohumol results in increased expression of GSTT1 protein
CTD
PMID:23085367
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
G
Hmox1
heme oxygenase 1
increases expression
ISO
xanthohumol results in increased expression of HMOX1 mRNA; xanthohumol results in increased expression of HMOX1 protein
CTD
PMID:23085367
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Icam1
intercellular adhesion molecule 1
decreases expression
ISO
xanthohumol results in decreased expression of ICAM1 protein
CTD
PMID:23503627
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Il1b
interleukin 1 beta
multiple interactions increases expression
ISO
Acetylcysteine inhibits the reaction [xanthohumol results in increased expression of IL1B protein]
CTD
PMID:31629901
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
decreases expression
ISO
xanthohumol results in decreased expression of IL6 mRNA
CTD
PMID:16019205
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation increases phosphorylation decreases activity
ISO
xanthohumol results in decreased phosphorylation of MAPK1 protein xanthohumol results in increased phosphorylation of MAPK1 protein xanthohumol results in decreased activity of MAPK1 protein
CTD
PMID:26297991 PMID:27317025 PMID:35229981
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk11
mitogen-activated protein kinase 11
decreases phosphorylation
ISO
xanthohumol results in decreased phosphorylation of MAPK11 protein
CTD
PMID:35229981
NCBI chr 7:120,218,471...120,225,488
Ensembl chr 7:120,218,478...120,225,395
G
Mapk12
mitogen-activated protein kinase 12
decreases phosphorylation
ISO
xanthohumol results in decreased phosphorylation of MAPK12 protein
CTD
PMID:35229981
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
G
Mapk14
mitogen activated protein kinase 14
decreases phosphorylation
ISO
xanthohumol results in decreased phosphorylation of MAPK14 protein
CTD
PMID:35229981
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions increases phosphorylation decreases activity decreases phosphorylation
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MAPK3 mRNA] xanthohumol results in increased phosphorylation of MAPK3 protein xanthohumol results in decreased activity of MAPK3 protein xanthohumol results in decreased phosphorylation of MAPK3 protein
CTD
PMID:23994090 PMID:26297991 PMID:27317025 PMID:35229981
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
xanthohumol results in increased phosphorylation of MAPK8 protein
CTD
PMID:35229981
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
xanthohumol results in increased phosphorylation of MAPK9 protein
CTD
PMID:35229981
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mki67
marker of proliferation Ki-67
decreases expression
ISO
xanthohumol results in decreased expression of MKI67 protein
CTD
PMID:35259468
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Mmp9
matrix metallopeptidase 9
multiple interactions decreases expression
ISO
xanthohumol results in decreased expression of and results in decreased activity of MMP9 protein xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA] xanthohumol results in decreased expression of MMP9 mRNA
CTD
PMID:23562496 PMID:23994090
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
xanthohumol inhibits the reaction [Azoxymethane results in increased expression of MYC protein]
CTD
PMID:31714664
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Myl2
myosin light chain 2
multiple interactions
ISO
xanthohumol results in decreased phosphorylation of and results in decreased activity of MYL2 protein
CTD
PMID:23503627
NCBI chr12:34,454,223...34,468,554
Ensembl chr12:34,454,218...34,468,983
G
Nat2
N-acetyltransferase 2
multiple interactions
ISO
[xanthohumol co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of NAT2 mRNA
CTD
PMID:22138251
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Nfatc1
nuclear factor of activated T-cells 1
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]
CTD
PMID:23994090
NCBI chr18:74,046,422...74,156,041
Ensembl chr18:74,046,904...74,156,028
G
Nfe2l2
NFE2 like bZIP transcription factor 2
affects localization multiple interactions increases expression increases activity
ISO
xanthohumol affects the localization of NFE2L2 protein [xanthohumol co-treated with phenethyl isothiocyanate] results in increased activity of NFE2L2 protein; [xanthohumol co-treated with phenethyl isothiocyanate] results in increased expression of and results in increased activity of NFE2L2 protein; [xanthohumol co-treated with phenethyl isothiocyanate] results in increased expression of NFE2L2 mRNA; [xanthohumol co-treated with Resveratrol] results in increased expression of NFE2L2 mRNA; [xanthohumol co-treated with Resveratrol] results in increased expression of NFE2L2 protein xanthohumol results in increased expression of NFE2L2 mRNA; xanthohumol results in increased expression of NFE2L2 protein xanthohumol results in increased activity of NFE2L2 protein
CTD
PMID:23085367 PMID:32070777
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions decreases activity decreases expression
ISO
[xanthohumol co-treated with phenethyl isothiocyanate] results in decreased expression of and results in decreased activity of NFKB1 protein; [xanthohumol co-treated with phenethyl isothiocyanate] results in decreased expression of NFKB1 mRNA; [xanthohumol co-treated with Resveratrol] results in decreased expression of NFKB1 mRNA xanthohumol results in decreased activity of NFKB1 protein xanthohumol results in decreased expression of NFKB1 mRNA
CTD
PMID:32070777
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
xanthohumol inhibits the reaction [Azoxymethane results in increased expression of NOS2 mRNA]
CTD
PMID:31714664
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression multiple interactions
ISO
xanthohumol results in increased expression of NQO1 protein [indole-3-carbinol co-treated with xanthohumol] results in increased expression of NQO1 mRNA; [phenethyl isothiocyanate co-treated with xanthohumol] results in increased expression of NQO1 mRNA; [Resveratrol co-treated with xanthohumol] results in increased expression of NQO1 mRNA; [xanthohumol co-treated with phenethyl isothiocyanate] results in increased expression of NQO1 protein xanthohumol results in increased expression of NQO1 mRNA; xanthohumol results in increased expression of NQO1 protein
CTD
PMID:23085367 PMID:26473469 PMID:32070777
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Ostm1
osteoclastogenesis associated transmembrane protein 1
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of OSTM1 mRNA]
CTD
PMID:23994090
NCBI chr20:46,071,657...46,187,049
Ensembl chr20:46,153,075...46,187,023
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
xanthohumol results in increased cleavage of PARP1 protein
CTD
PMID:15995977 PMID:35229981
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of PIK3CG mRNA]
CTD
PMID:23994090
NCBI chr 6:48,766,778...48,802,098
Ensembl chr 6:48,766,864...48,802,043
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity multiple interactions decreases expression
ISO EXP
xanthohumol results in decreased activity of PTGS2 protein [xanthohumol co-treated with indole-3-carbinol] results in decreased expression of PTGS2 mRNA; [xanthohumol co-treated with phenethyl isothiocyanate] results in decreased expression of PTGS2 mRNA; [xanthohumol co-treated with phenethyl isothiocyanate] results in decreased expression of PTGS2 protein; [xanthohumol co-treated with Resveratrol] results in decreased expression of PTGS2 mRNA xanthohumol results in decreased expression of PTGS2 mRNA xanthohumol inhibits the reaction [Azoxymethane results in increased expression of PTGS2 mRNA]
CTD
PMID:17590382 PMID:31714664 PMID:32070777
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pxn
paxillin
decreases expression
ISO
xanthohumol results in decreased expression of PXN protein
CTD
PMID:23503627
NCBI chr12:41,060,791...41,107,952
Ensembl chr12:41,060,791...41,107,931
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases activity decreases expression
ISO
[indole-3-carbinol co-treated with xanthohumol] results in decreased activity of RELA protein; [indole-3-carbinol co-treated with xanthohumol] results in decreased expression of RELA mRNA; [phenethyl isothiocyanate co-treated with xanthohumol] results in decreased expression of and results in decreased activity of RELA protein; [phenethyl isothiocyanate co-treated with xanthohumol] results in decreased expression of RELA mRNA; [Resveratrol co-treated with xanthohumol] results in decreased activity of RELA protein; [Resveratrol co-treated with xanthohumol] results in decreased expression of RELA mRNA xanthohumol results in decreased activity of RELA protein xanthohumol results in decreased expression of RELA mRNA
CTD
PMID:32070777
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Ripk1
receptor interacting serine/threonine kinase 1
increases cleavage
ISO
xanthohumol results in increased cleavage of RIPK1 protein
CTD
PMID:35229981
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
xanthohumol results in decreased expression of S100A4 protein
CTD
PMID:23503627
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
xanthohumol decreases expression of Scd1 mRNA in liver
RGD
PMID:23650230
RGD:401842363
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Sele
selectin E
multiple interactions
ISO
xanthohumol inhibits the reaction [TNF protein results in increased expression of SELE protein]
CTD
PMID:23503627
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]
CTD
PMID:23994090
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
G
Srebf1
sterol regulatory element binding transcription factor 1
decreases expression
ISO
xanthohumol decreases expression of Srebf1 mRNA in liver
RGD
PMID:23650230
RGD:401842363
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
decreases expression
ISO
xanthohumol decreases expression of Srebp2 protein in liver
RGD
PMID:23650230
RGD:401842363
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Sult1a1
sulfotransferase family 1A member 1
increases expression decreases expression
ISO
xanthohumol results in increased expression of SULT1A1 mRNA xanthohumol results in decreased expression of SULT1A1 mRNA
CTD
PMID:22138251
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tcirg1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit A3
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of TCIRG1 mRNA]
CTD
PMID:23994090
NCBI chr 1:201,127,034...201,138,787
Ensembl chr 1:201,127,034...201,138,742
G
Tff1
trefoil factor 1
increases expression
ISO
xanthohumol results in increased expression of TFF1 mRNA
CTD
PMID:16019205
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tnf
tumor necrosis factor
multiple interactions
ISO
xanthohumol inhibits the reaction [TNF protein results in increased expression of SELE protein]
CTD
PMID:23503627
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfsf11
TNF superfamily member 11
multiple interactions decreases response to substance
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of AKT2 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CAR2 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CLCN7 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of FOS mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of GAB2 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MAPK3 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of MMP9 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of NFATC1 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of OSTM1 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of PIK3CG mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of SRC mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of TCIRG1 mRNA]; xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of TRAF6 mRNA] xanthohumol results in decreased susceptibility to TNFSF11 protein
CTD
PMID:23994090
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
G
Tp53
tumor protein p53
increases expression
ISO
xanthohumol results in increased expression of TP53; xanthohumol results in increased expression of TP53 mRNA; xanthohumol results in increased expression of TP53 protein
CTD
PMID:23085367 PMID:26297991 PMID:27317025
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Traf6
TNF receptor associated factor 6
multiple interactions
ISO
xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of TRAF6 mRNA]
CTD
PMID:23994090
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
multiple interactions increases expression
ISO
xanthohumol promotes the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of UGT1A1 mRNA] xanthohumol results in increased expression of UGT1A1 mRNA
CTD
PMID:22138251
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
multiple interactions
ISO
[xanthohumol co-treated with 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline] results in increased expression of UGT1A2 mRNA
CTD
PMID:22138251
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Vwf
von Willebrand factor
increases expression
ISO
xanthohumol results in increased expression of VWF mRNA
CTD
PMID:16019205
NCBI chr 4:158,360,152...158,491,539
Ensembl chr 4:158,360,152...158,491,539
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19915
chemical entity
19913
atom
19879
nonmetal atom
19815
oxygen atom
19550
oxygen molecular entity
19586
flavonoids
11422
chalcones
936
(+)-tephrosone
0
(-)-Linderol A
0
(-)-Neolinderatin
0
(2 ́ ́S)-5 ́-Lavandulyl-4 ́-methoxy-2,4,2 ́,6 ́-tetrahydroxylchalcone
0
(2E)-3-(2-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
0
(2′′S)-5′-lavandulyl-2′-methoxy-2,4,4′,6′-tetrahydroxylchalcone
0
(E)-2,4,4'-Trihydroxychalcone
0
(E)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
0
(E)-4,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
(R)-Kanzonol Y
0
1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-1-propanone
0
1-(2,4-dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-(2-hydroxyphenyl)propan-1-one
0
1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one
0
1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one
0
1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one
0
1-(2,5-dihydro-6,8-dihydroxy-3-methyl-1-benzoxepin-7-yl)-3-phenyl-1-propanone
0
1-(2,5-dihydroxyphenyl)-3-(3-hydroxyphenyl)propan-1-one
0
1-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-one
0
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-2-propen-1-one
0
1-(3-nitrophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
1-(4-ethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
1-(4-hydroxyphenyl)-3-[4-[(4-methyl-1,2,4-triazol-3-yl)thio]-3-nitrophenyl]-2-propen-1-one
0
1-(4-methylphenyl)-3-(6-quinolinyl)-2-propen-1-one
0
1-(5-chloro-2-hydroxyphenyl)-3-[4-(dimethylamino)phenyl]-2-propen-1-one
0
1-[2,4,6-Trihydroxy-3,5-bis(beta-D-glucopyranosyl)phenyl]-3-phenyl-1-propanone
0
1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)propan-1-one
0
1-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-2-hydroxy-3-[4-hydroxy-3-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]propan-1-one
0
1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
0
1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-2-propen-1-one
0
1-phenyl-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
2',3,4,4',6'-pentahydroxychalcone +
0
2',3,4-trihydroxy-trans-chalcone +
0
2',4',4''-trihydroxy-3',6'',6''-trimethylpyrano[2'',3'':6',5']dihydrochalcone
0
2',4',5''-Trihydroxy-3',6'',6''-trimetylpyrano[2'',3'':6',5']dihydrochalcone
0
2',4',6',3,4-Pentahydroxy-3'-geranyl-5-prenyldihydrochalcone
0
2',4',6',3-Tetrahydroxy-3'-geranyl-6'',6''-dimethylpyrano[2'',3'':4,5]dihydrochalcone
0
2',4',6'-Trihydroxy-3'-methoxy-5'-prenyldihydrochalcone
0
2',4',6'-Trihydroxy-3'-prenyldihydrochalcone
0
2',4',6'-Trihydroxy-4-methoxychalcone
0
2',4',6'-Trihydroxy-4-methoxydihydrochalcone
0
2',4',6'-Trihydroxydihydrochalcone
0
2',4',alpha-Trihydroxy-4-methoxydihydrochalcone
0
2',4'-Dihydroxy-3',6'',6''-trimethylpyrano[2'',3'':6',5']chalcone
0
2',4'-Dihydroxy-3'-(1,1-dimethyl-2-propenyl)chalcone
0
2',4'-Dihydroxy-3,4,6'-trimethoxydihydrochalcone
0
2',4'-Dihydroxy-3,4-methylenedioxydihydrochalcone
0
2',4'-Dihydroxy-6'-methoxy-3'-(2-methylbutyryloxy)chalcone
0
2',4'-dihydroxy-3'-(2-hydroxy benzyl)-6'-methoxy chalcone
0
2',4'-dihydroxy-3'-methyl-6'-methoxychalcone
0
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone
12
2',4,4',6'-tetrahydroxychalcone +
2
2',4,4'-Trihydroxy-6'-methoxy-3',5'-diprenylchalcone
0
2',5'-Dihydroxychalcone
3
2',6'-Dihydroxy-3'-(1-p-menthen-3-yl)-4'-methoxychalcone
0
2',6'-Dihydroxy-4'-methoxy-3'-prenyldihydrochalcone
0
2',6'-Dihydroxy-4'-prenyloxydihydrochalcone
0
2',6'-Dihydroxy-4,3'-dimethoxy-4',5'-methylenedioxydihydrochalcone
0
2'-Hydroxy-3',4',6'-trimethoxydihydrochalcone
0
2'-Hydroxy-6'-methoxy-4'-prenyloxydihydrochalcone
0
2'-Hydroxyfurano[2'',3'':4',3']chalcone
0
2'-O-methylisoliquiritigenin
0
2'-hydroxy-2,5,6'-trimethoxychalcone
0
2'-hydroxychalcone
3
2,2',4'-Trihydroxy-6'-methoxychalcone
0
2,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
2,4,2',4'-Tetrahydroxychalcone
0
2,4-Dihydroxychalcone
4
2,5-dimethoxy-5'-fluoro-2'-hydroxychalcone
0
2-Geranyl-2',3,4,4'-tetrahydroxydihydrochalcone
0
2-[(3,4-dihydroxyphenyl)-oxomethyl]-3-(4-hydroxy-3-iodo-5-methoxyphenyl)-2-propenenitrile
0
2-[4-[3-[2-[(4-methoxycarbonylphenyl)methoxy]phenyl]-1-oxoprop-2-enyl]phenoxy]acetic acid
0
3',4'-Dihydroxychalcone
0
3',6'-dihydroxy-2',4,4'-trimethoxy-chalcone
0
3'-(3-methyl-2-butenyl)-4'-O-beta-D-glucopyranosyl-4,2'-dihydroxychalcone
0
3'-Angeloyloxy-4',6'-dihydroxy-2',5'-dimethoxychalcone
0
3'-Methyl-2',4',6'-trihydroxydihydrochalcone
0
3'-geranyl-3,4,2',4'-tetrahydroxy-6'-methoxydihydrochalcone
0
3,2',4',6'-Tetrahydroxy-4-methoxy-3',5-diprenyldihydrochalcone
0
3,2',4'-Trihydroxy-4-methoxychalcone
0
3,3',4,4'-Tetrahydroxy-2-methoxychalcone
0
3,4'-dimethoxy-2'-hydroxychalcone
0
3,4,2',4',alpha-Pentahydroxydihydrochalcone
0
3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(2-hydroxy-4-methylphenyl)-2-propen-1-one
0
3-(2,4-dihydroxy-5-methoxyphenyl)-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
0
3-(2-methoxyphenyl)-1-phenyl-2-propen-1-one
0
3-(3,4-dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one
0
3-(3,4-dihydroxyphenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)propan-1-one
0
3-(3,4-dihydroxyphenyl)-2-[(3,4-dihydroxyphenyl)-oxomethyl]-2-propenenitrile
0
3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)propan-1-one
0
3-(3-methylphenyl)-1-[4-(4-morpholinyl)phenyl]-2-propen-1-one
0
3-(4-hydroxy-3-methoxyphenyl)-1-\{2,4,6-trihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl\}propan-1-one
0
3-(4-hydroxyphenyl)-1-\{2,4,6-trihydroxy-3,5-bis(2S,3R,4R,5S,6R)[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl\}propan-1-one
0
3-(4-hydroxyphenyl)-1-\{2,4,6-trihydroxy-3-[(2Z)-4-hydroxy-3-(4-methylpent-3-en-1-yl)but-2-en-1-yl]phenyl\}propan-1-one
0
3-(4-methoxyphenyl)-1-(2,3,4,6-tetrahydroxyphenyl)propan-1-one
0
3-Geranyl-4,2',4',6'-tetrahydroxy-5-prenyldihydrochalcone
0
3-Hydroxyphloretin
0
3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)-2-propen-1-one
0
4',6'-dimethoxy-4-dimethylamino-2'-hydroxychalcone
0
4'-Methoxychalcone
9
4'-O-Methyldavidigenin
0
4'-O-methylbavachalcone
0
4'-O-methylxanthohumol
0
4'-hydroxychalcone
2
4,2',3',4'-Tetrahydroxychalcone
0
4,2',4'-Trihydroxy-3-methoxydihydrochalcone
0
4,2',4'-Trihydroxy-6'-methoxydihydrochalcone
0
4,2',6'-Trihydroxy-4'-methoxy-3',5'-dimethyldihydrochalcone
0
4,2',6'-Trihydroxy-4'-methoxy-3'-methyldihydrochalcone
0
4,2'-dihydroxy-3,4',6'-trimethoxychalcone
0
4-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-6-methyl-7-oxabicyclo[4.1.0]heptane-3-carboxylic acid
0
4-Hydroxyderricin
0
4-Methoxylonchocarpin
0
4-O-methylxanthohumol
0
4-[3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoic acid
0
4-benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalcone
0
4-chlorochalcone
0
4-hydroxychalcone
7
4-hydroxycordoin
0
6'',6''-Dimethylpyrano[2'',3'':6',5']-2'-hydroxy-3,4,4'-trimethoxychalcone
0
6'-Hydroxy-2,3,4,5,2',3',4'-heptamethoxychalcone
0
6-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-4-(hydroxymethyl)cyclohex-3-ene-1-carboxylic acid
0
6-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-6-hydroxy-4-methylcyclohex-3-ene-1-carboxylic acid
0
6-(\{6-[6-(2,4-dihydroxyphenyl)-2-\{3-[(2E)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyl]-2,2-dimethyl-2H-chromen-5-yl\}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
0
6-[4-(6-carboxy-5-\{3-[(2E)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl\}-3-methylcyclohex-3-en-1-yl)-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
0
7-methoxypraecansone B
0
Adunctin B
0
Adunctin C
0
Artonin D
0
Bartericin C
0
Bavachalcone
1
Brosimacutin G
0
Brosimacutin H
0
Calythropsin
0
Cardamonin
12
Castillene E
0
Cerasidin
0
Chresdihydrochalcone
0
Citrunobin
0
Crassichalcone
0
Crotaoprostrin
0
Derrichalcone
0
Derricidin
0
Derricin
0
Didymocalyxin B
0
Dihydrocordoin
0
Dihydrokanakugiol
0
Dihydropedicin
0
Flavokawain A
9
Flemingin F
0
Flemiwallichin B
0
Flemiwallichin D
0
Flemiwallichin E
0
Gemichalcone C
0
Glyinflanin E
0
Glypallichalcone
0
Hamilcone
0
Heliannone A
0
Helichrysetin
0
Helilandin B
0
Homobutein
0
Isocordoin
0
Isoliquiritigenin 4,4'-dimethyl ether
0
Isoxanthohumol B
0
Kanzonol B
0
Kanzonol C
0
Kukulkanin A
0
Kukulkanin B
0
Kurzichalcolactone
0
Kushenol D
0
LSM-4240
0
Licoagrochalcone B
0
Licoagrochalcone C
0
Licoagrochalcone D
0
Licochalcone A
56
Licochalcone B
761
Linderachalcone
0
Lonchocarpin
0
Methyllinderatin
0
Morachalcone A
0
Myrigalon B
0
Myrigalone E
0
Myrigalone G
0
Myrigalone H
0
N-[2-[2-[(E)-3-(2,3-Dimethoxyphenyl)prop-2-enoyl]-4,5-dimethoxyphenyl]ethyl]acetamide
0
N-[3-[3-(4-fluorophenyl)-1-oxoprop-2-enyl]phenyl]acetamide
0
N-[3-[3-(5-bromo-2-methoxyphenyl)-1-oxoprop-2-enyl]phenyl]propanamide
0
N-[4-[3-(2-methoxyphenyl)-1-oxoprop-2-enyl]phenyl]acetamide
0
Neoplathymenin
0
Neosakuranetin
0
Nubigenol
0
O-Methylpongamol
0
Oaxacacin
0
Orotinichalcone
0
Ovalitenin A
0
Paratocarpin B
0
Paratocarpin F
0
Paratocarpin G
0
Pinostrobin chalcone
0
Pongachalcone I
0
Pongagallone A
0
Pongagallone B
0
Prorepensin
0
Prosogerin B
0
Pseudosindorin
0
Rubone
0
Sophoradin
0
Spinochalcone A
0
Spinochalcone B
0
Spinochalcone C
0
Uvangoletin
0
Xanthoangelol C
0
Xanthoangelol D
0
Xanthohumol C
0
Xanthohumol E
0
[3-(2,5-dihydroxyphenyl)-3-oxo-1-phenylpropoxy]sulfonic acid
0
[4-[3-(4-iodophenyl)prop-2-enoyl]phenyl]boronic acid
0
\{3-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
\{4-[2,3-dioxo-3-(2,4,6-trihydroxy-3-methoxyphenyl)propyl]-2-hydroxy-6-methoxyphenyl\}oxidanesulfonic acid
0
\{4-[2,3-dioxo-3-(2,4,6-trihydroxyphenyl)propyl]phenyl\}oxidanesulfonic acid
0
\{4-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
\{4-[3-oxo-3-(2,4,6-trihydroxyphenyl)prop-1-en-1-yl]phenyl\}oxidanesulfonic acid
0
\{6-hydroxy-3-[3-(3-hydroxyphenyl)-3-oxoprop-1-en-1-yl]-2-methoxyphenyl\}oxidanesulfonic acid
0
\{[4-(5-\{3-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-2-hydroxy-3-oxopropyl\}-2-hydroxyphenyl)-2-methylbut-2-en-1-yl]oxy\}sulfonic acid
0
abyssinone A
0
abyssinone C
0
abyssinone D
0
abyssinone VI
0
alpha,4,2'-Trihydroxy-4-O-geranyldihydrochalcone
0
beta,2-Dihydroxy-4,6-dimethoxy-3-methylchalcone
0
butein
27
candidachalcone
0
chalcone +
115
demethoxyisogemichalcone C
0
desmethylxanthohumol
0
flavokawain B
19
flavokawain C
0
gemichalcone B
0
homoeriodictyol chalcone
0
isobavachalcone
5
isobutrin
0
isoliquiritigenin +
85
isoliquiritin
0
kuraridinol
0
mallotophilippen C
0
mallotophilippen D
0
mallotophilippen E +
0
naringin chalcone
0
obochalcolactone
0
okanin
3
oxygenated xanthohumol
0
phlorizin chalcone
4
pinocembrin chalcone
0
praecanson A
0
sappanchalcone
12
sofalcone
0
xanthogalenol
0
xanthohumol
86
xanthohumol B
0
xanthohumol D
0
Path 2
CHEBI ontology
19915
subatomic particle
19879
composite particle
19913
hadron
19879
baryon
19879
nucleon
19913
atomic nucleus
19879
atom
19879
main group element atom
19829
p-block element atom
19829
carbon group element atom
19807
carbon atom
19803
organic molecular entity
19803
organic group
18990
organic divalent group
18965
organodiyl group
18935
carbonyl group
18921
carbonyl compound
18921
ketone
17187
alpha,beta-unsaturated ketone
9974
enone
9964
chalcones
936
(+)-tephrosone
0
(-)-Linderol A
0
(-)-Neolinderatin
0
(2 ́ ́S)-5 ́-Lavandulyl-4 ́-methoxy-2,4,2 ́,6 ́-tetrahydroxylchalcone
0
(2E)-3-(2-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
0
(2′′S)-5′-lavandulyl-2′-methoxy-2,4,4′,6′-tetrahydroxylchalcone
0
(E)-2,4,4'-Trihydroxychalcone
0
(E)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
0
(E)-4,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
(R)-Kanzonol Y
0
1-(2,4-Dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-phenyl-1-propanone
0
1-(2,4-dihydroxy-6-methoxy-3,5-dimethylphenyl)-3-(2-hydroxyphenyl)propan-1-one
0
1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one
0
1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one
0
1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)-2-propen-1-one
0
1-(2,5-dihydro-6,8-dihydroxy-3-methyl-1-benzoxepin-7-yl)-3-phenyl-1-propanone
0
1-(2,5-dihydroxyphenyl)-3-(3-hydroxyphenyl)propan-1-one
0
1-(2-hydroxy-3,4,5,6-tetramethoxyphenyl)-3-(2,3,4,6-tetramethoxyphenyl)-2-propen-1-one
0
1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl-2-propen-1-one
0
1-(3-nitrophenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
1-(4-ethoxyphenyl)-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
1-(4-hydroxyphenyl)-3-[4-[(4-methyl-1,2,4-triazol-3-yl)thio]-3-nitrophenyl]-2-propen-1-one
0
1-(4-methylphenyl)-3-(6-quinolinyl)-2-propen-1-one
0
1-(5-chloro-2-hydroxyphenyl)-3-[4-(dimethylamino)phenyl]-2-propen-1-one
0
1-[2,4,6-Trihydroxy-3,5-bis(beta-D-glucopyranosyl)phenyl]-3-phenyl-1-propanone
0
1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)propan-1-one
0
1-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-2-hydroxy-3-[4-hydroxy-3-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]propan-1-one
0
1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)-2-propen-1-one
0
1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-2-propen-1-one
0
1-phenyl-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one
0
2',3,4,4',6'-pentahydroxychalcone +
0
2',3,4-trihydroxy-trans-chalcone +
0
2',4',4''-trihydroxy-3',6'',6''-trimethylpyrano[2'',3'':6',5']dihydrochalcone
0
2',4',5''-Trihydroxy-3',6'',6''-trimetylpyrano[2'',3'':6',5']dihydrochalcone
0
2',4',6',3,4-Pentahydroxy-3'-geranyl-5-prenyldihydrochalcone
0
2',4',6',3-Tetrahydroxy-3'-geranyl-6'',6''-dimethylpyrano[2'',3'':4,5]dihydrochalcone
0
2',4',6'-Trihydroxy-3'-methoxy-5'-prenyldihydrochalcone
0
2',4',6'-Trihydroxy-3'-prenyldihydrochalcone
0
2',4',6'-Trihydroxy-4-methoxychalcone
0
2',4',6'-Trihydroxy-4-methoxydihydrochalcone
0
2',4',6'-Trihydroxydihydrochalcone
0
2',4',alpha-Trihydroxy-4-methoxydihydrochalcone
0
2',4'-Dihydroxy-3',6'',6''-trimethylpyrano[2'',3'':6',5']chalcone
0
2',4'-Dihydroxy-3'-(1,1-dimethyl-2-propenyl)chalcone
0
2',4'-Dihydroxy-3,4,6'-trimethoxydihydrochalcone
0
2',4'-Dihydroxy-3,4-methylenedioxydihydrochalcone
0
2',4'-Dihydroxy-6'-methoxy-3'-(2-methylbutyryloxy)chalcone
0
2',4'-dihydroxy-3'-(2-hydroxy benzyl)-6'-methoxy chalcone
0
2',4'-dihydroxy-3'-methyl-6'-methoxychalcone
0
2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone
12
2',4,4',6'-tetrahydroxychalcone +
2
2',4,4'-Trihydroxy-6'-methoxy-3',5'-diprenylchalcone
0
2',5'-Dihydroxychalcone
3
2',6'-Dihydroxy-3'-(1-p-menthen-3-yl)-4'-methoxychalcone
0
2',6'-Dihydroxy-4'-methoxy-3'-prenyldihydrochalcone
0
2',6'-Dihydroxy-4'-prenyloxydihydrochalcone
0
2',6'-Dihydroxy-4,3'-dimethoxy-4',5'-methylenedioxydihydrochalcone
0
2'-Hydroxy-3',4',6'-trimethoxydihydrochalcone
0
2'-Hydroxy-6'-methoxy-4'-prenyloxydihydrochalcone
0
2'-Hydroxyfurano[2'',3'':4',3']chalcone
0
2'-O-methylisoliquiritigenin
0
2'-hydroxy-2,5,6'-trimethoxychalcone
0
2'-hydroxychalcone
3
2,2',4'-Trihydroxy-6'-methoxychalcone
0
2,2',4'-trihydroxy-6'-methoxy-3',5'-dimethylchalcone
0
2,4,2',4'-Tetrahydroxychalcone
0
2,4-Dihydroxychalcone
4
2,5-dimethoxy-5'-fluoro-2'-hydroxychalcone
0
2-Geranyl-2',3,4,4'-tetrahydroxydihydrochalcone
0
2-[(3,4-dihydroxyphenyl)-oxomethyl]-3-(4-hydroxy-3-iodo-5-methoxyphenyl)-2-propenenitrile
0
2-[4-[3-[2-[(4-methoxycarbonylphenyl)methoxy]phenyl]-1-oxoprop-2-enyl]phenoxy]acetic acid
0
3',4'-Dihydroxychalcone
0
3',6'-dihydroxy-2',4,4'-trimethoxy-chalcone
0
3'-(3-methyl-2-butenyl)-4'-O-beta-D-glucopyranosyl-4,2'-dihydroxychalcone
0
3'-Angeloyloxy-4',6'-dihydroxy-2',5'-dimethoxychalcone
0
3'-Methyl-2',4',6'-trihydroxydihydrochalcone
0
3'-geranyl-3,4,2',4'-tetrahydroxy-6'-methoxydihydrochalcone
0
3,2',4',6'-Tetrahydroxy-4-methoxy-3',5-diprenyldihydrochalcone
0
3,2',4'-Trihydroxy-4-methoxychalcone
0
3,3',4,4'-Tetrahydroxy-2-methoxychalcone
0
3,4'-dimethoxy-2'-hydroxychalcone
0
3,4,2',4',alpha-Pentahydroxydihydrochalcone
0
3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-(2-hydroxy-4-methylphenyl)-2-propen-1-one
0
3-(2,4-dihydroxy-5-methoxyphenyl)-1-[2,4,6-trihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
0
3-(2-methoxyphenyl)-1-phenyl-2-propen-1-one
0
3-(3,4-dihydroxyphenyl)-1-(2,3,4,5,6-pentahydroxyphenyl)prop-2-en-1-one
0
3-(3,4-dihydroxyphenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)propan-1-one
0
3-(3,4-dihydroxyphenyl)-2-[(3,4-dihydroxyphenyl)-oxomethyl]-2-propenenitrile
0
3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)propan-1-one
0
3-(3-methylphenyl)-1-[4-(4-morpholinyl)phenyl]-2-propen-1-one
0
3-(4-hydroxy-3-methoxyphenyl)-1-\{2,4,6-trihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl\}propan-1-one
0
3-(4-hydroxyphenyl)-1-\{2,4,6-trihydroxy-3,5-bis(2S,3R,4R,5S,6R)[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]phenyl\}propan-1-one
0
3-(4-hydroxyphenyl)-1-\{2,4,6-trihydroxy-3-[(2Z)-4-hydroxy-3-(4-methylpent-3-en-1-yl)but-2-en-1-yl]phenyl\}propan-1-one
0
3-(4-methoxyphenyl)-1-(2,3,4,6-tetrahydroxyphenyl)propan-1-one
0
3-Geranyl-4,2',4',6'-tetrahydroxy-5-prenyldihydrochalcone
0
3-Hydroxyphloretin
0
3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)-2-propen-1-one
0
4',6'-dimethoxy-4-dimethylamino-2'-hydroxychalcone
0
4'-Methoxychalcone
9
4'-O-Methyldavidigenin
0
4'-O-methylbavachalcone
0
4'-O-methylxanthohumol
0
4'-hydroxychalcone
2
4,2',3',4'-Tetrahydroxychalcone
0
4,2',4'-Trihydroxy-3-methoxydihydrochalcone
0
4,2',4'-Trihydroxy-6'-methoxydihydrochalcone
0
4,2',6'-Trihydroxy-4'-methoxy-3',5'-dimethyldihydrochalcone
0
4,2',6'-Trihydroxy-4'-methoxy-3'-methyldihydrochalcone
0
4,2'-dihydroxy-3,4',6'-trimethoxychalcone
0
4-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-6-methyl-7-oxabicyclo[4.1.0]heptane-3-carboxylic acid
0
4-Hydroxyderricin
0
4-Methoxylonchocarpin
0
4-O-methylxanthohumol
0
4-[3-(3,5-ditert-butylphenyl)-3-oxoprop-1-enyl]benzoic acid
0
4-benzyloxy-2'-hydroxy-3',4',5',6'-tetramethoxychalcone
0
4-chlorochalcone
0
4-hydroxychalcone
7
4-hydroxycordoin
0
6'',6''-Dimethylpyrano[2'',3'':6',5']-2'-hydroxy-3,4,4'-trimethoxychalcone
0
6'-Hydroxy-2,3,4,5,2',3',4'-heptamethoxychalcone
0
6-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-4-(hydroxymethyl)cyclohex-3-ene-1-carboxylic acid
0
6-(2,4-dihydroxyphenyl)-2-\{3-[3-(2,4-dihydroxyphenyl)propanoyl]-2,6-dihydroxyphenyl\}-6-hydroxy-4-methylcyclohex-3-ene-1-carboxylic acid
0
6-(\{6-[6-(2,4-dihydroxyphenyl)-2-\{3-[(2E)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl\}-4-methylcyclohex-3-ene-1-carbonyl]-2,2-dimethyl-2H-chromen-5-yl\}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
0
6-[4-(6-carboxy-5-\{3-[(2E)-3-(2,4-dihydroxyphenyl)prop-2-enoyl]-2,6-dihydroxyphenyl\}-3-methylcyclohex-3-en-1-yl)-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
0
7-methoxypraecansone B
0
Adunctin B
0
Adunctin C
0
Artonin D
0
Bartericin C
0
Bavachalcone
1
Brosimacutin G
0
Brosimacutin H
0
Calythropsin
0
Cardamonin
12
Castillene E
0
Cerasidin
0
Chresdihydrochalcone
0
Citrunobin
0
Crassichalcone
0
Crotaoprostrin
0
Derrichalcone
0
Derricidin
0
Derricin
0
Didymocalyxin B
0
Dihydrocordoin
0
Dihydrokanakugiol
0
Dihydropedicin
0
Flavokawain A
9
Flemingin F
0
Flemiwallichin B
0
Flemiwallichin D
0
Flemiwallichin E
0
Gemichalcone C
0
Glyinflanin E
0
Glypallichalcone
0
Hamilcone
0
Heliannone A
0
Helichrysetin
0
Helilandin B
0
Homobutein
0
Isocordoin
0
Isoliquiritigenin 4,4'-dimethyl ether
0
Isoxanthohumol B
0
Kanzonol B
0
Kanzonol C
0
Kukulkanin A
0
Kukulkanin B
0
Kurzichalcolactone
0
Kushenol D
0
LSM-4240
0
Licoagrochalcone B
0
Licoagrochalcone C
0
Licoagrochalcone D
0
Licochalcone A
56
Licochalcone B
761
Linderachalcone
0
Lonchocarpin
0
Methyllinderatin
0
Morachalcone A
0
Myrigalon B
0
Myrigalone E
0
Myrigalone G
0
Myrigalone H
0
N-[2-[2-[(E)-3-(2,3-Dimethoxyphenyl)prop-2-enoyl]-4,5-dimethoxyphenyl]ethyl]acetamide
0
N-[3-[3-(4-fluorophenyl)-1-oxoprop-2-enyl]phenyl]acetamide
0
N-[3-[3-(5-bromo-2-methoxyphenyl)-1-oxoprop-2-enyl]phenyl]propanamide
0
N-[4-[3-(2-methoxyphenyl)-1-oxoprop-2-enyl]phenyl]acetamide
0
Neoplathymenin
0
Neosakuranetin
0
Nubigenol
0
O-Methylpongamol
0
Oaxacacin
0
Orotinichalcone
0
Ovalitenin A
0
Paratocarpin B
0
Paratocarpin F
0
Paratocarpin G
0
Pinostrobin chalcone
0
Pongachalcone I
0
Pongagallone A
0
Pongagallone B
0
Prorepensin
0
Prosogerin B
0
Pseudosindorin
0
Rubone
0
Sophoradin
0
Spinochalcone A
0
Spinochalcone B
0
Spinochalcone C
0
Uvangoletin
0
Xanthoangelol C
0
Xanthoangelol D
0
Xanthohumol C
0
Xanthohumol E
0
[3-(2,5-dihydroxyphenyl)-3-oxo-1-phenylpropoxy]sulfonic acid
0
[4-[3-(4-iodophenyl)prop-2-enoyl]phenyl]boronic acid
0
\{3-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
\{4-[2,3-dioxo-3-(2,4,6-trihydroxy-3-methoxyphenyl)propyl]-2-hydroxy-6-methoxyphenyl\}oxidanesulfonic acid
0
\{4-[2,3-dioxo-3-(2,4,6-trihydroxyphenyl)propyl]phenyl\}oxidanesulfonic acid
0
\{4-[3-(2,5-dihydroxyphenyl)-3-oxopropyl]phenyl\}oxidanesulfonic acid
0
\{4-[3-oxo-3-(2,4,6-trihydroxyphenyl)prop-1-en-1-yl]phenyl\}oxidanesulfonic acid
0
\{6-hydroxy-3-[3-(3-hydroxyphenyl)-3-oxoprop-1-en-1-yl]-2-methoxyphenyl\}oxidanesulfonic acid
0
\{[4-(5-\{3-[2,4-dihydroxy-5-(3-methylbut-2-en-1-yl)phenyl]-2-hydroxy-3-oxopropyl\}-2-hydroxyphenyl)-2-methylbut-2-en-1-yl]oxy\}sulfonic acid
0
abyssinone A
0
abyssinone C
0
abyssinone D
0
abyssinone VI
0
alpha,4,2'-Trihydroxy-4-O-geranyldihydrochalcone
0
beta,2-Dihydroxy-4,6-dimethoxy-3-methylchalcone
0
butein
27
candidachalcone
0
chalcone +
115
demethoxyisogemichalcone C
0
desmethylxanthohumol
0
flavokawain B
19
flavokawain C
0
gemichalcone B
0
homoeriodictyol chalcone
0
isobavachalcone
5
isobutrin
0
isoliquiritigenin +
85
isoliquiritin
0
kuraridinol
0
mallotophilippen C
0
mallotophilippen D
0
mallotophilippen E +
0
naringin chalcone
0
obochalcolactone
0
okanin
3
oxygenated xanthohumol
0
phlorizin chalcone
4
pinocembrin chalcone
0
praecanson A
0
sappanchalcone
12
sofalcone
0
xanthogalenol
0
xanthohumol
86
xanthohumol B
0
xanthohumol D
0